Background  ||| S:24 E:43 ||| NNP
Metastasis  ||| S:43 E:54 ||| NNP
of  ||| S:54 E:57 ||| IN
tumor  ||| S:57 E:63 ||| NN
cells  ||| S:63 E:69 ||| NNS
is  ||| S:69 E:72 ||| VBZ
critically  ||| S:72 E:83 ||| RB
dependent  ||| S:83 E:93 ||| JJ
on  ||| S:93 E:96 ||| IN
the  ||| S:96 E:108 ||| DT
ability  ||| S:108 E:116 ||| NN
of  ||| S:116 E:119 ||| IN
cancer  ||| S:119 E:126 ||| NN
cells  ||| S:126 E:132 ||| NNS
to  ||| S:132 E:135 ||| TO
adhere  ||| S:135 E:142 ||| VB
and  ||| S:142 E:146 ||| CC
migrate ||| S:146 E:153 ||| NN
.  ||| S:153 E:155 ||| .
The  ||| S:155 E:159 ||| DT
cell  ||| S:159 E:172 ||| NN
surface  ||| S:172 E:180 ||| NN
expressed  ||| S:180 E:190 ||| VBD
integrins  ||| S:190 E:200 ||| NNS
can  ||| S:200 E:204 ||| MD
control  ||| S:204 E:212 ||| VB
this  ||| S:212 E:217 ||| DT
process  ||| S:217 E:225 ||| NN
by  ||| S:225 E:236 ||| IN
physically  ||| S:236 E:247 ||| JJ
interacting  ||| S:247 E:259 ||| NN
with  ||| S:259 E:264 ||| IN
the  ||| S:264 E:268 ||| DT
extracellular  ||| S:268 E:282 ||| JJ
matrix  ||| S:282 E:297 ||| JJ
proteins  ||| S:297 E:306 ||| NNS
and  ||| S:306 E:310 ||| CC
other  ||| S:310 E:316 ||| JJ
cell  ||| S:316 E:321 ||| NN
surface  ||| S:321 E:329 ||| NN
proteins  ||| S:329 E:338 ||| NNS
on  ||| S:338 E:341 ||| IN
endothelial  ||| S:341 E:361 ||| JJ
cells  ||| S:361 E:367 ||| NNS
lining  ||| S:367 E:374 ||| VBG
the  ||| S:374 E:378 ||| DT
blood  ||| S:378 E:384 ||| NN
vessel  ||| S:384 E:391 ||| NN
wall  ||| S:391 E:396 ||| NN
[  ||| S:396 E:398 ||| -LRB-
1  ||| S:398 E:400 ||| LS
]  ||| S:400 E:402 ||| -RRB-
.  ||| S:402 E:404 ||| .
These  ||| S:404 E:410 ||| DT
integrins  ||| S:410 E:428 ||| JJ
signal  ||| S:428 E:435 ||| NN
adhesion  ||| S:435 E:444 ||| NNS
and  ||| S:444 E:448 ||| CC
migration  ||| S:448 E:458 ||| NN
by  ||| S:458 E:461 ||| IN
communicating  ||| S:461 E:475 ||| NN
with  ||| S:475 E:480 ||| IN
several  ||| S:480 E:496 ||| JJ
tyrosine  ||| S:496 E:505 ||| JJ
kinases  ||| S:505 E:513 ||| NN
inside  ||| S:513 E:520 ||| IN
the  ||| S:520 E:524 ||| DT
cell ||| S:524 E:528 ||| NN
,  ||| S:528 E:530 ||| ,
including  ||| S:530 E:540 ||| VBG
the  ||| S:540 E:544 ||| DT
Focal  ||| S:544 E:558 ||| NNP
Adhesion  ||| S:558 E:567 ||| NNP
Kinase  ||| S:567 E:574 ||| NNP
( ||| S:574 E:575 ||| -LRB-
FAK ||| S:575 E:578 ||| NNP
)  ||| S:578 E:580 ||| -RRB-
and  ||| S:580 E:584 ||| CC
Src  ||| S:584 E:588 ||| NNP
family  ||| S:588 E:595 ||| NN
kinases  ||| S:595 E:603 ||| NNS
[  ||| S:603 E:605 ||| -LRB-
1  ||| S:605 E:607 ||| CD
2  ||| S:607 E:609 ||| CD
]  ||| S:609 E:611 ||| -RRB-
.  ||| S:611 E:613 ||| .
Src  ||| S:613 E:625 ||| JJ
kinases  ||| S:625 E:633 ||| NNS
control  ||| S:633 E:641 ||| VBP
the  ||| S:641 E:645 ||| DT
activation  ||| S:645 E:656 ||| NN
of  ||| S:656 E:659 ||| IN
FAK ||| S:659 E:662 ||| NNP
,  ||| S:662 E:664 ||| ,
as  ||| S:664 E:667 ||| RB
well  ||| S:667 E:672 ||| RB
as  ||| S:672 E:675 ||| IN
the  ||| S:675 E:687 ||| DT
tyrosine  ||| S:687 E:696 ||| JJ
phosphorylation  ||| S:696 E:712 ||| NN
of  ||| S:712 E:715 ||| IN
critical  ||| S:715 E:724 ||| JJ
substrates  ||| S:724 E:735 ||| NN
that  ||| S:735 E:748 ||| IN
regulate  ||| S:748 E:757 ||| JJ
adhesion  ||| S:757 E:766 ||| NN
and  ||| S:766 E:770 ||| CC
migration  ||| S:770 E:780 ||| NNS
[  ||| S:780 E:782 ||| -LRB-
3  ||| S:782 E:784 ||| LS
]  ||| S:784 E:786 ||| -RRB-
.  ||| S:786 E:788 ||| .
Indeed ||| S:788 E:794 ||| RB
,  ||| S:794 E:796 ||| ,
colon  ||| S:796 E:810 ||| NN
cancer  ||| S:810 E:817 ||| NN
cells  ||| S:817 E:823 ||| NNS
with  ||| S:823 E:828 ||| IN
high  ||| S:828 E:833 ||| JJ
metastatic  ||| S:833 E:844 ||| JJ
potential  ||| S:844 E:854 ||| NN
have  ||| S:854 E:859 ||| VBP
elevated  ||| S:859 E:876 ||| JJ
levels  ||| S:876 E:883 ||| NNS
of  ||| S:883 E:886 ||| IN
Src  ||| S:886 E:890 ||| NNP
activity  ||| S:890 E:899 ||| NN
or  ||| S:899 E:902 ||| CC
activating  ||| S:902 E:913 ||| JJ
mutations  ||| S:913 E:923 ||| NNS
in  ||| S:923 E:926 ||| IN
the  ||| S:926 E:930 ||| DT
Src  ||| S:930 E:942 ||| JJ
gene  ||| S:942 E:947 ||| NN
[  ||| S:947 E:949 ||| -LRB-
4  ||| S:949 E:951 ||| CD
5  ||| S:951 E:953 ||| CD
]  ||| S:953 E:955 ||| -RRB-
.  ||| S:955 E:957 ||| .
One  ||| S:957 E:961 ||| CD
Src  ||| S:961 E:965 ||| JJ
substrate  ||| S:965 E:975 ||| NN
that  ||| S:975 E:980 ||| WDT
is  ||| S:980 E:983 ||| VBZ
involved  ||| S:983 E:992 ||| VBN
in  ||| S:992 E:1003 ||| IN
regulating  ||| S:1003 E:1014 ||| VBG
an  ||| S:1014 E:1017 ||| DT
important  ||| S:1017 E:1027 ||| JJ
signaling  ||| S:1027 E:1037 ||| JJ
node  ||| S:1037 E:1042 ||| NN
in  ||| S:1042 E:1045 ||| IN
this  ||| S:1045 E:1050 ||| DT
process  ||| S:1050 E:1058 ||| NN
is  ||| S:1058 E:1069 ||| VBZ
the  ||| S:1069 E:1073 ||| DT
adaptor  ||| S:1073 E:1081 ||| FW
protein  ||| S:1081 E:1089 ||| FW
p130  ||| S:1089 E:1103 ||| FW
cas  ||| S:1103 E:1107 ||| FW
( ||| S:1107 E:1108 ||| -LRB-
Cas ||| S:1108 E:1111 ||| NNP
)  ||| S:1111 E:1113 ||| -RRB-
[  ||| S:1113 E:1115 ||| -LRB-
6  ||| S:1115 E:1117 ||| CD
7  ||| S:1117 E:1119 ||| CD
8  ||| S:1119 E:1121 ||| CD
9  ||| S:1121 E:1123 ||| CD
10  ||| S:1123 E:1126 ||| CD
]  ||| S:1126 E:1128 ||| -RRB-
.  ||| S:1128 E:1130 ||| .
Cas  ||| S:1130 E:1142 ||| NNP
appears  ||| S:1142 E:1150 ||| VBZ
to  ||| S:1150 E:1153 ||| TO
play  ||| S:1153 E:1158 ||| VB
a  ||| S:1158 E:1160 ||| DT
central  ||| S:1160 E:1168 ||| JJ
role  ||| S:1168 E:1173 ||| NN
in  ||| S:1173 E:1176 ||| IN
the  ||| S:1176 E:1180 ||| DT
transformation  ||| S:1180 E:1203 ||| NN
process  ||| S:1203 E:1211 ||| NN
by  ||| S:1211 E:1214 ||| IN
several  ||| S:1214 E:1222 ||| JJ
oncogenes  ||| S:1222 E:1232 ||| NNS
including  ||| S:1232 E:1242 ||| VBG
ras ||| S:1242 E:1245 ||| NN
,  ||| S:1245 E:1247 ||| ,
ornithine  ||| S:1247 E:1265 ||| FW
decarboxylase  ||| S:1265 E:1279 ||| FW
( ||| S:1279 E:1280 ||| -LRB-
ODC ||| S:1280 E:1283 ||| NNP
) ||| S:1283 E:1284 ||| -RRB-
,  ||| S:1284 E:1286 ||| ,
v-Src ||| S:1286 E:1291 ||| NNP
,  ||| S:1291 E:1293 ||| ,
v-crk ||| S:1293 E:1298 ||| NNP
,  ||| S:1298 E:1300 ||| ,
and  ||| S:1300 E:1304 ||| CC
Bcr-Abl ||| S:1304 E:1311 ||| JJ
,  ||| S:1311 E:1313 ||| ,
as  ||| S:1313 E:1316 ||| IN
these  ||| S:1316 E:1330 ||| DT
tumors  ||| S:1330 E:1337 ||| NNS
all  ||| S:1337 E:1341 ||| RB
have  ||| S:1341 E:1346 ||| VB
elevated  ||| S:1346 E:1355 ||| JJ
levels  ||| S:1355 E:1362 ||| NNS
of  ||| S:1362 E:1365 ||| IN
tyrosine  ||| S:1365 E:1374 ||| FW
phosphorylated  ||| S:1374 E:1397 ||| FW
Cas  ||| S:1397 E:1401 ||| FW
[  ||| S:1401 E:1403 ||| -LRB-
6  ||| S:1403 E:1405 ||| CD
11  ||| S:1405 E:1408 ||| CD
12  ||| S:1408 E:1411 ||| CD
13  ||| S:1411 E:1414 ||| CD
]  ||| S:1414 E:1416 ||| -RRB-
.  ||| S:1416 E:1418 ||| .
Cells  ||| S:1418 E:1424 ||| NNS
from  ||| S:1424 E:1429 ||| IN
mice  ||| S:1429 E:1434 ||| NNS
that  ||| S:1434 E:1439 ||| IN
lack  ||| S:1439 E:1444 ||| NN
Cas  ||| S:1444 E:1448 ||| NNS
have  ||| S:1448 E:1461 ||| VBP
much  ||| S:1461 E:1466 ||| RB
reduced  ||| S:1466 E:1474 ||| VBN
migration  ||| S:1474 E:1484 ||| NNS
and  ||| S:1484 E:1488 ||| CC
are  ||| S:1488 E:1492 ||| VBP
resistant  ||| S:1492 E:1502 ||| VBN
to  ||| S:1502 E:1505 ||| TO
transformation  ||| S:1505 E:1528 ||| VB
by  ||| S:1528 E:1531 ||| IN
v-Src ||| S:1531 E:1536 ||| NNP
,  ||| S:1536 E:1538 ||| ,
while  ||| S:1538 E:1544 ||| IN
expression  ||| S:1544 E:1555 ||| NN
of  ||| S:1555 E:1558 ||| IN
Cas  ||| S:1558 E:1562 ||| NNP
anti-sense  ||| S:1562 E:1573 ||| NNP
RNA  ||| S:1573 E:1577 ||| NNP
in  ||| S:1577 E:1580 ||| IN
cells  ||| S:1580 E:1594 ||| NNS
transformed  ||| S:1594 E:1606 ||| VBN
with  ||| S:1606 E:1611 ||| IN
ras ||| S:1611 E:1614 ||| NN
,  ||| S:1614 E:1616 ||| ,
v-Src  ||| S:1616 E:1622 ||| JJ
or  ||| S:1622 E:1625 ||| CC
ODC  ||| S:1625 E:1629 ||| NNP
result  ||| S:1629 E:1636 ||| NN
in  ||| S:1636 E:1639 ||| IN
reversion  ||| S:1639 E:1649 ||| NN
of  ||| S:1649 E:1660 ||| IN
the  ||| S:1660 E:1664 ||| DT
transformed  ||| S:1664 E:1676 ||| JJ
phenotype  ||| S:1676 E:1686 ||| NNS
[  ||| S:1686 E:1688 ||| -LRB-
11  ||| S:1688 E:1691 ||| CD
14  ||| S:1691 E:1694 ||| CD
15  ||| S:1694 E:1697 ||| CD
]  ||| S:1697 E:1699 ||| -RRB-
.  ||| S:1699 E:1701 ||| .
Furthermore ||| S:1701 E:1712 ||| RB
,  ||| S:1712 E:1722 ||| ,
increased  ||| S:1722 E:1732 ||| VBN
expression  ||| S:1732 E:1743 ||| NN
of  ||| S:1743 E:1746 ||| IN
Cas  ||| S:1746 E:1750 ||| NNP
can  ||| S:1750 E:1754 ||| MD
rescue  ||| S:1754 E:1761 ||| VB
cell  ||| S:1761 E:1766 ||| NN
migration  ||| S:1766 E:1776 ||| NNS
and  ||| S:1776 E:1788 ||| CC
adhesion  ||| S:1788 E:1797 ||| NN
in  ||| S:1797 E:1800 ||| IN
cells  ||| S:1800 E:1806 ||| NNS
expressing  ||| S:1806 E:1817 ||| VBG
the  ||| S:1817 E:1821 ||| DT
tumor  ||| S:1821 E:1827 ||| NN
suppressor  ||| S:1827 E:1838 ||| NN
PTEN ||| S:1838 E:1842 ||| NNP
,  ||| S:1842 E:1844 ||| ,
and  ||| S:1844 E:1856 ||| CC
can  ||| S:1856 E:1860 ||| MD
enhance  ||| S:1860 E:1868 ||| VB
cell  ||| S:1868 E:1873 ||| NN
migration  ||| S:1873 E:1883 ||| NNS
and  ||| S:1883 E:1887 ||| CC
adhesion  ||| S:1887 E:1896 ||| NN
in  ||| S:1896 E:1899 ||| IN
normal  ||| S:1899 E:1906 ||| JJ
cells ||| S:1906 E:1911 ||| NNS
,  ||| S:1911 E:1921 ||| ,
with  ||| S:1921 E:1926 ||| IN
a  ||| S:1926 E:1928 ||| DT
major  ||| S:1928 E:1934 ||| JJ
role  ||| S:1934 E:1939 ||| NN
being  ||| S:1939 E:1945 ||| VBG
played  ||| S:1945 E:1952 ||| VBN
by  ||| S:1952 E:1955 ||| IN
the  ||| S:1955 E:1959 ||| DT
substrate  ||| S:1959 E:1969 ||| JJ
domain  ||| S:1969 E:1976 ||| NN
[  ||| S:1976 E:1978 ||| -LRB-
16  ||| S:1978 E:1989 ||| CD
17  ||| S:1989 E:1992 ||| CD
]  ||| S:1992 E:1994 ||| -RRB-
.  ||| S:1994 E:2004 ||| .
Cas  ||| S:2004 E:2008 ||| NNP
is  ||| S:2008 E:2011 ||| VBZ
a  ||| S:2011 E:2013 ||| DT
protein  ||| S:2013 E:2021 ||| NN
which  ||| S:2021 E:2027 ||| WDT
migrates  ||| S:2027 E:2036 ||| VBZ
with  ||| S:2036 E:2041 ||| IN
an  ||| S:2041 E:2044 ||| DT
apparent  ||| S:2044 E:2053 ||| JJ
mass  ||| S:2053 E:2058 ||| NN
of  ||| S:2058 E:2069 ||| IN
approximately  ||| S:2069 E:2083 ||| RB
130  ||| S:2083 E:2087 ||| CD
kDa ||| S:2087 E:2090 ||| NN
,  ||| S:2090 E:2092 ||| ,
with  ||| S:2092 E:2097 ||| IN
a  ||| S:2097 E:2099 ||| DT
N-terminal  ||| S:2099 E:2110 ||| JJ
SH3  ||| S:2110 E:2114 ||| CD
domain ||| S:2114 E:2120 ||| NN
,  ||| S:2120 E:2122 ||| ,
a  ||| S:2122 E:2132 ||| DT
central  ||| S:2132 E:2140 ||| JJ
substrate  ||| S:2140 E:2150 ||| JJ
domain  ||| S:2150 E:2157 ||| NN
( ||| S:2157 E:2158 ||| -LRB-
SD ||| S:2158 E:2160 ||| NNP
)  ||| S:2160 E:2162 ||| -RRB-
with  ||| S:2162 E:2167 ||| IN
up  ||| S:2167 E:2170 ||| RB
to  ||| S:2170 E:2173 ||| TO
15  ||| S:2173 E:2176 ||| CD
tyrosines  ||| S:2176 E:2186 ||| NNS
which  ||| S:2186 E:2200 ||| WDT
can  ||| S:2200 E:2204 ||| MD
be  ||| S:2204 E:2207 ||| VB
phosphorylated ||| S:2207 E:2221 ||| NNS
,  ||| S:2221 E:2223 ||| ,
a  ||| S:2223 E:2225 ||| DT
C-terminal  ||| S:2225 E:2236 ||| JJ
region  ||| S:2236 E:2243 ||| NN
with  ||| S:2243 E:2248 ||| IN
a  ||| S:2248 E:2258 ||| DT
proline-rich  ||| S:2258 E:2271 ||| JJ
region ||| S:2271 E:2277 ||| NN
,  ||| S:2277 E:2279 ||| ,
and  ||| S:2279 E:2283 ||| CC
two  ||| S:2283 E:2287 ||| CD
tyrosine  ||| S:2287 E:2296 ||| CD
phosphorylation  ||| S:2296 E:2312 ||| CD
sites  ||| S:2312 E:2326 ||| NNS
capable  ||| S:2326 E:2334 ||| JJ
of  ||| S:2334 E:2337 ||| IN
binding  ||| S:2337 E:2345 ||| FW
Src  ||| S:2345 E:2349 ||| FW
kinases  ||| S:2349 E:2357 ||| FW
( ||| S:2357 E:2358 ||| -LRB-
Src  ||| S:2358 E:2362 ||| FW
binding  ||| S:2362 E:2370 ||| FW
domain  ||| S:2370 E:2377 ||| FW
( ||| S:2377 E:2378 ||| -LRB-
SBD ||| S:2378 E:2381 ||| NNP
) ||| S:2381 E:2382 ||| -RRB-
)  ||| S:2382 E:2384 ||| -RRB-
[  ||| S:2384 E:2394 ||| -LRB-
6  ||| S:2394 E:2396 ||| CD
18  ||| S:2396 E:2399 ||| CD
]  ||| S:2399 E:2401 ||| -RRB-
.  ||| S:2401 E:2403 ||| .
The  ||| S:2403 E:2407 ||| DT
latter  ||| S:2407 E:2414 ||| JJ
SBD  ||| S:2414 E:2418 ||| NNP
domain  ||| S:2418 E:2425 ||| NN
regulates  ||| S:2425 E:2435 ||| VBZ
the  ||| S:2435 E:2439 ||| DT
ability  ||| S:2439 E:2447 ||| NN
of  ||| S:2447 E:2450 ||| IN
Src  ||| S:2450 E:2462 ||| NNP
to  ||| S:2462 E:2465 ||| TO
activate  ||| S:2465 E:2474 ||| VB
the  ||| S:2474 E:2478 ||| DT
serum  ||| S:2478 E:2484 ||| JJ
response  ||| S:2484 E:2493 ||| NN
element ||| S:2493 E:2500 ||| NN
,  ||| S:2500 E:2502 ||| ,
as  ||| S:2502 E:2505 ||| RB
well  ||| S:2505 E:2510 ||| RB
as  ||| S:2510 E:2513 ||| RB
in  ||| S:2513 E:2516 ||| IN
the  ||| S:2516 E:2528 ||| DT
phosphorylation  ||| S:2528 E:2544 ||| NN
of  ||| S:2544 E:2547 ||| IN
the  ||| S:2547 E:2551 ||| DT
SD  ||| S:2551 E:2554 ||| NNP
of  ||| S:2554 E:2557 ||| IN
Cas  ||| S:2557 E:2561 ||| NNP
by  ||| S:2561 E:2564 ||| IN
Src  ||| S:2564 E:2568 ||| NNP
[  ||| S:2568 E:2570 ||| -LRB-
18  ||| S:2570 E:2573 ||| CD
19  ||| S:2573 E:2576 ||| CD
20  ||| S:2576 E:2579 ||| CD
]  ||| S:2579 E:2581 ||| -RRB-
.  ||| S:2581 E:2583 ||| .
The  ||| S:2583 E:2595 ||| DT
substrate  ||| S:2595 E:2605 ||| JJ
domain  ||| S:2605 E:2612 ||| NN
controls  ||| S:2612 E:2621 ||| VBZ
adhesion  ||| S:2621 E:2630 ||| VBN
and  ||| S:2630 E:2634 ||| CC
migration  ||| S:2634 E:2644 ||| NNS
and  ||| S:2644 E:2648 ||| CC
the  ||| S:2648 E:2660 ||| DT
majority  ||| S:2660 E:2669 ||| NN
of  ||| S:2669 E:2672 ||| IN
the  ||| S:2672 E:2676 ||| DT
tyrosines  ||| S:2676 E:2686 ||| NN
within  ||| S:2686 E:2693 ||| IN
this  ||| S:2693 E:2698 ||| DT
domain  ||| S:2698 E:2705 ||| NN
are  ||| S:2705 E:2709 ||| VBP
of  ||| S:2709 E:2712 ||| IN
the  ||| S:2712 E:2724 ||| DT
sequence  ||| S:2724 E:2733 ||| JJ
YQXP  ||| S:2733 E:2738 ||| NNP
( ||| S:2738 E:2739 ||| -LRB-
5 ||| S:2739 E:2740 ||| LS
)  ||| S:2740 E:2742 ||| -RRB-
or  ||| S:2742 E:2745 ||| CC
YDXP  ||| S:2745 E:2750 ||| NNP
( ||| S:2750 E:2751 ||| -LRB-
10 ||| S:2751 E:2753 ||| CD
) ||| S:2753 E:2754 ||| -RRB-
,  ||| S:2754 E:2756 ||| ,
which  ||| S:2756 E:2762 ||| WDT
when  ||| S:2762 E:2767 ||| WRB
phosphorylated ||| S:2767 E:2781 ||| NNS
,  ||| S:2781 E:2791 ||| ,
bind  ||| S:2791 E:2796 ||| NN
to  ||| S:2796 E:2799 ||| TO
the  ||| S:2799 E:2803 ||| DT
adaptors  ||| S:2803 E:2812 ||| JJ
c-crk ||| S:2812 E:2817 ||| NN
,  ||| S:2817 E:2819 ||| ,
nck  ||| S:2819 E:2823 ||| NN
and  ||| S:2823 E:2827 ||| CC
AND-34  ||| S:2827 E:2834 ||| NNP
[  ||| S:2834 E:2836 ||| -LRB-
16  ||| S:2836 E:2839 ||| CD
21  ||| S:2839 E:2842 ||| CD
22  ||| S:2842 E:2845 ||| CD
23  ||| S:2845 E:2848 ||| CD
]  ||| S:2848 E:2858 ||| -RRB-
.  ||| S:2858 E:2860 ||| .
The  ||| S:2860 E:2864 ||| DT
importance  ||| S:2864 E:2875 ||| NN
of  ||| S:2875 E:2878 ||| IN
these  ||| S:2878 E:2884 ||| DT
molecules  ||| S:2884 E:2894 ||| NN
in  ||| S:2894 E:2897 ||| IN
Cas  ||| S:2897 E:2901 ||| NNP
function  ||| S:2901 E:2910 ||| NN
is  ||| S:2910 E:2921 ||| VBZ
unclear ||| S:2921 E:2928 ||| JJ
,  ||| S:2928 E:2930 ||| ,
however  ||| S:2930 E:2938 ||| RB
c-crk  ||| S:2938 E:2944 ||| JJ
seems  ||| S:2944 E:2950 ||| VBZ
to  ||| S:2950 E:2953 ||| TO
be  ||| S:2953 E:2956 ||| VB
critical  ||| S:2956 E:2965 ||| JJ
in  ||| S:2965 E:2968 ||| IN
the  ||| S:2968 E:2980 ||| DT
regulation  ||| S:2980 E:2991 ||| NN
of  ||| S:2991 E:2994 ||| IN
adhesion  ||| S:2994 E:3003 ||| NN
and  ||| S:3003 E:3007 ||| CC
migration  ||| S:3007 E:3017 ||| JJ
mediated  ||| S:3017 E:3026 ||| NN
by  ||| S:3026 E:3029 ||| IN
Cas ||| S:3029 E:3032 ||| NNP
.  ||| S:3032 E:3034 ||| .
In  ||| S:3034 E:3045 ||| IN
addition ||| S:3045 E:3053 ||| NN
,  ||| S:3053 E:3055 ||| ,
the  ||| S:3055 E:3059 ||| DT
SH3  ||| S:3059 E:3063 ||| JJ
domain  ||| S:3063 E:3070 ||| NN
of  ||| S:3070 E:3073 ||| IN
Cas  ||| S:3073 E:3077 ||| NNP
mediates  ||| S:3077 E:3086 ||| VBD
an  ||| S:3086 E:3089 ||| DT
interaction  ||| S:3089 E:3109 ||| NN
with  ||| S:3109 E:3114 ||| IN
FAK ||| S:3114 E:3117 ||| NNP
,  ||| S:3117 E:3119 ||| ,
C3G ||| S:3119 E:3122 ||| NNP
,  ||| S:3122 E:3124 ||| ,
CMS ||| S:3124 E:3127 ||| NNP
,  ||| S:3127 E:3129 ||| ,
and  ||| S:3129 E:3133 ||| CC
the  ||| S:3133 E:3137 ||| DT
zinc  ||| S:3137 E:3142 ||| NN
finger  ||| S:3142 E:3149 ||| NN
containing  ||| S:3149 E:3160 ||| VBG
protein  ||| S:3160 E:3176 ||| NN
CIZ ||| S:3176 E:3179 ||| NNP
,  ||| S:3179 E:3181 ||| ,
while  ||| S:3181 E:3187 ||| IN
nephrocystin  ||| S:3187 E:3200 ||| JJ
interacts  ||| S:3200 E:3210 ||| NN
with  ||| S:3210 E:3215 ||| IN
Cas  ||| S:3215 E:3219 ||| NNP
via  ||| S:3219 E:3223 ||| IN
its  ||| S:3223 E:3227 ||| PRP$
SH3  ||| S:3227 E:3239 ||| JJ
domain  ||| S:3239 E:3246 ||| NN
and  ||| S:3246 E:3250 ||| CC
proline  ||| S:3250 E:3258 ||| JJ
rich  ||| S:3258 E:3263 ||| JJ
sequences  ||| S:3263 E:3273 ||| NN
in  ||| S:3273 E:3276 ||| IN
Cas  ||| S:3276 E:3280 ||| NNP
[  ||| S:3280 E:3282 ||| -LRB-
24  ||| S:3282 E:3285 ||| CD
25  ||| S:3285 E:3288 ||| CD
26  ||| S:3288 E:3291 ||| CD
27  ||| S:3291 E:3294 ||| CD
28  ||| S:3294 E:3305 ||| CD
29  ||| S:3305 E:3308 ||| CD
30  ||| S:3308 E:3311 ||| CD
]  ||| S:3311 E:3313 ||| -RRB-
.  ||| S:3313 E:3315 ||| .
The  ||| S:3315 E:3319 ||| DT
SH3  ||| S:3319 E:3323 ||| JJ
domain  ||| S:3323 E:3330 ||| NN
of  ||| S:3330 E:3333 ||| IN
Cas  ||| S:3333 E:3337 ||| NNP
can  ||| S:3337 E:3341 ||| MD
also  ||| S:3341 E:3346 ||| RB
interact  ||| S:3346 E:3355 ||| VBN
with  ||| S:3355 E:3360 ||| IN
the  ||| S:3360 E:3372 ||| DT
tyrosine  ||| S:3372 E:3381 ||| JJ
phosphatase  ||| S:3381 E:3393 ||| JJ
PTP1B ||| S:3393 E:3398 ||| NN
,  ||| S:3398 E:3400 ||| ,
and  ||| S:3400 E:3404 ||| CC
expression  ||| S:3404 E:3415 ||| NN
of  ||| S:3415 E:3418 ||| IN
PTP1B  ||| S:3418 E:3424 ||| CD
in  ||| S:3424 E:3435 ||| IN
transformed  ||| S:3435 E:3447 ||| JJ
cells  ||| S:3447 E:3453 ||| NNS
reverts  ||| S:3453 E:3461 ||| VBZ
the  ||| S:3461 E:3465 ||| DT
phenotype ||| S:3465 E:3474 ||| NN
,  ||| S:3474 E:3476 ||| ,
in  ||| S:3476 E:3479 ||| IN
part  ||| S:3479 E:3484 ||| NN
by  ||| S:3484 E:3495 ||| IN
dephosphorylating  ||| S:3495 E:3513 ||| JJ
Cas  ||| S:3513 E:3517 ||| NNP
[  ||| S:3517 E:3519 ||| -LRB-
31  ||| S:3519 E:3522 ||| CD
32  ||| S:3522 E:3525 ||| CD
]  ||| S:3525 E:3527 ||| -RRB-
.  ||| S:3527 E:3537 ||| .
Tyrosine  ||| S:3537 E:3546 ||| JJ
phosphorylation  ||| S:3546 E:3562 ||| NN
of  ||| S:3562 E:3565 ||| IN
Cas  ||| S:3565 E:3569 ||| NNP
is  ||| S:3569 E:3572 ||| VBZ
regulated  ||| S:3572 E:3582 ||| VBN
by  ||| S:3582 E:3593 ||| IN
adhesion ||| S:3593 E:3601 ||| NN
,  ||| S:3601 E:3603 ||| ,
such  ||| S:3603 E:3608 ||| PDT
that  ||| S:3608 E:3613 ||| DT
adherent  ||| S:3613 E:3622 ||| NN
and  ||| S:3622 E:3626 ||| CC
migrating  ||| S:3626 E:3636 ||| JJ
cells  ||| S:3636 E:3642 ||| NNS
have  ||| S:3642 E:3647 ||| VBP
high  ||| S:3647 E:3660 ||| JJ
levels  ||| S:3660 E:3667 ||| NNS
of  ||| S:3667 E:3670 ||| IN
tyrosine  ||| S:3670 E:3679 ||| JJ
phosphorylated  ||| S:3679 E:3694 ||| JJ
Cas ||| S:3694 E:3697 ||| NNP
,  ||| S:3697 E:3699 ||| ,
whereas  ||| S:3699 E:3707 ||| IN
cells  ||| S:3707 E:3713 ||| NNS
in  ||| S:3713 E:3724 ||| IN
suspension  ||| S:3724 E:3735 ||| NN
have  ||| S:3735 E:3740 ||| VBP
reduced  ||| S:3740 E:3748 ||| VBN
levels  ||| S:3748 E:3755 ||| NNS
of  ||| S:3755 E:3758 ||| IN
Cas  ||| S:3758 E:3762 ||| NNP
phosphorylation  ||| S:3762 E:3778 ||| NNS
[  ||| S:3778 E:3780 ||| -LRB-
10  ||| S:3780 E:3791 ||| CD
33  ||| S:3791 E:3794 ||| CD
]  ||| S:3794 E:3796 ||| -RRB-
.  ||| S:3796 E:3798 ||| .
In  ||| S:3798 E:3801 ||| IN
addition ||| S:3801 E:3809 ||| NN
,  ||| S:3809 E:3811 ||| ,
as  ||| S:3811 E:3814 ||| RB
mentioned  ||| S:3814 E:3824 ||| VBN
above ||| S:3824 E:3829 ||| IN
,  ||| S:3829 E:3831 ||| ,
transformed  ||| S:3831 E:3843 ||| VBN
cells  ||| S:3843 E:3857 ||| NNS
that  ||| S:3857 E:3862 ||| WDT
are  ||| S:3862 E:3866 ||| VBP
able  ||| S:3866 E:3871 ||| JJ
to  ||| S:3871 E:3874 ||| TO
grow  ||| S:3874 E:3879 ||| VB
in  ||| S:3879 E:3882 ||| IN
an  ||| S:3882 E:3885 ||| DT
anchorage  ||| S:3885 E:3895 ||| JJ
independent  ||| S:3895 E:3907 ||| JJ
manner  ||| S:3907 E:3922 ||| NN
show  ||| S:3922 E:3927 ||| NN
increased  ||| S:3927 E:3937 ||| VBD
tyrosine  ||| S:3937 E:3946 ||| JJ
phosphorylation  ||| S:3946 E:3962 ||| NN
of  ||| S:3962 E:3965 ||| IN
Cas  ||| S:3965 E:3969 ||| NNP
[  ||| S:3969 E:3971 ||| -LRB-
10  ||| S:3971 E:3974 ||| CD
33  ||| S:3974 E:3977 ||| CD
]  ||| S:3977 E:3979 ||| -RRB-
.  ||| S:3979 E:3989 ||| .
These  ||| S:3989 E:3995 ||| DT
data  ||| S:3995 E:4000 ||| NNS
suggest  ||| S:4000 E:4008 ||| VBP
that  ||| S:4008 E:4013 ||| IN
tyrosine  ||| S:4013 E:4022 ||| JJ
phosphorylation  ||| S:4022 E:4038 ||| NN
of  ||| S:4038 E:4041 ||| IN
Cas  ||| S:4041 E:4045 ||| NNP
in  ||| S:4045 E:4056 ||| IN
part  ||| S:4056 E:4061 ||| NN
regulates  ||| S:4061 E:4071 ||| VBZ
a  ||| S:4071 E:4073 ||| DT
switch  ||| S:4073 E:4080 ||| NN
from  ||| S:4080 E:4085 ||| IN
adhesion  ||| S:4085 E:4094 ||| JJ
dependent  ||| S:4094 E:4104 ||| JJ
growth  ||| S:4104 E:4111 ||| NN
to  ||| S:4111 E:4122 ||| TO
adhesion  ||| S:4122 E:4131 ||| VB
independent  ||| S:4131 E:4143 ||| JJ
growth ||| S:4143 E:4149 ||| NN
.  ||| S:4149 E:4151 ||| .
Whether  ||| S:4151 E:4159 ||| IN
mere  ||| S:4159 E:4164 ||| JJ
tyrosine  ||| S:4164 E:4181 ||| JJ
phosphorylation  ||| S:4181 E:4197 ||| NN
or  ||| S:4197 E:4200 ||| CC
localization  ||| S:4200 E:4213 ||| NN
of  ||| S:4213 E:4216 ||| IN
Cas  ||| S:4216 E:4220 ||| NNP
is  ||| S:4220 E:4223 ||| VBZ
more  ||| S:4223 E:4228 ||| RBR
important  ||| S:4228 E:4246 ||| JJ
for  ||| S:4246 E:4250 ||| IN
its  ||| S:4250 E:4254 ||| PRP$
regulation  ||| S:4254 E:4265 ||| NN
of  ||| S:4265 E:4268 ||| IN
adhesion  ||| S:4268 E:4277 ||| NN
and  ||| S:4277 E:4281 ||| CC
migration  ||| S:4281 E:4291 ||| NN
is  ||| S:4291 E:4294 ||| VBZ
unclear ||| S:4294 E:4301 ||| JJ
.  ||| S:4301 E:4311 ||| .
Tyrosine  ||| S:4311 E:4320 ||| JJ
phosphorylation  ||| S:4320 E:4336 ||| NN
of  ||| S:4336 E:4339 ||| IN
adaptor  ||| S:4339 E:4347 ||| JJ
molecules  ||| S:4347 E:4357 ||| NNS
such  ||| S:4357 E:4362 ||| JJ
as  ||| S:4362 E:4365 ||| IN
Cas  ||| S:4365 E:4377 ||| NNP
is  ||| S:4377 E:4380 ||| VBZ
dependent  ||| S:4380 E:4390 ||| JJ
on  ||| S:4390 E:4393 ||| IN
upstream  ||| S:4393 E:4402 ||| JJ
signals  ||| S:4402 E:4410 ||| NNS
that  ||| S:4410 E:4415 ||| WDT
lead  ||| S:4415 E:4420 ||| VBP
to  ||| S:4420 E:4423 ||| TO
the  ||| S:4423 E:4435 ||| DT
phosphorylation  ||| S:4435 E:4451 ||| NN
of  ||| S:4451 E:4454 ||| IN
the  ||| S:4454 E:4458 ||| DT
adaptor ||| S:4458 E:4465 ||| NN
,  ||| S:4465 E:4467 ||| ,
and  ||| S:4467 E:4471 ||| CC
with  ||| S:4471 E:4476 ||| IN
multiple  ||| S:4476 E:4485 ||| JJ
pathways  ||| S:4485 E:4502 ||| NNS
leading  ||| S:4502 E:4510 ||| VBG
from  ||| S:4510 E:4515 ||| IN
these  ||| S:4515 E:4521 ||| DT
upstream  ||| S:4521 E:4530 ||| JJ
signals  ||| S:4530 E:4538 ||| NNS
it  ||| S:4538 E:4541 ||| PRP
is  ||| S:4541 E:4544 ||| VBZ
difficult  ||| S:4544 E:4554 ||| JJ
to  ||| S:4554 E:4565 ||| TO
tease  ||| S:4565 E:4571 ||| VB
out  ||| S:4571 E:4575 ||| RP
the  ||| S:4575 E:4579 ||| DT
events  ||| S:4579 E:4586 ||| NNS
resulting  ||| S:4586 E:4596 ||| VBG
from  ||| S:4596 E:4601 ||| IN
the  ||| S:4601 E:4605 ||| DT
phosphorylated  ||| S:4605 E:4628 ||| NN
adaptor  ||| S:4628 E:4636 ||| VBD
itself ||| S:4636 E:4642 ||| PRP
.  ||| S:4642 E:4644 ||| .
We  ||| S:4644 E:4647 ||| PRP
have  ||| S:4647 E:4652 ||| VBP
tried  ||| S:4652 E:4658 ||| VBN
to  ||| S:4658 E:4661 ||| TO
address  ||| S:4661 E:4669 ||| VB
this  ||| S:4669 E:4674 ||| DT
problem  ||| S:4674 E:4682 ||| NN
by  ||| S:4682 E:4693 ||| IN
constructing  ||| S:4693 E:4706 ||| VBG
a  ||| S:4706 E:4708 ||| DT
chimeric  ||| S:4708 E:4717 ||| FW
Cas  ||| S:4717 E:4721 ||| FW
molecule  ||| S:4721 E:4730 ||| FW
( ||| S:4730 E:4731 ||| -LRB-
Src* ||| S:4731 E:4735 ||| NNP
/ ||| S:4735 E:4736 ||| NNP
Cas ||| S:4736 E:4739 ||| NNP
( ||| S:4739 E:4740 ||| -LRB-
SD ||| S:4740 E:4742 ||| NNP
) ||| S:4742 E:4743 ||| -RRB-
)  ||| S:4743 E:4745 ||| -RRB-
that  ||| S:4745 E:4750 ||| WDT
is  ||| S:4750 E:4761 ||| VBZ
phosphorylated  ||| S:4761 E:4776 ||| VBN
independently  ||| S:4776 E:4790 ||| RB
of  ||| S:4790 E:4793 ||| IN
upstream  ||| S:4793 E:4802 ||| JJ
signals  ||| S:4802 E:4810 ||| NNS
by  ||| S:4810 E:4813 ||| IN
fusing  ||| S:4813 E:4828 ||| VBG
the  ||| S:4828 E:4832 ||| DT
SD  ||| S:4832 E:4835 ||| NNP
of  ||| S:4835 E:4838 ||| IN
Cas  ||| S:4838 E:4842 ||| NNP
to  ||| S:4842 E:4845 ||| TO
a  ||| S:4845 E:4847 ||| DT
Src  ||| S:4847 E:4851 ||| JJ
kinase  ||| S:4851 E:4858 ||| JJ
domain  ||| S:4858 E:4865 ||| NN
that  ||| S:4865 E:4870 ||| WDT
had  ||| S:4870 E:4874 ||| VBD
been  ||| S:4874 E:4887 ||| VBN
attenuated  ||| S:4887 E:4898 ||| VBN
by  ||| S:4898 E:4901 ||| IN
mutating  ||| S:4901 E:4910 ||| VBG
the  ||| S:4910 E:4914 ||| DT
activation  ||| S:4914 E:4925 ||| JJ
tyrosine  ||| S:4925 E:4934 ||| NNS
( ||| S:4934 E:4935 ||| -LRB-
Y  ||| S:4935 E:4937 ||| NNP
416 ||| S:4937 E:4940 ||| CD
)  ||| S:4940 E:4942 ||| -RRB-
to  ||| S:4942 E:4953 ||| TO
phenylalanine ||| S:4953 E:4966 ||| VB
.  ||| S:4966 E:4968 ||| .
Such  ||| S:4968 E:4973 ||| PDT
a  ||| S:4973 E:4975 ||| DT
mutant  ||| S:4975 E:4982 ||| NN
is  ||| S:4982 E:4985 ||| VBZ
inactive  ||| S:4985 E:4994 ||| VBN
against  ||| S:4994 E:5002 ||| IN
exogenous  ||| S:5002 E:5020 ||| JJ
substrates  ||| S:5020 E:5031 ||| NNS
[  ||| S:5031 E:5033 ||| -LRB-
34  ||| S:5033 E:5036 ||| CD
35  ||| S:5036 E:5039 ||| CD
36  ||| S:5039 E:5042 ||| CD
]  ||| S:5042 E:5044 ||| -RRB-
.  ||| S:5044 E:5046 ||| .
We  ||| S:5046 E:5049 ||| PRP
found  ||| S:5049 E:5055 ||| VBD
that  ||| S:5055 E:5060 ||| IN
this  ||| S:5060 E:5065 ||| DT
Src* ||| S:5065 E:5069 ||| NNP
/ ||| S:5069 E:5070 ||| NNP
Cas ||| S:5070 E:5073 ||| NNP
( ||| S:5073 E:5074 ||| -LRB-
SD ||| S:5074 E:5076 ||| NNP
)  ||| S:5076 E:5086 ||| -RRB-
molecule  ||| S:5086 E:5095 ||| NN
is  ||| S:5095 E:5098 ||| VBZ
constitutively  ||| S:5098 E:5113 ||| JJ
tyrosine  ||| S:5113 E:5122 ||| JJ
phosphorylated  ||| S:5122 E:5137 ||| NN
when  ||| S:5137 E:5150 ||| WRB
expressed  ||| S:5150 E:5160 ||| VBD
either  ||| S:5160 E:5167 ||| DT
transiently  ||| S:5167 E:5179 ||| NN
or  ||| S:5179 E:5182 ||| CC
stably  ||| S:5182 E:5189 ||| NN
in  ||| S:5189 E:5192 ||| IN
cells ||| S:5192 E:5197 ||| NNS
,  ||| S:5197 E:5199 ||| ,
and  ||| S:5199 E:5203 ||| CC
acts  ||| S:5203 E:5216 ||| NNS
as  ||| S:5216 E:5219 ||| IN
a  ||| S:5219 E:5221 ||| DT
dominant  ||| S:5221 E:5230 ||| JJ
negative  ||| S:5230 E:5239 ||| JJ
mutant ||| S:5239 E:5245 ||| NN
,  ||| S:5245 E:5247 ||| ,
attenuating  ||| S:5247 E:5259 ||| JJ
v-crk  ||| S:5259 E:5265 ||| JJ
mediated  ||| S:5265 E:5282 ||| JJ
transformation  ||| S:5282 E:5297 ||| NN
when  ||| S:5297 E:5302 ||| WRB
expressed  ||| S:5302 E:5312 ||| VBN
in  ||| S:5312 E:5315 ||| IN
cells  ||| S:5315 E:5321 ||| NNS
transformed  ||| S:5321 E:5333 ||| VBN
by  ||| S:5333 E:5336 ||| IN
this  ||| S:5336 E:5349 ||| DT
oncogene ||| S:5349 E:5357 ||| NN
.  ||| S:5357 E:5359 ||| .
We  ||| S:5359 E:5362 ||| PRP
also  ||| S:5362 E:5367 ||| RB
observed  ||| S:5367 E:5376 ||| VBD
a  ||| S:5376 E:5378 ||| DT
reduction  ||| S:5378 E:5388 ||| NN
in  ||| S:5388 E:5391 ||| IN
basal  ||| S:5391 E:5397 ||| JJ
JNK  ||| S:5397 E:5409 ||| NNP
activity  ||| S:5409 E:5418 ||| NN
in  ||| S:5418 E:5421 ||| IN
normal  ||| S:5421 E:5428 ||| JJ
cells  ||| S:5428 E:5434 ||| NNS
expressing  ||| S:5434 E:5445 ||| VBG
this  ||| S:5445 E:5450 ||| DT
chimera  ||| S:5450 E:5458 ||| NN
and  ||| S:5458 E:5462 ||| CC
in  ||| S:5462 E:5473 ||| IN
v-crk  ||| S:5473 E:5479 ||| JJ
mediated  ||| S:5479 E:5488 ||| JJ
activation  ||| S:5488 E:5499 ||| NN
of  ||| S:5499 E:5502 ||| IN
JNK  ||| S:5502 E:5506 ||| NNP
in  ||| S:5506 E:5509 ||| IN
cell  ||| S:5509 E:5514 ||| NN
expressing  ||| S:5514 E:5525 ||| VBG
both  ||| S:5525 E:5538 ||| DT
v-crk  ||| S:5538 E:5544 ||| JJ
and  ||| S:5544 E:5548 ||| CC
the  ||| S:5548 E:5552 ||| DT
chimera ||| S:5552 E:5559 ||| NN
.  ||| S:5559 E:5561 ||| .
By  ||| S:5561 E:5564 ||| IN
contrast ||| S:5564 E:5572 ||| NN
,  ||| S:5572 E:5574 ||| ,
tyrosine  ||| S:5574 E:5591 ||| JJ
phosphorylation  ||| S:5591 E:5607 ||| NN
of  ||| S:5607 E:5610 ||| IN
endogenous  ||| S:5610 E:5621 ||| JJ
Cas  ||| S:5621 E:5625 ||| NNP
and  ||| S:5625 E:5629 ||| CC
FAK  ||| S:5629 E:5633 ||| NNP
was  ||| S:5633 E:5637 ||| VBD
unaffected  ||| S:5637 E:5648 ||| VBN
by  ||| S:5648 E:5659 ||| IN
the  ||| S:5659 E:5663 ||| DT
Cas  ||| S:5663 E:5667 ||| JJ
chimera ||| S:5667 E:5674 ||| NN
,  ||| S:5674 E:5676 ||| ,
indicating  ||| S:5676 E:5687 ||| VBG
that  ||| S:5687 E:5692 ||| IN
these  ||| S:5692 E:5698 ||| DT
processes  ||| S:5698 E:5708 ||| NNS
lie  ||| S:5708 E:5720 ||| VBP
upstream  ||| S:5720 E:5729 ||| RB
of  ||| S:5729 E:5732 ||| IN
the  ||| S:5732 E:5736 ||| DT
tyrosine  ||| S:5736 E:5745 ||| JJ
phosphorylated  ||| S:5745 E:5760 ||| JJ
Cas  ||| S:5760 E:5764 ||| NNP
SD ||| S:5764 E:5766 ||| NNP
.  ||| S:5766 E:5768 ||| .
Finally ||| S:5768 E:5775 ||| RB
,  ||| S:5775 E:5777 ||| ,
we  ||| S:5777 E:5788 ||| PRP
show  ||| S:5788 E:5793 ||| VBP
that  ||| S:5793 E:5798 ||| IN
this  ||| S:5798 E:5803 ||| DT
chimera  ||| S:5803 E:5811 ||| NN
can  ||| S:5811 E:5815 ||| MD
act  ||| S:5815 E:5819 ||| VB
as  ||| S:5819 E:5822 ||| IN
a  ||| S:5822 E:5824 ||| DT
decoy  ||| S:5824 E:5830 ||| NN
to  ||| S:5830 E:5833 ||| TO
selectively  ||| S:5833 E:5853 ||| RB
disrupt  ||| S:5853 E:5861 ||| VB
signaling  ||| S:5861 E:5871 ||| VBG
events  ||| S:5871 E:5878 ||| NNS
downstream  ||| S:5878 E:5889 ||| VBN
of  ||| S:5889 E:5892 ||| IN
the  ||| S:5892 E:5896 ||| DT
tyrosine  ||| S:5896 E:5913 ||| JJ
phosphorylated  ||| S:5913 E:5928 ||| JJ
SD  ||| S:5928 E:5931 ||| NN
of  ||| S:5931 E:5934 ||| IN
endogenous  ||| S:5934 E:5945 ||| JJ
Cas ||| S:5945 E:5948 ||| NNP
,  ||| S:5948 E:5950 ||| ,
acting  ||| S:5950 E:5957 ||| VBG
as  ||| S:5957 E:5960 ||| IN
a  ||| S:5960 E:5962 ||| DT
dominant  ||| S:5962 E:5979 ||| JJ
negative  ||| S:5979 E:5988 ||| JJ
mutant ||| S:5988 E:5994 ||| NN
.  ||| S:5994 E:5996 ||| .
We  ||| S:5996 E:5999 ||| PRP
suggest  ||| S:5999 E:6007 ||| VBP
that  ||| S:6007 E:6012 ||| IN
this  ||| S:6012 E:6017 ||| DT
approach  ||| S:6017 E:6026 ||| NN
and  ||| S:6026 E:6030 ||| CC
modified  ||| S:6030 E:6047 ||| JJ
versions  ||| S:6047 E:6056 ||| NNS
of  ||| S:6056 E:6059 ||| IN
this  ||| S:6059 E:6064 ||| DT
approach  ||| S:6064 E:6073 ||| NN
can  ||| S:6073 E:6077 ||| MD
be  ||| S:6077 E:6080 ||| VB
a  ||| S:6080 E:6082 ||| DT
general  ||| S:6082 E:6090 ||| JJ
method  ||| S:6090 E:6097 ||| NN
to  ||| S:6097 E:6108 ||| TO
determine  ||| S:6108 E:6118 ||| VB
the  ||| S:6118 E:6122 ||| DT
role  ||| S:6122 E:6127 ||| NN
of  ||| S:6127 E:6130 ||| IN
tyrosine  ||| S:6130 E:6139 ||| JJ
phosphorylated  ||| S:6139 E:6154 ||| JJ
domains  ||| S:6154 E:6170 ||| NN
without  ||| S:6170 E:6178 ||| IN
regard  ||| S:6178 E:6185 ||| NN
to  ||| S:6185 E:6188 ||| TO
upstream  ||| S:6188 E:6197 ||| VB
signals ||| S:6197 E:6204 ||| NNS
.  ||| S:6204 E:6228 ||| .
Results  ||| S:6228 E:6255 ||| NNS
Creation  ||| S:6255 E:6264 ||| NN
of  ||| S:6264 E:6267 ||| IN
a  ||| S:6267 E:6269 ||| DT
dominantly  ||| S:6269 E:6280 ||| FW
tyrosine  ||| S:6280 E:6289 ||| FW
phosphorylated  ||| S:6289 E:6314 ||| FW
Cas  ||| S:6314 E:6318 ||| FW
substrate  ||| S:6318 E:6328 ||| FW
domain  ||| S:6328 E:6345 ||| FW
The  ||| S:6345 E:6349 ||| DT
adaptor  ||| S:6349 E:6357 ||| JJ
protein  ||| S:6357 E:6365 ||| NN
Cas  ||| S:6365 E:6369 ||| NNP
has  ||| S:6369 E:6373 ||| VBZ
a  ||| S:6373 E:6375 ||| DT
N-terminal  ||| S:6375 E:6386 ||| JJ
SH3  ||| S:6386 E:6390 ||| CD
domain ||| S:6390 E:6396 ||| NN
,  ||| S:6396 E:6398 ||| ,
a  ||| S:6398 E:6410 ||| DT
large  ||| S:6410 E:6416 ||| JJ
number  ||| S:6416 E:6423 ||| NN
of  ||| S:6423 E:6426 ||| IN
tyrosines  ||| S:6426 E:6436 ||| NNS
that  ||| S:6436 E:6441 ||| WDT
serve  ||| S:6441 E:6447 ||| VBP
as  ||| S:6447 E:6450 ||| RB
potential  ||| S:6450 E:6460 ||| JJ
kinase  ||| S:6460 E:6477 ||| JJ
substrates  ||| S:6477 E:6488 ||| NN
within  ||| S:6488 E:6495 ||| IN
its  ||| S:6495 E:6499 ||| PRP$
substrate  ||| S:6499 E:6509 ||| JJ
domain  ||| S:6509 E:6516 ||| NN
and  ||| S:6516 E:6520 ||| CC
a  ||| S:6520 E:6522 ||| DT
C-terminal  ||| S:6522 E:6543 ||| JJ
Src  ||| S:6543 E:6547 ||| JJ
binding  ||| S:6547 E:6555 ||| JJ
domain  ||| S:6555 E:6562 ||| NN
( ||| S:6562 E:6563 ||| -LRB-
Fig.  ||| S:6563 E:6568 ||| CD
1 ||| S:6568 E:6569 ||| CD
) ||| S:6569 E:6570 ||| -RRB-
.  ||| S:6570 E:6572 ||| .
Understanding  ||| S:6572 E:6586 ||| VBG
the  ||| S:6586 E:6590 ||| DT
function  ||| S:6590 E:6609 ||| NN
of  ||| S:6609 E:6612 ||| IN
this  ||| S:6612 E:6617 ||| DT
substrate  ||| S:6617 E:6627 ||| JJ
domain  ||| S:6627 E:6634 ||| NN
and  ||| S:6634 E:6638 ||| CC
the  ||| S:6638 E:6642 ||| DT
tyrosines  ||| S:6642 E:6652 ||| NN
within  ||| S:6652 E:6659 ||| IN
it  ||| S:6659 E:6672 ||| PRP
could  ||| S:6672 E:6678 ||| MD
lead  ||| S:6678 E:6683 ||| VB
to  ||| S:6683 E:6686 ||| TO
a  ||| S:6686 E:6688 ||| DT
better  ||| S:6688 E:6695 ||| JJR
understanding  ||| S:6695 E:6709 ||| NN
of  ||| S:6709 E:6712 ||| IN
the  ||| S:6712 E:6716 ||| DT
signaling  ||| S:6716 E:6736 ||| JJ
pathways  ||| S:6736 E:6745 ||| NNS
regulated  ||| S:6745 E:6755 ||| VBN
by  ||| S:6755 E:6758 ||| IN
this  ||| S:6758 E:6763 ||| DT
protein ||| S:6763 E:6770 ||| NN
.  ||| S:6770 E:6772 ||| .
Previously ||| S:6772 E:6782 ||| RB
,  ||| S:6782 E:6794 ||| ,
investigators  ||| S:6794 E:6808 ||| NNS
have  ||| S:6808 E:6813 ||| VBP
created  ||| S:6813 E:6821 ||| VBN
dominant  ||| S:6821 E:6830 ||| JJ
negative  ||| S:6830 E:6839 ||| JJ
versions  ||| S:6839 E:6848 ||| NNS
of  ||| S:6848 E:6861 ||| IN
this  ||| S:6861 E:6866 ||| DT
protein  ||| S:6866 E:6874 ||| NN
lacking  ||| S:6874 E:6882 ||| VBG
its  ||| S:6882 E:6886 ||| PRP$
substrate  ||| S:6886 E:6896 ||| JJ
domain  ||| S:6896 E:6903 ||| NN
and  ||| S:6903 E:6907 ||| CC
shown  ||| S:6907 E:6913 ||| VBN
that  ||| S:6913 E:6928 ||| IN
it  ||| S:6928 E:6931 ||| PRP
is  ||| S:6931 E:6934 ||| VBZ
required  ||| S:6934 E:6943 ||| VBN
for  ||| S:6943 E:6947 ||| IN
cell  ||| S:6947 E:6952 ||| NN
adhesion  ||| S:6952 E:6961 ||| NNS
and  ||| S:6961 E:6965 ||| CC
migration ||| S:6965 E:6974 ||| NN
.  ||| S:6974 E:6976 ||| .
However ||| S:6976 E:6983 ||| RB
,  ||| S:6983 E:6995 ||| ,
these  ||| S:6995 E:7001 ||| DT
studies  ||| S:7001 E:7009 ||| NNS
depend  ||| S:7009 E:7016 ||| VBP
on  ||| S:7016 E:7019 ||| IN
upstream  ||| S:7019 E:7028 ||| JJ
signals  ||| S:7028 E:7036 ||| NNS
and  ||| S:7036 E:7040 ||| CC
so  ||| S:7040 E:7043 ||| RB
it  ||| S:7043 E:7046 ||| PRP
is  ||| S:7046 E:7049 ||| VBZ
not  ||| S:7049 E:7063 ||| RB
clear  ||| S:7063 E:7069 ||| VB
which  ||| S:7069 E:7075 ||| WDT
signals  ||| S:7075 E:7083 ||| NNS
are  ||| S:7083 E:7087 ||| VBP
directly  ||| S:7087 E:7096 ||| RB
emanating  ||| S:7096 E:7106 ||| VBN
from  ||| S:7106 E:7111 ||| IN
the  ||| S:7111 E:7125 ||| DT
substrate  ||| S:7125 E:7135 ||| JJ
domain  ||| S:7135 E:7142 ||| NN
itself ||| S:7142 E:7148 ||| PRP
,  ||| S:7148 E:7150 ||| ,
as  ||| S:7150 E:7153 ||| IN
this  ||| S:7153 E:7158 ||| DT
domain  ||| S:7158 E:7165 ||| NN
requires  ||| S:7165 E:7174 ||| VBZ
the  ||| S:7174 E:7188 ||| DT
activation  ||| S:7188 E:7199 ||| NN
of  ||| S:7199 E:7202 ||| IN
upstream  ||| S:7202 E:7211 ||| JJ
kinases  ||| S:7211 E:7219 ||| NN
for  ||| S:7219 E:7223 ||| IN
its  ||| S:7223 E:7227 ||| PRP$
phosphorylation  ||| S:7227 E:7253 ||| NN
and  ||| S:7253 E:7257 ||| CC
function ||| S:7257 E:7265 ||| NN
.  ||| S:7265 E:7267 ||| .
We  ||| S:7267 E:7270 ||| PRP
have  ||| S:7270 E:7275 ||| VBP
tried  ||| S:7275 E:7281 ||| VBN
to  ||| S:7281 E:7284 ||| TO
address  ||| S:7284 E:7292 ||| VB
this  ||| S:7292 E:7297 ||| DT
problem  ||| S:7297 E:7305 ||| NN
by  ||| S:7305 E:7318 ||| IN
attempting  ||| S:7318 E:7329 ||| VBG
to  ||| S:7329 E:7332 ||| TO
create  ||| S:7332 E:7339 ||| VB
a  ||| S:7339 E:7341 ||| DT
dominant  ||| S:7341 E:7350 ||| JJ
active  ||| S:7350 E:7357 ||| JJ
substrate  ||| S:7357 E:7367 ||| JJ
domain  ||| S:7367 E:7384 ||| NN
of  ||| S:7384 E:7387 ||| IN
Cas ||| S:7387 E:7390 ||| NNP
,  ||| S:7390 E:7392 ||| ,
i.e.  ||| S:7392 E:7397 ||| FW
a  ||| S:7397 E:7399 ||| FW
Cas  ||| S:7399 E:7403 ||| FW
substrate  ||| S:7403 E:7413 ||| FW
domain  ||| S:7413 E:7420 ||| NN
that  ||| S:7420 E:7425 ||| WDT
is  ||| S:7425 E:7438 ||| VBZ
constitutively  ||| S:7438 E:7453 ||| JJ
tyrosine  ||| S:7453 E:7462 ||| JJ
phosphorylated  ||| S:7462 E:7477 ||| NN
and  ||| S:7477 E:7481 ||| CC
able  ||| S:7481 E:7486 ||| JJ
to  ||| S:7486 E:7489 ||| TO
send  ||| S:7489 E:7504 ||| VB
signals  ||| S:7504 E:7512 ||| NNS
independently  ||| S:7512 E:7526 ||| RB
of  ||| S:7526 E:7529 ||| IN
upstream  ||| S:7529 E:7538 ||| JJ
signals ||| S:7538 E:7545 ||| NNS
.  ||| S:7545 E:7547 ||| .
We  ||| S:7547 E:7550 ||| PRP
did  ||| S:7550 E:7554 ||| VBD
this  ||| S:7554 E:7559 ||| DT
by  ||| S:7559 E:7572 ||| IN
fusing  ||| S:7572 E:7579 ||| VBG
the  ||| S:7579 E:7583 ||| DT
SD  ||| S:7583 E:7586 ||| NNP
of  ||| S:7586 E:7589 ||| IN
Cas  ||| S:7589 E:7593 ||| NNP
to  ||| S:7593 E:7596 ||| TO
a  ||| S:7596 E:7598 ||| DT
Src  ||| S:7598 E:7602 ||| JJ
kinase  ||| S:7602 E:7609 ||| JJ
domain  ||| S:7609 E:7616 ||| NN
that  ||| S:7616 E:7621 ||| WDT
had  ||| S:7621 E:7625 ||| VBD
been  ||| S:7625 E:7640 ||| VBN
attenuated  ||| S:7640 E:7651 ||| VBN
by  ||| S:7651 E:7654 ||| IN
mutating  ||| S:7654 E:7663 ||| VBG
the  ||| S:7663 E:7667 ||| DT
activation  ||| S:7667 E:7678 ||| JJ
tyrosine  ||| S:7678 E:7687 ||| NNS
( ||| S:7687 E:7688 ||| -LRB-
Y  ||| S:7688 E:7690 ||| NNP
416 ||| S:7690 E:7693 ||| CD
)  ||| S:7693 E:7695 ||| -RRB-
to  ||| S:7695 E:7708 ||| TO
phenylalanine  ||| S:7708 E:7722 ||| VB
( ||| S:7722 E:7723 ||| -LRB-
Src* ||| S:7723 E:7727 ||| NNP
/ ||| S:7727 E:7728 ||| NNP
Cas ||| S:7728 E:7731 ||| NNP
( ||| S:7731 E:7732 ||| -LRB-
SD ||| S:7732 E:7734 ||| NNP
) ||| S:7734 E:7735 ||| -RRB-
,  ||| S:7735 E:7737 ||| ,
Fig.  ||| S:7737 E:7742 ||| CD
2 ||| S:7742 E:7743 ||| CD
) ||| S:7743 E:7744 ||| -RRB-
.  ||| S:7744 E:7746 ||| .
This  ||| S:7746 E:7751 ||| DT
Src  ||| S:7751 E:7755 ||| JJ
mutant  ||| S:7755 E:7762 ||| NN
is  ||| S:7762 E:7775 ||| VBZ
inactive  ||| S:7775 E:7784 ||| VBN
against  ||| S:7784 E:7792 ||| IN
exogenous  ||| S:7792 E:7802 ||| JJ
substrates  ||| S:7802 E:7813 ||| NNS
[  ||| S:7813 E:7815 ||| -LRB-
34  ||| S:7815 E:7818 ||| CD
35  ||| S:7818 E:7821 ||| CD
36  ||| S:7821 E:7824 ||| CD
]  ||| S:7824 E:7826 ||| -RRB-
.  ||| S:7826 E:7828 ||| .
We  ||| S:7828 E:7841 ||| PRP
also  ||| S:7841 E:7846 ||| RB
generated  ||| S:7846 E:7856 ||| VBD
fusions  ||| S:7856 E:7864 ||| VBN
of  ||| S:7864 E:7867 ||| IN
the  ||| S:7867 E:7871 ||| DT
Cas  ||| S:7871 E:7875 ||| NNP
SD  ||| S:7875 E:7878 ||| NNP
with  ||| S:7878 E:7883 ||| IN
a  ||| S:7883 E:7885 ||| DT
Src  ||| S:7885 E:7889 ||| NNP
kinase  ||| S:7889 E:7906 ||| FW
inactive  ||| S:7906 E:7915 ||| FW
mutant  ||| S:7915 E:7922 ||| FW
( ||| S:7922 E:7923 ||| -LRB-
K295M ||| S:7923 E:7928 ||| NNP
)  ||| S:7928 E:7930 ||| -RRB-
that  ||| S:7930 E:7935 ||| WDT
has  ||| S:7935 E:7939 ||| VBZ
no  ||| S:7939 E:7942 ||| DT
enzymatic  ||| S:7942 E:7952 ||| JJ
activity  ||| S:7952 E:7971 ||| NN
( ||| S:7971 E:7972 ||| -LRB-
Src  ||| S:7972 E:7976 ||| NNP
KM ||| S:7976 E:7978 ||| NNP
/ ||| S:7978 E:7979 ||| NNP
Cas ||| S:7979 E:7982 ||| NNP
( ||| S:7982 E:7983 ||| -LRB-
SD ||| S:7983 E:7985 ||| NNP
) ||| S:7985 E:7986 ||| -RRB-
) ||| S:7986 E:7987 ||| -RRB-
,  ||| S:7987 E:7989 ||| ,
fusions  ||| S:7989 E:7997 ||| VBG
of  ||| S:7997 E:8000 ||| IN
either  ||| S:8000 E:8007 ||| RB
the  ||| S:8007 E:8011 ||| DT
attenuated  ||| S:8011 E:8022 ||| JJ
kinase  ||| S:8022 E:8039 ||| JJ
domain  ||| S:8039 E:8046 ||| NN
or  ||| S:8046 E:8049 ||| CC
kinase  ||| S:8049 E:8056 ||| JJ
inactive  ||| S:8056 E:8065 ||| JJ
domain  ||| S:8065 E:8072 ||| NN
to  ||| S:8072 E:8075 ||| TO
the  ||| S:8075 E:8079 ||| DT
5 ||| S:8079 E:8080 ||| CD
'  ||| S:8080 E:8082 ||| ''
or  ||| S:8082 E:8085 ||| CC
3 ||| S:8085 E:8086 ||| CD
'  ||| S:8086 E:8088 ||| POS
regions  ||| S:8088 E:8106 ||| NNS
of  ||| S:8106 E:8109 ||| IN
the  ||| S:8109 E:8113 ||| DT
Cas  ||| S:8113 E:8117 ||| NNP
SD  ||| S:8117 E:8120 ||| NNP
( ||| S:8120 E:8121 ||| -LRB-
Src* ||| S:8121 E:8125 ||| NNP
/ ||| S:8125 E:8126 ||| NNP
Cas ||| S:8126 E:8129 ||| NNP
( ||| S:8129 E:8130 ||| -LRB-
5 ||| S:8130 E:8131 ||| CD
' ||| S:8131 E:8132 ||| POS
SD ||| S:8132 E:8134 ||| NNP
) ||| S:8134 E:8135 ||| -RRB-
,  ||| S:8135 E:8137 ||| ,
Src* ||| S:8137 E:8141 ||| NNP
/ ||| S:8141 E:8142 ||| NNP
Cas ||| S:8142 E:8145 ||| NNP
( ||| S:8145 E:8146 ||| -LRB-
3 ||| S:8146 E:8147 ||| LS
' ||| S:8147 E:8148 ||| :
SD ||| S:8148 E:8150 ||| NNP
) ||| S:8150 E:8151 ||| -RRB-
,  ||| S:8151 E:8153 ||| ,
Src  ||| S:8153 E:8167 ||| NNP
KM ||| S:8167 E:8169 ||| NNP
/ ||| S:8169 E:8170 ||| NNP
Cas ||| S:8170 E:8173 ||| NNP
( ||| S:8173 E:8174 ||| -LRB-
5 ||| S:8174 E:8175 ||| CD
' ||| S:8175 E:8176 ||| POS
SD ||| S:8176 E:8178 ||| NNP
) ||| S:8178 E:8179 ||| -RRB-
,  ||| S:8179 E:8181 ||| ,
Src  ||| S:8181 E:8185 ||| NNP
KM ||| S:8185 E:8187 ||| NNP
/ ||| S:8187 E:8188 ||| NNP
Cas ||| S:8188 E:8191 ||| NNP
( ||| S:8191 E:8192 ||| -LRB-
3 ||| S:8192 E:8193 ||| LS
' ||| S:8193 E:8194 ||| :
SD ||| S:8194 E:8196 ||| NNP
) ||| S:8196 E:8197 ||| -RRB-
) ||| S:8197 E:8198 ||| -RRB-
,  ||| S:8198 E:8200 ||| ,
as  ||| S:8200 E:8203 ||| RB
well  ||| S:8203 E:8208 ||| RB
as  ||| S:8208 E:8211 ||| IN
the  ||| S:8211 E:8225 ||| DT
attenuated  ||| S:8225 E:8236 ||| FW
Src  ||| S:8236 E:8240 ||| FW
kinase  ||| S:8240 E:8247 ||| FW
( ||| S:8247 E:8248 ||| -LRB-
Src* ||| S:8248 E:8252 ||| NNP
)  ||| S:8252 E:8254 ||| -RRB-
alone  ||| S:8254 E:8260 ||| RB
without  ||| S:8260 E:8268 ||| IN
the  ||| S:8268 E:8272 ||| DT
attached  ||| S:8272 E:8291 ||| VBN
Cas  ||| S:8291 E:8295 ||| NNP
SD  ||| S:8295 E:8298 ||| NNP
( ||| S:8298 E:8299 ||| -LRB-
Fig.  ||| S:8299 E:8304 ||| CD
2 ||| S:8304 E:8305 ||| CD
) ||| S:8305 E:8306 ||| -RRB-
.  ||| S:8306 E:8308 ||| .
Transient  ||| S:8308 E:8318 ||| JJ
expression  ||| S:8318 E:8329 ||| NN
of  ||| S:8329 E:8332 ||| IN
the  ||| S:8332 E:8336 ||| DT
Src* ||| S:8336 E:8340 ||| NNP
/ ||| S:8340 E:8341 ||| NNP
Cas ||| S:8341 E:8344 ||| NNP
( ||| S:8344 E:8345 ||| -LRB-
SD ||| S:8345 E:8347 ||| NNP
)  ||| S:8347 E:8359 ||| -RRB-
in  ||| S:8359 E:8362 ||| IN
Cos-7  ||| S:8362 E:8368 ||| CD
cells  ||| S:8368 E:8374 ||| NNS
followed  ||| S:8374 E:8383 ||| VBN
by  ||| S:8383 E:8386 ||| IN
analysis  ||| S:8386 E:8395 ||| NN
of  ||| S:8395 E:8398 ||| IN
total  ||| S:8398 E:8404 ||| JJ
cell  ||| S:8404 E:8409 ||| NN
lysates  ||| S:8409 E:8427 ||| VBZ
using  ||| S:8427 E:8433 ||| VBG
anti-phosphotyrosine  ||| S:8433 E:8454 ||| JJ
antibodies  ||| S:8454 E:8465 ||| NNS
demonstrated  ||| S:8465 E:8478 ||| VBN
that  ||| S:8478 E:8493 ||| IN
while  ||| S:8493 E:8499 ||| IN
the  ||| S:8499 E:8503 ||| DT
attenuated  ||| S:8503 E:8514 ||| JJ
Src  ||| S:8514 E:8518 ||| JJ
kinase  ||| S:8518 E:8525 ||| JJ
domain  ||| S:8525 E:8532 ||| NN
alone  ||| S:8532 E:8538 ||| RB
did  ||| S:8538 E:8542 ||| VBD
not  ||| S:8542 E:8556 ||| RB
increase  ||| S:8556 E:8565 ||| VB
total  ||| S:8565 E:8571 ||| JJ
cellular  ||| S:8571 E:8580 ||| JJ
tyrosine  ||| S:8580 E:8589 ||| JJ
phosphorylated  ||| S:8589 E:8604 ||| JJ
proteins  ||| S:8604 E:8623 ||| NNS
as  ||| S:8623 E:8626 ||| RB
expected ||| S:8626 E:8634 ||| VBN
,  ||| S:8634 E:8636 ||| ,
expression  ||| S:8636 E:8647 ||| NN
of  ||| S:8647 E:8650 ||| IN
the  ||| S:8650 E:8654 ||| DT
Src* ||| S:8654 E:8658 ||| NNP
/ ||| S:8658 E:8659 ||| NNP
Cas ||| S:8659 E:8662 ||| NNP
( ||| S:8662 E:8663 ||| -LRB-
SD ||| S:8663 E:8665 ||| NNP
)  ||| S:8665 E:8667 ||| -RRB-
fusion  ||| S:8667 E:8684 ||| NN
resulted  ||| S:8684 E:8693 ||| VBD
in  ||| S:8693 E:8696 ||| IN
tyrosine  ||| S:8696 E:8705 ||| JJ
phosphorylation  ||| S:8705 E:8721 ||| NN
of  ||| S:8721 E:8724 ||| IN
a  ||| S:8724 E:8726 ||| DT
protein  ||| S:8726 E:8734 ||| NN
of  ||| S:8734 E:8737 ||| IN
the  ||| S:8737 E:8751 ||| DT
expected  ||| S:8751 E:8760 ||| JJ
size  ||| S:8760 E:8765 ||| NN
of  ||| S:8765 E:8768 ||| IN
the  ||| S:8768 E:8772 ||| DT
chimera ||| S:8772 E:8779 ||| NN
,  ||| S:8779 E:8781 ||| ,
as  ||| S:8781 E:8784 ||| RB
well  ||| S:8784 E:8789 ||| RB
as  ||| S:8789 E:8792 ||| IN
other  ||| S:8792 E:8798 ||| JJ
proteins  ||| S:8798 E:8817 ||| NNS
( ||| S:8817 E:8818 ||| -LRB-
Fig.  ||| S:8818 E:8823 ||| NNP
3a ||| S:8823 E:8825 ||| NNP
,  ||| S:8825 E:8827 ||| ,
3b ||| S:8827 E:8829 ||| CD
) ||| S:8829 E:8830 ||| -RRB-
.  ||| S:8830 E:8832 ||| .
Expression  ||| S:8832 E:8843 ||| NN
of  ||| S:8843 E:8846 ||| IN
the  ||| S:8846 E:8850 ||| DT
Cas ||| S:8850 E:8853 ||| NNP
( ||| S:8853 E:8854 ||| -LRB-
SD ||| S:8854 E:8856 ||| NNP
)  ||| S:8856 E:8858 ||| -RRB-
or  ||| S:8858 E:8861 ||| CC
the  ||| S:8861 E:8865 ||| DT
Src  ||| S:8865 E:8879 ||| NNP
KM ||| S:8879 E:8881 ||| NNP
/ ||| S:8881 E:8882 ||| NNP
Cas ||| S:8882 E:8885 ||| NNP
( ||| S:8885 E:8886 ||| -LRB-
SD ||| S:8886 E:8888 ||| NNP
) ||| S:8888 E:8889 ||| -RRB-
,  ||| S:8889 E:8891 ||| ,
fusion  ||| S:8891 E:8898 ||| NN
did  ||| S:8898 E:8902 ||| VBD
not  ||| S:8902 E:8906 ||| RB
result  ||| S:8906 E:8913 ||| VB
in  ||| S:8913 E:8916 ||| IN
any  ||| S:8916 E:8920 ||| DT
increase  ||| S:8920 E:8929 ||| NN
in  ||| S:8929 E:8942 ||| IN
total  ||| S:8942 E:8948 ||| JJ
phosphotyrosine  ||| S:8948 E:8964 ||| NNS
containing  ||| S:8964 E:8975 ||| VBG
proteins  ||| S:8975 E:8984 ||| NNS
nor  ||| S:8984 E:8988 ||| CC
in  ||| S:8988 E:8991 ||| IN
the  ||| S:8991 E:9005 ||| DT
tyrosine  ||| S:9005 E:9014 ||| JJ
phosphorylation  ||| S:9014 E:9030 ||| NN
of  ||| S:9030 E:9033 ||| IN
the  ||| S:9033 E:9037 ||| DT
Cas  ||| S:9037 E:9041 ||| NNP
SD  ||| S:9041 E:9044 ||| NNP
( ||| S:9044 E:9045 ||| -LRB-
data  ||| S:9045 E:9050 ||| NNS
not  ||| S:9050 E:9054 ||| RB
shown  ||| S:9054 E:9070 ||| VBN
and  ||| S:9070 E:9074 ||| CC
see  ||| S:9074 E:9078 ||| VB
Fig.  ||| S:9078 E:9083 ||| CD
4 ||| S:9083 E:9084 ||| CD
) ||| S:9084 E:9085 ||| -RRB-
.  ||| S:9085 E:9115 ||| .
The  ||| S:9115 E:9119 ||| DT
C-terminus  ||| S:9119 E:9130 ||| JJ
of  ||| S:9130 E:9133 ||| IN
the  ||| S:9133 E:9137 ||| DT
Cas  ||| S:9137 E:9141 ||| NNP
SD  ||| S:9141 E:9144 ||| NNP
is  ||| S:9144 E:9147 ||| VBZ
involved  ||| S:9147 E:9156 ||| VBN
in  ||| S:9156 E:9159 ||| IN
the  ||| S:9159 E:9173 ||| DT
interaction  ||| S:9173 E:9185 ||| NN
with  ||| S:9185 E:9190 ||| IN
v-crk  ||| S:9190 E:9206 ||| JJ
Investigators  ||| S:9206 E:9220 ||| NNS
have  ||| S:9220 E:9225 ||| VBP
shown  ||| S:9225 E:9231 ||| VBN
that  ||| S:9231 E:9236 ||| IN
v-crk  ||| S:9236 E:9242 ||| JJ
interacts  ||| S:9242 E:9252 ||| NN
via  ||| S:9252 E:9256 ||| IN
its  ||| S:9256 E:9270 ||| PRP$
SH2  ||| S:9270 E:9274 ||| JJ
domain  ||| S:9274 E:9281 ||| NN
with  ||| S:9281 E:9286 ||| IN
the  ||| S:9286 E:9290 ||| DT
substrate  ||| S:9290 E:9300 ||| JJ
domain  ||| S:9300 E:9307 ||| NN
of  ||| S:9307 E:9310 ||| IN
Cas  ||| S:9310 E:9314 ||| NNP
[  ||| S:9314 E:9316 ||| -LRB-
6  ||| S:9316 E:9318 ||| CD
]  ||| S:9318 E:9320 ||| -RRB-
.  ||| S:9320 E:9332 ||| .
Association  ||| S:9332 E:9344 ||| NNP
of  ||| S:9344 E:9347 ||| IN
v-crk  ||| S:9347 E:9353 ||| JJ
with  ||| S:9353 E:9358 ||| IN
endogenous  ||| S:9358 E:9369 ||| JJ
Cas  ||| S:9369 E:9373 ||| NNP
is  ||| S:9373 E:9376 ||| VBZ
believed  ||| S:9376 E:9385 ||| VBN
to  ||| S:9385 E:9398 ||| TO
protect  ||| S:9398 E:9406 ||| VB
the  ||| S:9406 E:9410 ||| DT
phosphorylation  ||| S:9410 E:9426 ||| JJ
status  ||| S:9426 E:9433 ||| NN
of  ||| S:9433 E:9436 ||| IN
this  ||| S:9436 E:9441 ||| DT
molecule  ||| S:9441 E:9450 ||| JJ
due  ||| S:9450 E:9464 ||| JJ
to  ||| S:9464 E:9467 ||| TO
protection  ||| S:9467 E:9478 ||| NN
from  ||| S:9478 E:9483 ||| IN
phosphatases  ||| S:9483 E:9496 ||| NNS
[  ||| S:9496 E:9498 ||| -LRB-
12  ||| S:9498 E:9501 ||| CD
]  ||| S:9501 E:9503 ||| -RRB-
.  ||| S:9503 E:9505 ||| .
Expression  ||| S:9505 E:9516 ||| NN
of  ||| S:9516 E:9519 ||| IN
an  ||| S:9519 E:9532 ||| DT
unphosphorylated  ||| S:9532 E:9549 ||| JJ
Cas  ||| S:9549 E:9553 ||| NNP
SD  ||| S:9553 E:9556 ||| NNP
along  ||| S:9556 E:9562 ||| RB
with  ||| S:9562 E:9567 ||| IN
v-crk  ||| S:9567 E:9573 ||| NNP
should  ||| S:9573 E:9580 ||| MD
therefore  ||| S:9580 E:9600 ||| RB
result  ||| S:9600 E:9607 ||| VB
in  ||| S:9607 E:9610 ||| IN
stable  ||| S:9610 E:9617 ||| JJ
tyrosine  ||| S:9617 E:9626 ||| JJ
phosphorylation  ||| S:9626 E:9642 ||| NN
of  ||| S:9642 E:9645 ||| IN
the  ||| S:9645 E:9649 ||| DT
Cas  ||| S:9649 E:9653 ||| NNP
SD  ||| S:9653 E:9666 ||| NNP
if  ||| S:9666 E:9669 ||| IN
they  ||| S:9669 E:9674 ||| PRP
interact ||| S:9674 E:9682 ||| VBD
.  ||| S:9682 E:9684 ||| .
The  ||| S:9684 E:9688 ||| DT
Cas  ||| S:9688 E:9692 ||| NNP
SD  ||| S:9692 E:9695 ||| NNP
has  ||| S:9695 E:9699 ||| VBZ
two  ||| S:9699 E:9703 ||| CD
sets  ||| S:9703 E:9708 ||| NNS
of  ||| S:9708 E:9711 ||| IN
potential  ||| S:9711 E:9731 ||| JJ
SH2  ||| S:9731 E:9735 ||| FW
interacting  ||| S:9735 E:9747 ||| FW
tyrosines ||| S:9747 E:9756 ||| FW
,  ||| S:9756 E:9758 ||| ,
the  ||| S:9758 E:9762 ||| DT
N-terminal  ||| S:9762 E:9773 ||| JJ
subdomain  ||| S:9773 E:9793 ||| NNS
containing  ||| S:9793 E:9804 ||| VBG
4  ||| S:9804 E:9806 ||| CD
YQXP  ||| S:9806 E:9811 ||| NNS
motifs  ||| S:9811 E:9818 ||| VBP
located  ||| S:9818 E:9826 ||| VBN
between  ||| S:9826 E:9834 ||| IN
a.a ||| S:9834 E:9837 ||| CD
.  ||| S:9837 E:9839 ||| .
L  ||| S:9839 E:9841 ||| NNP
157to  ||| S:9841 E:9847 ||| NNP
A  ||| S:9847 E:9859 ||| NNP
324and  ||| S:9859 E:9866 ||| CD
the  ||| S:9866 E:9870 ||| DT
C-terminal  ||| S:9870 E:9881 ||| JJ
subdomain  ||| S:9881 E:9891 ||| JJ
containing ||| S:9891 E:9901 ||| NN
,  ||| S:9901 E:9903 ||| ,
9  ||| S:9903 E:9905 ||| CD
YDXP  ||| S:9905 E:9910 ||| NNS
motifs  ||| S:9910 E:9927 ||| VBP
located  ||| S:9927 E:9935 ||| VBN
between  ||| S:9935 E:9943 ||| IN
a.a ||| S:9943 E:9946 ||| CD
.  ||| S:9946 E:9948 ||| .
S  ||| S:9948 E:9950 ||| NNP
325to  ||| S:9950 E:9956 ||| NNP
R  ||| S:9956 E:9958 ||| NNP
516 ||| S:9958 E:9961 ||| CD
.  ||| S:9961 E:9963 ||| .
The  ||| S:9963 E:9967 ||| DT
v-crk  ||| S:9967 E:9973 ||| JJ
SH2  ||| S:9973 E:9977 ||| CD
domain  ||| S:9977 E:9994 ||| NN
interacts  ||| S:9994 E:10004 ||| NN
with  ||| S:10004 E:10009 ||| IN
YXXP  ||| S:10009 E:10014 ||| NNP
motifs  ||| S:10014 E:10021 ||| NNS
upon  ||| S:10021 E:10026 ||| IN
phosphorylation ||| S:10026 E:10041 ||| NN
,  ||| S:10041 E:10053 ||| ,
suggesting  ||| S:10053 E:10064 ||| VBG
that  ||| S:10064 E:10069 ||| IN
both  ||| S:10069 E:10074 ||| DT
of  ||| S:10074 E:10077 ||| IN
these  ||| S:10077 E:10083 ||| DT
regions  ||| S:10083 E:10091 ||| NNS
may  ||| S:10091 E:10095 ||| MD
be  ||| S:10095 E:10098 ||| VB
able  ||| S:10098 E:10103 ||| JJ
to  ||| S:10103 E:10116 ||| TO
interact  ||| S:10116 E:10125 ||| VB
with  ||| S:10125 E:10130 ||| IN
v-crk  ||| S:10130 E:10136 ||| NNP
[  ||| S:10136 E:10138 ||| -LRB-
37  ||| S:10138 E:10141 ||| CD
]  ||| S:10141 E:10143 ||| -RRB-
.  ||| S:10143 E:10145 ||| .
Fusions  ||| S:10145 E:10153 ||| NNP
of  ||| S:10153 E:10156 ||| IN
the  ||| S:10156 E:10160 ||| DT
kinase  ||| S:10160 E:10177 ||| FW
inactive  ||| S:10177 E:10186 ||| FW
Src  ||| S:10186 E:10190 ||| FW
kinase  ||| S:10190 E:10197 ||| FW
domain  ||| S:10197 E:10204 ||| FW
and  ||| S:10204 E:10208 ||| CC
either  ||| S:10208 E:10215 ||| RB
the  ||| S:10215 E:10219 ||| DT
full  ||| S:10219 E:10224 ||| JJ
Cas  ||| S:10224 E:10228 ||| NNP
SD ||| S:10228 E:10230 ||| NNP
,  ||| S:10230 E:10242 ||| ,
the  ||| S:10242 E:10246 ||| DT
5 ||| S:10246 E:10247 ||| CD
'  ||| S:10247 E:10249 ||| POS
region  ||| S:10249 E:10256 ||| NN
of  ||| S:10256 E:10259 ||| IN
the  ||| S:10259 E:10263 ||| DT
Cas  ||| S:10263 E:10267 ||| NNP
SD  ||| S:10267 E:10270 ||| NNP
( ||| S:10270 E:10271 ||| -LRB-
Cas ||| S:10271 E:10274 ||| NNP
( ||| S:10274 E:10275 ||| -LRB-
5 ||| S:10275 E:10276 ||| CD
' ||| S:10276 E:10277 ||| POS
SD ||| S:10277 E:10279 ||| NNP
) ||| S:10279 E:10280 ||| -RRB-
,  ||| S:10280 E:10282 ||| ,
containing  ||| S:10282 E:10293 ||| VBG
4  ||| S:10293 E:10295 ||| CD
YQXP  ||| S:10295 E:10310 ||| NN
motifs ||| S:10310 E:10316 ||| NNS
)  ||| S:10316 E:10318 ||| -RRB-
or  ||| S:10318 E:10321 ||| CC
the  ||| S:10321 E:10325 ||| DT
3 ||| S:10325 E:10326 ||| CD
'  ||| S:10326 E:10328 ||| ''
of  ||| S:10328 E:10331 ||| IN
the  ||| S:10331 E:10335 ||| DT
Cas  ||| S:10335 E:10339 ||| NNP
SD  ||| S:10339 E:10342 ||| NNP
( ||| S:10342 E:10343 ||| -LRB-
Cas ||| S:10343 E:10346 ||| NNP
( ||| S:10346 E:10347 ||| -LRB-
3 ||| S:10347 E:10348 ||| LS
' ||| S:10348 E:10349 ||| :
SD ||| S:10349 E:10351 ||| NNP
) ||| S:10351 E:10352 ||| -RRB-
,  ||| S:10352 E:10354 ||| ,
containing  ||| S:10354 E:10365 ||| VBG
9  ||| S:10365 E:10377 ||| CD
YDXP  ||| S:10377 E:10382 ||| NN
motifs ||| S:10382 E:10388 ||| NNS
) ||| S:10388 E:10389 ||| -RRB-
,  ||| S:10389 E:10391 ||| ,
are  ||| S:10391 E:10395 ||| VBP
not  ||| S:10395 E:10399 ||| RB
stably  ||| S:10399 E:10406 ||| JJ
tyrosine  ||| S:10406 E:10415 ||| JJ
phosphorylated  ||| S:10415 E:10430 ||| NN
when  ||| S:10430 E:10445 ||| WRB
expressed  ||| S:10445 E:10455 ||| VBD
alone  ||| S:10455 E:10461 ||| RB
in  ||| S:10461 E:10464 ||| IN
cells  ||| S:10464 E:10470 ||| NNS
( ||| S:10470 E:10471 ||| -LRB-
data  ||| S:10471 E:10476 ||| NNS
not  ||| S:10476 E:10480 ||| RB
shown  ||| S:10480 E:10486 ||| VBN
and  ||| S:10486 E:10490 ||| CC
see  ||| S:10490 E:10494 ||| VB
Fig.  ||| S:10494 E:10509 ||| CD
4b ||| S:10509 E:10511 ||| CD
) ||| S:10511 E:10512 ||| -RRB-
.  ||| S:10512 E:10514 ||| .
We  ||| S:10514 E:10517 ||| PRP
therefore  ||| S:10517 E:10527 ||| RB
used  ||| S:10527 E:10532 ||| VBN
these  ||| S:10532 E:10538 ||| DT
fusions  ||| S:10538 E:10546 ||| NN
to  ||| S:10546 E:10549 ||| TO
determine  ||| S:10549 E:10559 ||| VB
which  ||| S:10559 E:10575 ||| WDT
region  ||| S:10575 E:10582 ||| NN
of  ||| S:10582 E:10585 ||| IN
the  ||| S:10585 E:10589 ||| DT
Cas  ||| S:10589 E:10593 ||| NNP
SD  ||| S:10593 E:10596 ||| NNP
interacts  ||| S:10596 E:10606 ||| NN
with  ||| S:10606 E:10611 ||| IN
v-crk ||| S:10611 E:10616 ||| JJ
.  ||| S:10616 E:10618 ||| .
Initially ||| S:10618 E:10627 ||| RB
,  ||| S:10627 E:10629 ||| ,
we  ||| S:10629 E:10642 ||| PRP
expressed  ||| S:10642 E:10652 ||| VBD
the  ||| S:10652 E:10656 ||| DT
Src  ||| S:10656 E:10660 ||| NNP
KM ||| S:10660 E:10662 ||| NNP
/ ||| S:10662 E:10663 ||| NNP
Cas ||| S:10663 E:10666 ||| NNP
( ||| S:10666 E:10667 ||| -LRB-
SD ||| S:10667 E:10669 ||| NNP
)  ||| S:10669 E:10671 ||| -RRB-
( ||| S:10671 E:10672 ||| -LRB-
entire  ||| S:10672 E:10679 ||| JJ
Cas  ||| S:10679 E:10683 ||| NNP
SD ||| S:10683 E:10685 ||| NNP
)  ||| S:10685 E:10687 ||| -RRB-
in  ||| S:10687 E:10690 ||| IN
Cos-7  ||| S:10690 E:10706 ||| CD
cells  ||| S:10706 E:10712 ||| NNS
alone ||| S:10712 E:10717 ||| RB
,  ||| S:10717 E:10719 ||| ,
or  ||| S:10719 E:10722 ||| CC
along  ||| S:10722 E:10728 ||| RB
with  ||| S:10728 E:10733 ||| IN
wild  ||| S:10733 E:10738 ||| JJ
type  ||| S:10738 E:10743 ||| NN
( ||| S:10743 E:10744 ||| -LRB-
WT ||| S:10744 E:10746 ||| NNP
)  ||| S:10746 E:10748 ||| -RRB-
v-crk ||| S:10748 E:10753 ||| NNP
,  ||| S:10753 E:10755 ||| ,
or  ||| S:10755 E:10758 ||| CC
v-crk  ||| S:10758 E:10774 ||| NNP
SH2  ||| S:10774 E:10778 ||| NNP
or  ||| S:10778 E:10781 ||| CC
SH3  ||| S:10781 E:10785 ||| CD
mutants  ||| S:10785 E:10793 ||| NNS
and  ||| S:10793 E:10797 ||| CC
assayed  ||| S:10797 E:10805 ||| NN
for  ||| S:10805 E:10809 ||| IN
tyrosine  ||| S:10809 E:10828 ||| JJ
phosphorylation  ||| S:10828 E:10844 ||| NN
and  ||| S:10844 E:10848 ||| CC
association  ||| S:10848 E:10860 ||| NN
by  ||| S:10860 E:10863 ||| IN
co-immunoprecipitation  ||| S:10863 E:10896 ||| NNP
( ||| S:10896 E:10897 ||| -LRB-
Fig.  ||| S:10897 E:10902 ||| NNP
4a ||| S:10902 E:10904 ||| NNP
) ||| S:10904 E:10905 ||| -RRB-
.  ||| S:10905 E:10907 ||| .
Figure  ||| S:10907 E:10914 ||| NN
4ademonstrates  ||| S:10914 E:10929 ||| NN
that  ||| S:10929 E:10934 ||| IN
while  ||| S:10934 E:10940 ||| IN
the  ||| S:10940 E:10944 ||| DT
chimera  ||| S:10944 E:10962 ||| NN
was  ||| S:10962 E:10966 ||| VBD
not  ||| S:10966 E:10970 ||| RB
stably  ||| S:10970 E:10977 ||| JJ
tyrosine  ||| S:10977 E:10986 ||| JJ
phosphorylated  ||| S:10986 E:11001 ||| NN
when  ||| S:11001 E:11006 ||| WRB
expressed  ||| S:11006 E:11026 ||| VBD
alone ||| S:11026 E:11031 ||| RB
,  ||| S:11031 E:11033 ||| ,
expression  ||| S:11033 E:11044 ||| NN
of  ||| S:11044 E:11047 ||| IN
the  ||| S:11047 E:11051 ||| DT
Src  ||| S:11051 E:11055 ||| NNP
KM ||| S:11055 E:11057 ||| NNP
/ ||| S:11057 E:11058 ||| NNP
Cas ||| S:11058 E:11061 ||| NNP
( ||| S:11061 E:11062 ||| -LRB-
SD ||| S:11062 E:11064 ||| NNP
)  ||| S:11064 E:11066 ||| -RRB-
chimera  ||| S:11066 E:11074 ||| VBD
along  ||| S:11074 E:11090 ||| RP
with  ||| S:11090 E:11095 ||| IN
either  ||| S:11095 E:11102 ||| DT
WT  ||| S:11102 E:11105 ||| NNP
or  ||| S:11105 E:11108 ||| CC
an  ||| S:11108 E:11111 ||| DT
SH3  ||| S:11111 E:11115 ||| JJ
domain  ||| S:11115 E:11122 ||| NN
mutant  ||| S:11122 E:11129 ||| NN
of  ||| S:11129 E:11132 ||| IN
v-crk  ||| S:11132 E:11138 ||| NNP
resulted  ||| S:11138 E:11157 ||| VBD
in  ||| S:11157 E:11160 ||| IN
its  ||| S:11160 E:11164 ||| PRP$
stable  ||| S:11164 E:11171 ||| JJ
tyrosine  ||| S:11171 E:11180 ||| JJ
phosphorylation  ||| S:11180 E:11196 ||| NN
and  ||| S:11196 E:11210 ||| CC
co-immunoprecipitation  ||| S:11210 E:11233 ||| JJ
with  ||| S:11233 E:11238 ||| IN
v-crk  ||| S:11238 E:11244 ||| NNP
( ||| S:11244 E:11245 ||| -LRB-
Fig.  ||| S:11245 E:11250 ||| NNP
4a ||| S:11250 E:11252 ||| NNP
,  ||| S:11252 E:11254 ||| ,
lanes  ||| S:11254 E:11260 ||| CD
2  ||| S:11260 E:11262 ||| CD
&  ||| S:11262 E:11274 ||| CC
4 ||| S:11274 E:11275 ||| LS
) ||| S:11275 E:11276 ||| -RRB-
.  ||| S:11276 E:11278 ||| .
However ||| S:11278 E:11285 ||| RB
,  ||| S:11285 E:11287 ||| ,
co-expression  ||| S:11287 E:11301 ||| JJ
of  ||| S:11301 E:11304 ||| IN
the  ||| S:11304 E:11308 ||| DT
Src  ||| S:11308 E:11312 ||| NNP
KM ||| S:11312 E:11314 ||| NNP
/ ||| S:11314 E:11315 ||| NNP
Cas ||| S:11315 E:11318 ||| NNP
( ||| S:11318 E:11319 ||| -LRB-
SD ||| S:11319 E:11321 ||| NNP
)  ||| S:11321 E:11323 ||| -RRB-
chimera  ||| S:11323 E:11341 ||| VBD
along  ||| S:11341 E:11347 ||| RP
with  ||| S:11347 E:11352 ||| IN
a  ||| S:11352 E:11354 ||| DT
SH2  ||| S:11354 E:11358 ||| JJ
mutant  ||| S:11358 E:11365 ||| NN
of  ||| S:11365 E:11368 ||| IN
v-crk  ||| S:11368 E:11374 ||| JJ
demonstrated  ||| S:11374 E:11387 ||| NN
that  ||| S:11387 E:11392 ||| IN
an  ||| S:11392 E:11405 ||| DT
intact  ||| S:11405 E:11412 ||| JJ
v-crk  ||| S:11412 E:11418 ||| JJ
SH2  ||| S:11418 E:11422 ||| CD
domain  ||| S:11422 E:11429 ||| NN
is  ||| S:11429 E:11432 ||| VBZ
required  ||| S:11432 E:11441 ||| VBN
for  ||| S:11441 E:11445 ||| IN
association  ||| S:11445 E:11457 ||| NN
with  ||| S:11457 E:11472 ||| IN
the  ||| S:11472 E:11476 ||| DT
tyrosine  ||| S:11476 E:11485 ||| FW
phosphorylated  ||| S:11485 E:11500 ||| FW
Src  ||| S:11500 E:11504 ||| FW
KM ||| S:11504 E:11506 ||| FW
/ ||| S:11506 E:11507 ||| FW
Cas ||| S:11507 E:11510 ||| FW
( ||| S:11510 E:11511 ||| -LRB-
SD ||| S:11511 E:11513 ||| NNP
)  ||| S:11513 E:11515 ||| -RRB-
( ||| S:11515 E:11516 ||| -LRB-
Fig.  ||| S:11516 E:11521 ||| NNP
4a ||| S:11521 E:11523 ||| NNP
,  ||| S:11523 E:11525 ||| ,
lane  ||| S:11525 E:11540 ||| CD
3 ||| S:11540 E:11541 ||| CD
) ||| S:11541 E:11542 ||| -RRB-
.  ||| S:11542 E:11544 ||| .
These  ||| S:11544 E:11550 ||| DT
data  ||| S:11550 E:11555 ||| NNS
suggest  ||| S:11555 E:11563 ||| VBP
that  ||| S:11563 E:11568 ||| IN
the  ||| S:11568 E:11572 ||| DT
kinase  ||| S:11572 E:11579 ||| JJ
inactive  ||| S:11579 E:11588 ||| JJ
fusion  ||| S:11588 E:11605 ||| NN
with  ||| S:11605 E:11610 ||| IN
the  ||| S:11610 E:11614 ||| DT
Cas  ||| S:11614 E:11618 ||| NNP
SD  ||| S:11618 E:11621 ||| NNP
is  ||| S:11621 E:11624 ||| VBZ
either  ||| S:11624 E:11631 ||| DT
transiently  ||| S:11631 E:11643 ||| JJ
tyrosine  ||| S:11643 E:11662 ||| JJ
phosphorylated  ||| S:11662 E:11677 ||| NN
in  ||| S:11677 E:11680 ||| IN
cells  ||| S:11680 E:11686 ||| NNS
and  ||| S:11686 E:11690 ||| CC
v-crk  ||| S:11690 E:11696 ||| NNP
protects  ||| S:11696 E:11705 ||| VBZ
them  ||| S:11705 E:11710 ||| PRP
from  ||| S:11710 E:11725 ||| IN
being  ||| S:11725 E:11731 ||| VBG
dephosphorylated  ||| S:11731 E:11748 ||| NN
by  ||| S:11748 E:11751 ||| IN
interacting  ||| S:11751 E:11763 ||| NN
with  ||| S:11763 E:11768 ||| IN
them  ||| S:11768 E:11773 ||| PRP
via  ||| S:11773 E:11777 ||| IN
its  ||| S:11777 E:11791 ||| PRP$
SH2  ||| S:11791 E:11795 ||| JJ
domain ||| S:11795 E:11801 ||| NN
,  ||| S:11801 E:11803 ||| ,
or  ||| S:11803 E:11806 ||| CC
alternatively ||| S:11806 E:11819 ||| RB
,  ||| S:11819 E:11821 ||| ,
that  ||| S:11821 E:11826 ||| IN
v-crk  ||| S:11826 E:11832 ||| NNP
induces  ||| S:11832 E:11840 ||| VBZ
their  ||| S:11840 E:11856 ||| PRP$
tyrosine  ||| S:11856 E:11865 ||| JJ
phosphorylation ||| S:11865 E:11880 ||| NN
.  ||| S:11880 E:11892 ||| .
We  ||| S:11892 E:11895 ||| PRP
then  ||| S:11895 E:11900 ||| RB
used  ||| S:11900 E:11905 ||| VBN
the  ||| S:11905 E:11909 ||| DT
5 ||| S:11909 E:11910 ||| CD
'  ||| S:11910 E:11912 ||| ''
and  ||| S:11912 E:11916 ||| CC
3 ||| S:11916 E:11917 ||| CD
'  ||| S:11917 E:11919 ||| POS
fusions  ||| S:11919 E:11927 ||| NN
of  ||| S:11927 E:11930 ||| IN
the  ||| S:11930 E:11934 ||| DT
Cas  ||| S:11934 E:11938 ||| NNP
SD  ||| S:11938 E:11941 ||| NNP
to  ||| S:11941 E:11954 ||| TO
determine  ||| S:11954 E:11964 ||| VB
which  ||| S:11964 E:11970 ||| WDT
motif ||| S:11970 E:11975 ||| VBZ
,  ||| S:11975 E:11977 ||| ,
YQXP  ||| S:11977 E:11982 ||| NNP
or  ||| S:11982 E:11985 ||| CC
YDXP ||| S:11985 E:11989 ||| NNP
,  ||| S:11989 E:11991 ||| ,
interacts  ||| S:11991 E:12001 ||| VBG
with  ||| S:12001 E:12006 ||| IN
the  ||| S:12006 E:12020 ||| DT
v-crk  ||| S:12020 E:12026 ||| JJ
SH2  ||| S:12026 E:12030 ||| CD
domain ||| S:12030 E:12036 ||| NN
.  ||| S:12036 E:12038 ||| .
Expression  ||| S:12038 E:12049 ||| NN
of  ||| S:12049 E:12052 ||| IN
the  ||| S:12052 E:12056 ||| DT
Src  ||| S:12056 E:12060 ||| JJ
KMfused  ||| S:12060 E:12068 ||| JJ
to  ||| S:12068 E:12071 ||| TO
the  ||| S:12071 E:12085 ||| DT
full  ||| S:12085 E:12090 ||| JJ
length  ||| S:12090 E:12097 ||| NN
Cas  ||| S:12097 E:12101 ||| NNP
SD ||| S:12101 E:12103 ||| NNP
,  ||| S:12103 E:12105 ||| ,
5 ||| S:12105 E:12106 ||| CD
'  ||| S:12106 E:12108 ||| POS
N-terminal  ||| S:12108 E:12119 ||| JJ
YQXP  ||| S:12119 E:12124 ||| NN
motifs  ||| S:12124 E:12131 ||| NNS
or  ||| S:12131 E:12134 ||| CC
3 ||| S:12134 E:12135 ||| CD
'  ||| S:12135 E:12147 ||| POS
C-terminal  ||| S:12147 E:12158 ||| JJ
YDXP  ||| S:12158 E:12163 ||| NN
motifs  ||| S:12163 E:12170 ||| NNS
alone  ||| S:12170 E:12176 ||| RB
demonstrated  ||| S:12176 E:12189 ||| VBN
that  ||| S:12189 E:12194 ||| IN
these  ||| S:12194 E:12210 ||| DT
fusions  ||| S:12210 E:12218 ||| NN
were  ||| S:12218 E:12223 ||| VBD
not  ||| S:12223 E:12227 ||| RB
stably  ||| S:12227 E:12234 ||| JJ
tyrosine  ||| S:12234 E:12243 ||| JJ
phosphorylated  ||| S:12243 E:12258 ||| NN
in  ||| S:12258 E:12261 ||| IN
cells  ||| S:12261 E:12277 ||| NNS
( ||| S:12277 E:12278 ||| -LRB-
Fig.  ||| S:12278 E:12283 ||| NNP
4b ||| S:12283 E:12285 ||| NNP
,  ||| S:12285 E:12287 ||| ,
lanes  ||| S:12287 E:12293 ||| CD
1-3 ||| S:12293 E:12296 ||| CD
) ||| S:12296 E:12297 ||| -RRB-
,  ||| S:12297 E:12299 ||| ,
although  ||| S:12299 E:12308 ||| IN
they  ||| S:12308 E:12313 ||| PRP
can  ||| S:12313 E:12317 ||| MD
be  ||| S:12317 E:12320 ||| VB
stably  ||| S:12320 E:12337 ||| JJ
tyrosine  ||| S:12337 E:12346 ||| JJ
phosphorylated  ||| S:12346 E:12361 ||| NN
when  ||| S:12361 E:12366 ||| WRB
fused  ||| S:12366 E:12372 ||| JJ
to  ||| S:12372 E:12375 ||| TO
the  ||| S:12375 E:12379 ||| DT
attenuated  ||| S:12379 E:12390 ||| FW
Src  ||| S:12390 E:12404 ||| FW
kinase  ||| S:12404 E:12411 ||| FW
domain  ||| S:12411 E:12418 ||| FW
( ||| S:12418 E:12419 ||| -LRB-
data  ||| S:12419 E:12424 ||| NNS
not  ||| S:12424 E:12428 ||| RB
shown  ||| S:12428 E:12434 ||| VBN
and  ||| S:12434 E:12438 ||| CC
see  ||| S:12438 E:12442 ||| VB
Fig.  ||| S:12442 E:12447 ||| CD
7a ||| S:12447 E:12449 ||| CD
) ||| S:12449 E:12450 ||| -RRB-
.  ||| S:12450 E:12452 ||| .
By  ||| S:12452 E:12465 ||| IN
contrast ||| S:12465 E:12473 ||| NN
,  ||| S:12473 E:12475 ||| ,
co-expression  ||| S:12475 E:12489 ||| JJ
of  ||| S:12489 E:12492 ||| IN
these  ||| S:12492 E:12498 ||| DT
fusions  ||| S:12498 E:12506 ||| NN
along  ||| S:12506 E:12512 ||| IN
with  ||| S:12512 E:12517 ||| IN
v-crk  ||| S:12517 E:12533 ||| JJ
results  ||| S:12533 E:12541 ||| NNS
in  ||| S:12541 E:12544 ||| IN
stable  ||| S:12544 E:12551 ||| JJ
tyrosine  ||| S:12551 E:12560 ||| JJ
phosphorylation  ||| S:12560 E:12576 ||| NN
of  ||| S:12576 E:12579 ||| IN
the  ||| S:12579 E:12583 ||| DT
3 ||| S:12583 E:12584 ||| CD
'  ||| S:12584 E:12596 ||| POS
C-terminal  ||| S:12596 E:12607 ||| JJ
YDXP  ||| S:12607 E:12612 ||| NN
motifs  ||| S:12612 E:12619 ||| NNS
and  ||| S:12619 E:12623 ||| CC
the  ||| S:12623 E:12627 ||| DT
full  ||| S:12627 E:12632 ||| JJ
length  ||| S:12632 E:12639 ||| NN
Cas  ||| S:12639 E:12643 ||| NNP
SD  ||| S:12643 E:12656 ||| NNP
( ||| S:12656 E:12657 ||| -LRB-
carrying  ||| S:12657 E:12666 ||| VBG
both  ||| S:12666 E:12671 ||| DT
motifs ||| S:12671 E:12677 ||| NN
) ||| S:12677 E:12678 ||| -RRB-
,  ||| S:12678 E:12680 ||| ,
but  ||| S:12680 E:12684 ||| CC
not  ||| S:12684 E:12688 ||| RB
the  ||| S:12688 E:12692 ||| DT
5 ||| S:12692 E:12693 ||| CD
'  ||| S:12693 E:12695 ||| POS
N-terminal  ||| S:12695 E:12706 ||| JJ
YQXP  ||| S:12706 E:12721 ||| NN
motifs  ||| S:12721 E:12728 ||| NNS
( ||| S:12728 E:12729 ||| -LRB-
Fig.  ||| S:12729 E:12734 ||| NNP
4b ||| S:12734 E:12736 ||| NNP
,  ||| S:12736 E:12738 ||| ,
lanes  ||| S:12738 E:12744 ||| CD
4-6 ||| S:12744 E:12747 ||| CD
) ||| S:12747 E:12748 ||| -RRB-
.  ||| S:12748 E:12750 ||| .
These  ||| S:12750 E:12756 ||| DT
data  ||| S:12756 E:12761 ||| NNS
indicate  ||| S:12761 E:12770 ||| VBP
that  ||| S:12770 E:12775 ||| IN
the  ||| S:12775 E:12789 ||| DT
v-crk  ||| S:12789 E:12795 ||| JJ
SH2  ||| S:12795 E:12799 ||| CD
domain  ||| S:12799 E:12806 ||| NN
interacts  ||| S:12806 E:12816 ||| NN
with  ||| S:12816 E:12821 ||| IN
the  ||| S:12821 E:12825 ||| DT
C-terminal  ||| S:12825 E:12836 ||| JJ
YDXP  ||| S:12836 E:12851 ||| NN
motifs ||| S:12851 E:12857 ||| NNS
,  ||| S:12857 E:12859 ||| ,
and  ||| S:12859 E:12863 ||| CC
as  ||| S:12863 E:12866 ||| RB
suggested  ||| S:12866 E:12876 ||| VBN
by  ||| S:12876 E:12879 ||| IN
Birge  ||| S:12879 E:12885 ||| NNP
et  ||| S:12885 E:12888 ||| FW
al ||| S:12888 E:12890 ||| FW
,  ||| S:12890 E:12892 ||| ,
v-crk  ||| S:12892 E:12898 ||| NNP
may  ||| S:12898 E:12902 ||| MD
be  ||| S:12902 E:12915 ||| VB
able  ||| S:12915 E:12920 ||| JJ
to  ||| S:12920 E:12923 ||| TO
protect  ||| S:12923 E:12931 ||| VB
them  ||| S:12931 E:12936 ||| PRP
from  ||| S:12936 E:12941 ||| IN
dephosphorylation  ||| S:12941 E:12959 ||| NN
and ||| S:12959 E:12962 ||| CC
/ ||| S:12962 E:12963 ||| NNP
or  ||| S:12963 E:12976 ||| CC
induces  ||| S:12976 E:12984 ||| VBZ
their  ||| S:12984 E:12990 ||| PRP$
phosphorylation  ||| S:12990 E:13006 ||| NNS
[  ||| S:13006 E:13008 ||| -LRB-
12  ||| S:13008 E:13011 ||| CD
]  ||| S:13011 E:13013 ||| -RRB-
.  ||| S:13013 E:13015 ||| .
They  ||| S:13015 E:13020 ||| PRP
also  ||| S:13020 E:13025 ||| RB
suggest  ||| S:13025 E:13043 ||| VB
that  ||| S:13043 E:13048 ||| IN
the  ||| S:13048 E:13052 ||| DT
YQXP  ||| S:13052 E:13057 ||| NNP
motifs  ||| S:13057 E:13064 ||| NNS
may  ||| S:13064 E:13068 ||| MD
be  ||| S:13068 E:13071 ||| VB
involved  ||| S:13071 E:13080 ||| VBN
in  ||| S:13080 E:13083 ||| IN
binding  ||| S:13083 E:13091 ||| VBG
to  ||| S:13091 E:13094 ||| TO
other  ||| S:13094 E:13110 ||| JJ
intracellular  ||| S:13110 E:13124 ||| NNS
signaling  ||| S:13124 E:13134 ||| VBG
molecules ||| S:13134 E:13143 ||| NNS
.  ||| S:13143 E:13173 ||| .
Suppression  ||| S:13173 E:13185 ||| NN
of  ||| S:13185 E:13188 ||| IN
v-crk  ||| S:13188 E:13194 ||| JJ
mediated  ||| S:13194 E:13203 ||| JJ
transformation  ||| S:13203 E:13218 ||| NN
by  ||| S:13218 E:13231 ||| IN
tyrosine  ||| S:13231 E:13240 ||| JJ
phosphorylated  ||| S:13240 E:13255 ||| JJ
Cas  ||| S:13255 E:13259 ||| NNP
SD  ||| S:13259 E:13272 ||| NNP
As  ||| S:13272 E:13275 ||| IN
our  ||| S:13275 E:13279 ||| PRP$
tyrosine  ||| S:13279 E:13288 ||| FW
phosphorylated  ||| S:13288 E:13303 ||| FW
Cas  ||| S:13303 E:13307 ||| FW
SD  ||| S:13307 E:13310 ||| FW
chimera  ||| S:13310 E:13318 ||| FW
can  ||| S:13318 E:13332 ||| MD
interact  ||| S:13332 E:13341 ||| VB
with  ||| S:13341 E:13346 ||| IN
v-crk ||| S:13346 E:13351 ||| NNP
,  ||| S:13351 E:13353 ||| ,
we  ||| S:13353 E:13356 ||| PRP
decided  ||| S:13356 E:13364 ||| VBD
to  ||| S:13364 E:13367 ||| TO
find  ||| S:13367 E:13372 ||| VB
out  ||| S:13372 E:13376 ||| RP
if  ||| S:13376 E:13379 ||| IN
the  ||| S:13379 E:13393 ||| DT
chimera  ||| S:13393 E:13401 ||| NN
would  ||| S:13401 E:13407 ||| MD
affect  ||| S:13407 E:13414 ||| VB
cell  ||| S:13414 E:13419 ||| NN
growth  ||| S:13419 E:13426 ||| NN
and ||| S:13426 E:13429 ||| CC
/ ||| S:13429 E:13430 ||| NNP
or  ||| S:13430 E:13433 ||| CC
transformation  ||| S:13433 E:13448 ||| NN
in  ||| S:13448 E:13461 ||| IN
normal  ||| S:13461 E:13468 ||| JJ
cells  ||| S:13468 E:13474 ||| NNS
and  ||| S:13474 E:13478 ||| CC
those  ||| S:13478 E:13484 ||| DT
transformed  ||| S:13484 E:13496 ||| NN
with  ||| S:13496 E:13501 ||| IN
v-crk ||| S:13501 E:13506 ||| JJ
.  ||| S:13506 E:13508 ||| .
NIH3T3  ||| S:13508 E:13525 ||| NNP
cells  ||| S:13525 E:13531 ||| NNS
or  ||| S:13531 E:13534 ||| CC
those  ||| S:13534 E:13540 ||| DT
transformed  ||| S:13540 E:13552 ||| NN
with  ||| S:13552 E:13557 ||| IN
v-crk  ||| S:13557 E:13563 ||| NNP
were  ||| S:13563 E:13568 ||| VBD
stably  ||| S:13568 E:13585 ||| JJ
transfected  ||| S:13585 E:13597 ||| NN
with  ||| S:13597 E:13602 ||| IN
the  ||| S:13602 E:13606 ||| DT
Cas  ||| S:13606 E:13610 ||| NNP
SD  ||| S:13610 E:13613 ||| NNP
chimera  ||| S:13613 E:13621 ||| NNS
( ||| S:13621 E:13622 ||| -LRB-
Fig.  ||| S:13622 E:13627 ||| CD
5 ||| S:13627 E:13628 ||| CD
) ||| S:13628 E:13629 ||| -RRB-
.  ||| S:13629 E:13631 ||| .
Several  ||| S:13631 E:13649 ||| JJ
independent  ||| S:13649 E:13661 ||| JJ
clones  ||| S:13661 E:13668 ||| NNS
were  ||| S:13668 E:13673 ||| VBD
obtained  ||| S:13673 E:13682 ||| VBN
for  ||| S:13682 E:13686 ||| IN
each  ||| S:13686 E:13691 ||| DT
set  ||| S:13691 E:13695 ||| NN
of  ||| S:13695 E:13708 ||| IN
transfections  ||| S:13708 E:13722 ||| NNS
suggesting  ||| S:13722 E:13733 ||| VBG
that  ||| S:13733 E:13738 ||| DT
expression  ||| S:13738 E:13749 ||| NN
of  ||| S:13749 E:13752 ||| IN
the  ||| S:13752 E:13756 ||| DT
tyrosine  ||| S:13756 E:13775 ||| JJ
phosphorylated  ||| S:13775 E:13790 ||| JJ
Cas  ||| S:13790 E:13794 ||| NNP
SD  ||| S:13794 E:13797 ||| NNP
domain  ||| S:13797 E:13804 ||| NN
did  ||| S:13804 E:13808 ||| VBD
not  ||| S:13808 E:13812 ||| RB
negatively  ||| S:13812 E:13823 ||| RB
affect  ||| S:13823 E:13840 ||| VB
cell  ||| S:13840 E:13845 ||| NN
growth  ||| S:13845 E:13852 ||| NN
( ||| S:13852 E:13853 ||| -LRB-
data  ||| S:13853 E:13858 ||| NNS
not  ||| S:13858 E:13862 ||| RB
shown ||| S:13862 E:13867 ||| VBN
) ||| S:13867 E:13868 ||| -RRB-
.  ||| S:13868 E:13870 ||| .
Figure  ||| S:13870 E:13877 ||| NN
5ademonstrates  ||| S:13877 E:13892 ||| NN
that  ||| S:13892 E:13907 ||| IN
stable  ||| S:13907 E:13914 ||| JJ
expression  ||| S:13914 E:13925 ||| NN
of  ||| S:13925 E:13928 ||| IN
the  ||| S:13928 E:13932 ||| DT
Src* ||| S:13932 E:13936 ||| NNP
/ ||| S:13936 E:13937 ||| NNP
Cas ||| S:13937 E:13940 ||| NNP
( ||| S:13940 E:13941 ||| -LRB-
SD ||| S:13941 E:13943 ||| NNP
)  ||| S:13943 E:13945 ||| -RRB-
chimera  ||| S:13945 E:13953 ||| VBZ
resulted  ||| S:13953 E:13962 ||| VBN
in  ||| S:13962 E:13975 ||| IN
constitutive  ||| S:13975 E:13988 ||| JJ
tyrosine  ||| S:13988 E:13997 ||| JJ
phosphorylation  ||| S:13997 E:14013 ||| NN
of  ||| S:14013 E:14016 ||| IN
this  ||| S:14016 E:14021 ||| DT
protein  ||| S:14021 E:14029 ||| NN
in  ||| S:14029 E:14042 ||| IN
NIH3T3  ||| S:14042 E:14049 ||| CD
cells ||| S:14049 E:14054 ||| NNS
.  ||| S:14054 E:14056 ||| .
Analysis  ||| S:14056 E:14065 ||| NN
of  ||| S:14065 E:14068 ||| IN
the  ||| S:14068 E:14072 ||| DT
effect  ||| S:14072 E:14079 ||| NN
of  ||| S:14079 E:14082 ||| IN
this  ||| S:14082 E:14087 ||| DT
chimera  ||| S:14087 E:14095 ||| NN
in  ||| S:14095 E:14108 ||| IN
non-transformed  ||| S:14108 E:14124 ||| JJ
NIH3T3  ||| S:14124 E:14131 ||| CD
cells  ||| S:14131 E:14137 ||| NNS
indicates  ||| S:14137 E:14147 ||| VBZ
that  ||| S:14147 E:14152 ||| IN
these  ||| S:14152 E:14158 ||| DT
cells  ||| S:14158 E:14174 ||| NNS
were  ||| S:14174 E:14179 ||| VBD
not  ||| S:14179 E:14183 ||| RB
transformed  ||| S:14183 E:14195 ||| VBN
and  ||| S:14195 E:14199 ||| CC
had  ||| S:14199 E:14203 ||| VBD
normal  ||| S:14203 E:14210 ||| JJ
morphology ||| S:14210 E:14220 ||| NN
,  ||| S:14220 E:14222 ||| ,
although  ||| S:14222 E:14241 ||| IN
they  ||| S:14241 E:14246 ||| PRP
grew  ||| S:14246 E:14251 ||| VBD
slightly  ||| S:14251 E:14260 ||| RB
slower  ||| S:14260 E:14267 ||| JJR
than  ||| S:14267 E:14272 ||| IN
vector-transfected  ||| S:14272 E:14291 ||| JJ
cells  ||| S:14291 E:14307 ||| NNS
( ||| S:14307 E:14308 ||| -LRB-
data  ||| S:14308 E:14313 ||| NNS
not  ||| S:14313 E:14317 ||| RB
shown ||| S:14317 E:14322 ||| VBN
) ||| S:14322 E:14323 ||| -RRB-
.  ||| S:14323 E:14325 ||| .
Analysis  ||| S:14325 E:14334 ||| NN
of  ||| S:14334 E:14337 ||| IN
the  ||| S:14337 E:14341 ||| DT
growth  ||| S:14341 E:14348 ||| NN
of  ||| S:14348 E:14351 ||| IN
either  ||| S:14351 E:14368 ||| DT
non-transformed  ||| S:14368 E:14384 ||| JJ
or  ||| S:14384 E:14387 ||| CC
v-crk  ||| S:14387 E:14393 ||| NNP
transformed  ||| S:14393 E:14405 ||| VBD
NIH3T3  ||| S:14405 E:14412 ||| CD
cells  ||| S:14412 E:14418 ||| NNS
in  ||| S:14418 E:14421 ||| IN
soft  ||| S:14421 E:14436 ||| JJ
agar  ||| S:14436 E:14441 ||| NN
confirmed  ||| S:14441 E:14451 ||| VBD
that  ||| S:14451 E:14456 ||| DT
expression  ||| S:14456 E:14467 ||| NN
of  ||| S:14467 E:14470 ||| IN
tyrosine  ||| S:14470 E:14479 ||| JJ
phosphorylated  ||| S:14479 E:14504 ||| JJ
Cas  ||| S:14504 E:14508 ||| NNP
SD  ||| S:14508 E:14511 ||| NNP
chimera  ||| S:14511 E:14519 ||| NN
did  ||| S:14519 E:14523 ||| VBD
not  ||| S:14523 E:14527 ||| RB
transform  ||| S:14527 E:14537 ||| VB
NIH3T3  ||| S:14537 E:14544 ||| CD
cells  ||| S:14544 E:14550 ||| NNS
as  ||| S:14550 E:14553 ||| IN
no  ||| S:14553 E:14566 ||| DT
colonies  ||| S:14566 E:14575 ||| NN
of  ||| S:14575 E:14578 ||| IN
these  ||| S:14578 E:14584 ||| DT
cells  ||| S:14584 E:14590 ||| NNS
grew  ||| S:14590 E:14595 ||| VBD
in  ||| S:14595 E:14598 ||| IN
soft  ||| S:14598 E:14603 ||| JJ
agar  ||| S:14603 E:14608 ||| NNS
( ||| S:14608 E:14609 ||| -LRB-
data  ||| S:14609 E:14614 ||| NNS
not  ||| S:14614 E:14628 ||| RB
shown ||| S:14628 E:14633 ||| VBN
) ||| S:14633 E:14634 ||| -RRB-
.  ||| S:14634 E:14636 ||| .
Instead ||| S:14636 E:14643 ||| RB
,  ||| S:14643 E:14645 ||| ,
expression  ||| S:14645 E:14656 ||| NN
of  ||| S:14656 E:14659 ||| IN
tyrosine  ||| S:14659 E:14668 ||| JJ
phosphorylated  ||| S:14668 E:14693 ||| JJ
Cas  ||| S:14693 E:14697 ||| NNP
SD  ||| S:14697 E:14700 ||| NNP
chimera  ||| S:14700 E:14708 ||| VBD
resulted  ||| S:14708 E:14717 ||| VBN
in  ||| S:14717 E:14720 ||| IN
significant  ||| S:14720 E:14732 ||| JJ
reduction  ||| S:14732 E:14742 ||| NN
in  ||| S:14742 E:14745 ||| IN
the  ||| S:14745 E:14759 ||| DT
number  ||| S:14759 E:14766 ||| NN
of  ||| S:14766 E:14769 ||| IN
v-crk ||| S:14769 E:14774 ||| JJ
/ ||| S:14774 E:14775 ||| CD
NIH3T3  ||| S:14775 E:14782 ||| CD
soft  ||| S:14782 E:14787 ||| JJ
agar  ||| S:14787 E:14792 ||| JJ
colonies  ||| S:14792 E:14801 ||| NNS
as  ||| S:14801 E:14804 ||| IN
well  ||| S:14804 E:14809 ||| RB
as  ||| S:14809 E:14822 ||| IN
their  ||| S:14822 E:14828 ||| PRP$
size  ||| S:14828 E:14833 ||| NN
( ||| S:14833 E:14834 ||| -LRB-
Fig.  ||| S:14834 E:14839 ||| NNP
5b ||| S:14839 E:14841 ||| NNP
) ||| S:14841 E:14842 ||| -RRB-
,  ||| S:14842 E:14844 ||| ,
suggesting  ||| S:14844 E:14855 ||| VBG
that  ||| S:14855 E:14860 ||| IN
the  ||| S:14860 E:14864 ||| DT
Src* ||| S:14864 E:14868 ||| NNP
/ ||| S:14868 E:14869 ||| NNP
Cas ||| S:14869 E:14872 ||| NNP
( ||| S:14872 E:14873 ||| -LRB-
SD ||| S:14873 E:14875 ||| NNP
)  ||| S:14875 E:14887 ||| -RRB-
chimera  ||| S:14887 E:14895 ||| VBZ
blocked  ||| S:14895 E:14903 ||| VBN
the  ||| S:14903 E:14907 ||| DT
ability  ||| S:14907 E:14915 ||| NN
of  ||| S:14915 E:14918 ||| IN
v-crk  ||| S:14918 E:14924 ||| JJ
to  ||| S:14924 E:14927 ||| TO
transform  ||| S:14927 E:14937 ||| VB
these  ||| S:14937 E:14953 ||| DT
cells ||| S:14953 E:14958 ||| NNS
.  ||| S:14958 E:14988 ||| .
Tyrosine  ||| S:14988 E:14997 ||| FW
phosphorylated  ||| S:14997 E:15012 ||| FW
Cas  ||| S:15012 E:15016 ||| FW
SD  ||| S:15016 E:15019 ||| FW
blocks  ||| S:15019 E:15026 ||| FW
JNK  ||| S:15026 E:15040 ||| FW
activation  ||| S:15040 E:15051 ||| FW
by  ||| S:15051 E:15054 ||| IN
v-crk  ||| S:15054 E:15070 ||| JJ
The  ||| S:15070 E:15074 ||| DT
JNK  ||| S:15074 E:15078 ||| NNP
pathway  ||| S:15078 E:15086 ||| NN
is  ||| S:15086 E:15089 ||| VBZ
regulated  ||| S:15089 E:15099 ||| VBN
by  ||| S:15099 E:15102 ||| IN
interaction  ||| S:15102 E:15114 ||| NN
of  ||| S:15114 E:15117 ||| IN
c-  ||| S:15117 E:15120 ||| JJ
or  ||| S:15120 E:15133 ||| CC
v-crk  ||| S:15133 E:15139 ||| JJ
with  ||| S:15139 E:15144 ||| IN
Cas  ||| S:15144 E:15148 ||| NNP
via  ||| S:15148 E:15152 ||| IN
the  ||| S:15152 E:15156 ||| DT
substrate  ||| S:15156 E:15166 ||| JJ
domain  ||| S:15166 E:15173 ||| NN
[  ||| S:15173 E:15175 ||| -LRB-
38  ||| S:15175 E:15178 ||| CD
]  ||| S:15178 E:15180 ||| -RRB-
.  ||| S:15180 E:15182 ||| .
In  ||| S:15182 E:15195 ||| IN
determining  ||| S:15195 E:15207 ||| NNS
which  ||| S:15207 E:15213 ||| WDT
pathways  ||| S:15213 E:15222 ||| NNS
are  ||| S:15222 E:15226 ||| VBP
affected  ||| S:15226 E:15235 ||| VBN
in  ||| S:15235 E:15238 ||| IN
our  ||| S:15238 E:15242 ||| PRP$
stable  ||| S:15242 E:15259 ||| JJ
cell  ||| S:15259 E:15264 ||| NN
lines  ||| S:15264 E:15270 ||| NNS
generated ||| S:15270 E:15279 ||| VBD
,  ||| S:15279 E:15281 ||| ,
we  ||| S:15281 E:15284 ||| PRP
determined  ||| S:15284 E:15295 ||| VBD
if  ||| S:15295 E:15298 ||| IN
JNK  ||| S:15298 E:15302 ||| NNP
was  ||| S:15302 E:15306 ||| VBD
activated  ||| S:15306 E:15326 ||| VBN
in  ||| S:15326 E:15329 ||| IN
the  ||| S:15329 E:15333 ||| DT
v-crk  ||| S:15333 E:15339 ||| JJ
transformed  ||| S:15339 E:15351 ||| JJ
cells ||| S:15351 E:15356 ||| NNS
,  ||| S:15356 E:15358 ||| ,
and  ||| S:15358 E:15362 ||| CC
if  ||| S:15362 E:15365 ||| IN
the  ||| S:15365 E:15369 ||| DT
tyrosine  ||| S:15369 E:15388 ||| JJ
phosphorylated  ||| S:15388 E:15403 ||| JJ
Cas  ||| S:15403 E:15407 ||| JJ
chimera  ||| S:15407 E:15415 ||| NN
was  ||| S:15415 E:15419 ||| VBD
affecting  ||| S:15419 E:15429 ||| VBG
this  ||| S:15429 E:15434 ||| DT
activation ||| S:15434 E:15444 ||| NN
.  ||| S:15444 E:15456 ||| .
JNK  ||| S:15456 E:15460 ||| NNP
was  ||| S:15460 E:15464 ||| VBD
immunoprecipitated  ||| S:15464 E:15483 ||| JJ
and  ||| S:15483 E:15487 ||| CC
tested  ||| S:15487 E:15494 ||| VBN
for  ||| S:15494 E:15498 ||| IN
activity  ||| S:15498 E:15507 ||| NN
from  ||| S:15507 E:15522 ||| IN
control  ||| S:15522 E:15530 ||| NN
NIH3T3  ||| S:15530 E:15537 ||| CD
cells ||| S:15537 E:15542 ||| NNS
,  ||| S:15542 E:15544 ||| ,
those  ||| S:15544 E:15550 ||| DT
expressing  ||| S:15550 E:15561 ||| VBG
the  ||| S:15561 E:15565 ||| DT
Cas  ||| S:15565 E:15569 ||| JJ
chimera  ||| S:15569 E:15587 ||| NN
and  ||| S:15587 E:15591 ||| CC
those  ||| S:15591 E:15597 ||| DT
expressing  ||| S:15597 E:15608 ||| VBG
the  ||| S:15608 E:15612 ||| DT
Cas  ||| S:15612 E:15616 ||| JJ
chimera  ||| S:15616 E:15624 ||| NN
and  ||| S:15624 E:15628 ||| CC
v-crk  ||| S:15628 E:15634 ||| NNP
( ||| S:15634 E:15635 ||| -LRB-
Fig.  ||| S:15635 E:15640 ||| NNP
6a ||| S:15640 E:15642 ||| NNP
) ||| S:15642 E:15643 ||| -RRB-
.  ||| S:15643 E:15655 ||| .
We  ||| S:15655 E:15658 ||| PRP
found  ||| S:15658 E:15664 ||| VBD
that  ||| S:15664 E:15669 ||| IN
while  ||| S:15669 E:15675 ||| IN
JNK  ||| S:15675 E:15679 ||| NNP
activity  ||| S:15679 E:15688 ||| NN
was  ||| S:15688 E:15692 ||| VBD
elevated  ||| S:15692 E:15701 ||| VBN
in  ||| S:15701 E:15704 ||| IN
v-crk  ||| S:15704 E:15720 ||| NNP
transformed  ||| S:15720 E:15732 ||| VBD
NIH3T3  ||| S:15732 E:15739 ||| CD
cells ||| S:15739 E:15744 ||| NNS
,  ||| S:15744 E:15746 ||| ,
expression  ||| S:15746 E:15757 ||| NN
of  ||| S:15757 E:15760 ||| IN
the  ||| S:15760 E:15764 ||| DT
tyrosine  ||| S:15764 E:15783 ||| JJ
phosphorylated  ||| S:15783 E:15798 ||| JJ
Cas  ||| S:15798 E:15802 ||| NNP
chimera  ||| S:15802 E:15810 ||| VBD
resulted  ||| S:15810 E:15819 ||| VBN
in  ||| S:15819 E:15822 ||| IN
reduced  ||| S:15822 E:15830 ||| JJ
activity  ||| S:15830 E:15849 ||| NN
of  ||| S:15849 E:15852 ||| IN
JNK  ||| S:15852 E:15856 ||| NNP
( ||| S:15856 E:15857 ||| -LRB-
Fig.  ||| S:15857 E:15862 ||| NNP
6a ||| S:15862 E:15864 ||| NNP
,  ||| S:15864 E:15866 ||| ,
cf.  ||| S:15866 E:15870 ||| CD
lanes  ||| S:15870 E:15876 ||| CD
1 ||| S:15876 E:15877 ||| CD
,  ||| S:15877 E:15879 ||| ,
5  ||| S:15879 E:15881 ||| CD
and  ||| S:15881 E:15885 ||| CC
7 ||| S:15885 E:15886 ||| CD
) ||| S:15886 E:15887 ||| -RRB-
.  ||| S:15887 E:15889 ||| .
Interestingly ||| S:15889 E:15902 ||| RB
,  ||| S:15902 E:15914 ||| ,
JNK  ||| S:15914 E:15918 ||| NNP
activity  ||| S:15918 E:15927 ||| NN
was  ||| S:15927 E:15931 ||| VBD
also  ||| S:15931 E:15936 ||| RB
lower  ||| S:15936 E:15942 ||| JJR
in  ||| S:15942 E:15945 ||| IN
the  ||| S:15945 E:15949 ||| DT
NIH3T3  ||| S:15949 E:15956 ||| CD
cells  ||| S:15956 E:15972 ||| NNS
expressing  ||| S:15972 E:15983 ||| VBG
the  ||| S:15983 E:15987 ||| DT
tyrosine  ||| S:15987 E:15996 ||| JJ
phosphorylated  ||| S:15996 E:16011 ||| JJ
Cas  ||| S:16011 E:16015 ||| JJ
chimera  ||| S:16015 E:16023 ||| NN
than  ||| S:16023 E:16038 ||| IN
the  ||| S:16038 E:16042 ||| DT
vector  ||| S:16042 E:16049 ||| JJ
transfected  ||| S:16049 E:16061 ||| JJ
cells ||| S:16061 E:16066 ||| NNS
,  ||| S:16066 E:16068 ||| ,
suggesting  ||| S:16068 E:16079 ||| VBG
that  ||| S:16079 E:16084 ||| IN
this  ||| S:16084 E:16099 ||| DT
chimera  ||| S:16099 E:16107 ||| NN
also  ||| S:16107 E:16112 ||| RB
affected  ||| S:16112 E:16121 ||| VBN
JNK  ||| S:16121 E:16125 ||| NNP
activity  ||| S:16125 E:16134 ||| NN
in  ||| S:16134 E:16137 ||| IN
those  ||| S:16137 E:16143 ||| DT
cells  ||| S:16143 E:16149 ||| NNS
( ||| S:16149 E:16150 ||| -LRB-
Fig.  ||| S:16150 E:16165 ||| NNP
6a ||| S:16165 E:16167 ||| NNP
,  ||| S:16167 E:16169 ||| ,
cf.  ||| S:16169 E:16173 ||| CD
lanes  ||| S:16173 E:16179 ||| CD
1  ||| S:16179 E:16181 ||| CD
and  ||| S:16181 E:16185 ||| CC
4 ||| S:16185 E:16186 ||| LS
) ||| S:16186 E:16187 ||| -RRB-
.  ||| S:16187 E:16189 ||| .
These  ||| S:16189 E:16195 ||| DT
data  ||| S:16195 E:16200 ||| NNS
suggest  ||| S:16200 E:16208 ||| VBP
that  ||| S:16208 E:16213 ||| IN
the  ||| S:16213 E:16227 ||| DT
tyrosine  ||| S:16227 E:16236 ||| FW
phosphorylated  ||| S:16236 E:16251 ||| FW
Cas  ||| S:16251 E:16255 ||| FW
chimera  ||| S:16255 E:16263 ||| FW
perturbs  ||| S:16263 E:16272 ||| FW
signaling  ||| S:16272 E:16292 ||| FW
via  ||| S:16292 E:16296 ||| IN
v-crk  ||| S:16296 E:16302 ||| JJ
and  ||| S:16302 E:16306 ||| CC
probably  ||| S:16306 E:16315 ||| RB
via  ||| S:16315 E:16319 ||| IN
endogenous  ||| S:16319 E:16330 ||| JJ
c-crk  ||| S:16330 E:16336 ||| JJ
to  ||| S:16336 E:16339 ||| TO
affect  ||| S:16339 E:16346 ||| VB
the  ||| S:16346 E:16360 ||| DT
activation  ||| S:16360 E:16371 ||| NN
of  ||| S:16371 E:16374 ||| IN
the  ||| S:16374 E:16378 ||| DT
JNK  ||| S:16378 E:16382 ||| NNP
pathway ||| S:16382 E:16389 ||| NN
.  ||| S:16389 E:16401 ||| .
We  ||| S:16401 E:16404 ||| PRP
also  ||| S:16404 E:16409 ||| RB
verified  ||| S:16409 E:16418 ||| VBN
that  ||| S:16418 E:16423 ||| IN
the  ||| S:16423 E:16427 ||| DT
tyrosine  ||| S:16427 E:16436 ||| FW
phosphorylated  ||| S:16436 E:16451 ||| FW
Cas  ||| S:16451 E:16465 ||| FW
chimera  ||| S:16465 E:16473 ||| FW
could  ||| S:16473 E:16479 ||| MD
affect  ||| S:16479 E:16486 ||| VB
the  ||| S:16486 E:16490 ||| DT
ability  ||| S:16490 E:16498 ||| NN
of  ||| S:16498 E:16501 ||| IN
v-crk  ||| S:16501 E:16507 ||| JJ
to  ||| S:16507 E:16510 ||| TO
activate  ||| S:16510 E:16519 ||| VB
the  ||| S:16519 E:16533 ||| DT
JNK  ||| S:16533 E:16537 ||| NNP
pathway  ||| S:16537 E:16545 ||| NN
in  ||| S:16545 E:16548 ||| IN
transient  ||| S:16548 E:16558 ||| JJ
transfection  ||| S:16558 E:16571 ||| JJ
experiments  ||| S:16571 E:16583 ||| NNS
( ||| S:16583 E:16584 ||| -LRB-
Fig.  ||| S:16584 E:16599 ||| NNP
6b ||| S:16599 E:16601 ||| NNP
) ||| S:16601 E:16602 ||| -RRB-
.  ||| S:16602 E:16604 ||| .
Transfection  ||| S:16604 E:16617 ||| NNP
of  ||| S:16617 E:16620 ||| IN
v-crk  ||| S:16620 E:16626 ||| JJ
along  ||| S:16626 E:16632 ||| IN
with  ||| S:16632 E:16637 ||| IN
gst-JNK  ||| S:16637 E:16645 ||| JJ
into  ||| S:16645 E:16650 ||| IN
Cos-7  ||| S:16650 E:16666 ||| CD
cells  ||| S:16666 E:16672 ||| NNS
resulted  ||| S:16672 E:16681 ||| VBD
in  ||| S:16681 E:16684 ||| IN
activation  ||| S:16684 E:16695 ||| NN
of  ||| S:16695 E:16698 ||| IN
the  ||| S:16698 E:16702 ||| DT
co-transfected  ||| S:16702 E:16717 ||| JJ
JNK  ||| S:16717 E:16731 ||| NNP
( ||| S:16731 E:16732 ||| -LRB-
Fig.  ||| S:16732 E:16737 ||| NNP
6b ||| S:16737 E:16739 ||| NNP
,  ||| S:16739 E:16741 ||| ,
cf.  ||| S:16741 E:16745 ||| CD
lanes  ||| S:16745 E:16751 ||| CD
1  ||| S:16751 E:16753 ||| CD
and  ||| S:16753 E:16757 ||| CC
2 ||| S:16757 E:16758 ||| LS
) ||| S:16758 E:16759 ||| -RRB-
.  ||| S:16759 E:16761 ||| .
However ||| S:16761 E:16768 ||| RB
,  ||| S:16768 E:16770 ||| ,
co-transfection  ||| S:16770 E:16786 ||| JJ
of  ||| S:16786 E:16799 ||| IN
v-crk  ||| S:16799 E:16805 ||| JJ
and  ||| S:16805 E:16809 ||| CC
gst-JNK  ||| S:16809 E:16817 ||| JJ
with  ||| S:16817 E:16822 ||| IN
the  ||| S:16822 E:16826 ||| DT
tyrosine  ||| S:16826 E:16835 ||| JJ
phosphorylated  ||| S:16835 E:16850 ||| JJ
Cas  ||| S:16850 E:16864 ||| JJ
chimera  ||| S:16864 E:16872 ||| NN
blocked  ||| S:16872 E:16880 ||| VBD
the  ||| S:16880 E:16884 ||| DT
activation  ||| S:16884 E:16895 ||| NN
of  ||| S:16895 E:16898 ||| IN
JNK  ||| S:16898 E:16902 ||| NNP
induced  ||| S:16902 E:16910 ||| NN
by  ||| S:16910 E:16913 ||| IN
v-crk  ||| S:16913 E:16929 ||| NNP
( ||| S:16929 E:16930 ||| -LRB-
Fig.  ||| S:16930 E:16935 ||| NNP
6b ||| S:16935 E:16937 ||| NNP
,  ||| S:16937 E:16939 ||| ,
cf.  ||| S:16939 E:16943 ||| CD
lanes  ||| S:16943 E:16949 ||| CD
2  ||| S:16949 E:16951 ||| CD
&  ||| S:16951 E:16953 ||| CC
3 ||| S:16953 E:16954 ||| LS
) ||| S:16954 E:16955 ||| -RRB-
,  ||| S:16955 E:16957 ||| ,
confirming  ||| S:16957 E:16968 ||| VBG
that  ||| S:16968 E:16973 ||| IN
tyrosine  ||| S:16973 E:16992 ||| JJ
phosphorylated  ||| S:16992 E:17007 ||| JJ
Cas  ||| S:17007 E:17011 ||| NNP
SD  ||| S:17011 E:17014 ||| NNP
can  ||| S:17014 E:17018 ||| MD
inhibit  ||| S:17018 E:17026 ||| VB
the  ||| S:17026 E:17030 ||| DT
ability  ||| S:17030 E:17038 ||| NN
of  ||| S:17038 E:17041 ||| IN
v-crk  ||| S:17041 E:17047 ||| JJ
to  ||| S:17047 E:17060 ||| TO
activate  ||| S:17060 E:17069 ||| VB
the  ||| S:17069 E:17073 ||| DT
JNK  ||| S:17073 E:17077 ||| NNP
pathway ||| S:17077 E:17084 ||| NN
.  ||| S:17084 E:17086 ||| .
Transient  ||| S:17086 E:17096 ||| JJ
expression  ||| S:17096 E:17107 ||| NN
of  ||| S:17107 E:17110 ||| IN
the  ||| S:17110 E:17124 ||| DT
Src*  ||| S:17124 E:17129 ||| NNP
increased  ||| S:17129 E:17139 ||| VBD
JNK  ||| S:17139 E:17143 ||| NNP
activity  ||| S:17143 E:17152 ||| NN
slightly  ||| S:17152 E:17161 ||| RB
while  ||| S:17161 E:17167 ||| IN
expression  ||| S:17167 E:17178 ||| NN
of  ||| S:17178 E:17191 ||| IN
the  ||| S:17191 E:17195 ||| DT
Src  ||| S:17195 E:17199 ||| NNP
KM ||| S:17199 E:17201 ||| NNP
/ ||| S:17201 E:17202 ||| NNP
Cas ||| S:17202 E:17205 ||| NNP
( ||| S:17205 E:17206 ||| -LRB-
SD ||| S:17206 E:17208 ||| NNP
)  ||| S:17208 E:17210 ||| -RRB-
fusion  ||| S:17210 E:17217 ||| NN
did  ||| S:17217 E:17221 ||| VBD
not  ||| S:17221 E:17225 ||| RB
affect  ||| S:17225 E:17232 ||| VB
JNK  ||| S:17232 E:17236 ||| JJ
activity  ||| S:17236 E:17255 ||| NN
( ||| S:17255 E:17256 ||| -LRB-
data  ||| S:17256 E:17261 ||| NNS
not  ||| S:17261 E:17265 ||| RB
shown ||| S:17265 E:17270 ||| VBN
) ||| S:17270 E:17271 ||| -RRB-
.  ||| S:17271 E:17283 ||| .
To  ||| S:17283 E:17286 ||| TO
determine  ||| S:17286 E:17296 ||| VB
if  ||| S:17296 E:17299 ||| IN
the  ||| S:17299 E:17303 ||| DT
tyrosine-phosphorylated  ||| S:17303 E:17327 ||| JJ
Cas  ||| S:17327 E:17331 ||| NNP
SD  ||| S:17331 E:17344 ||| NNP
chimera  ||| S:17344 E:17352 ||| VBD
affected  ||| S:17352 E:17361 ||| VBN
other  ||| S:17361 E:17367 ||| JJ
signaling  ||| S:17367 E:17377 ||| JJ
pathways ||| S:17377 E:17385 ||| NN
,  ||| S:17385 E:17387 ||| ,
we  ||| S:17387 E:17390 ||| PRP
tested  ||| S:17390 E:17407 ||| VBD
whether  ||| S:17407 E:17415 ||| IN
the  ||| S:17415 E:17419 ||| DT
association  ||| S:17419 E:17431 ||| NN
between  ||| S:17431 E:17439 ||| IN
c-crk  ||| S:17439 E:17445 ||| JJ
and  ||| S:17445 E:17449 ||| CC
C3G  ||| S:17449 E:17453 ||| NNP
was  ||| S:17453 E:17467 ||| VBD
affected  ||| S:17467 E:17476 ||| VBN
in  ||| S:17476 E:17479 ||| IN
NIH3T3  ||| S:17479 E:17486 ||| CD
cells  ||| S:17486 E:17492 ||| NNS
expressing  ||| S:17492 E:17503 ||| VBG
the  ||| S:17503 E:17507 ||| DT
chimera  ||| S:17507 E:17515 ||| NN
( ||| S:17515 E:17516 ||| -LRB-
Fig.  ||| S:17516 E:17531 ||| NNP
7a ||| S:17531 E:17533 ||| NNP
) ||| S:17533 E:17534 ||| -RRB-
.  ||| S:17534 E:17536 ||| .
Immunoprecipitating  ||| S:17536 E:17556 ||| JJ
endogenous  ||| S:17556 E:17567 ||| JJ
c-crk  ||| S:17567 E:17573 ||| JJ
and  ||| S:17573 E:17577 ||| CC
probing  ||| S:17577 E:17585 ||| VBG
for  ||| S:17585 E:17599 ||| IN
associated  ||| S:17599 E:17610 ||| VBN
C3G  ||| S:17610 E:17614 ||| RB
demonstrated  ||| S:17614 E:17627 ||| VBN
that  ||| S:17627 E:17632 ||| IN
C3G  ||| S:17632 E:17636 ||| CD
association  ||| S:17636 E:17648 ||| NN
with  ||| S:17648 E:17663 ||| IN
c-crk  ||| S:17663 E:17669 ||| NNP
was  ||| S:17669 E:17673 ||| VBD
reduced  ||| S:17673 E:17681 ||| VBN
in  ||| S:17681 E:17684 ||| IN
the  ||| S:17684 E:17688 ||| DT
presence  ||| S:17688 E:17697 ||| NN
of  ||| S:17697 E:17700 ||| IN
the  ||| S:17700 E:17704 ||| DT
tyrosine  ||| S:17704 E:17723 ||| FW
phosphorylated  ||| S:17723 E:17738 ||| FW
chimera  ||| S:17738 E:17746 ||| FW
( ||| S:17746 E:17747 ||| -LRB-
Fig.  ||| S:17747 E:17752 ||| NNP
7a ||| S:17752 E:17754 ||| NNP
,  ||| S:17754 E:17756 ||| ,
cf.  ||| S:17756 E:17760 ||| CD
lanes  ||| S:17760 E:17766 ||| CD
3 ||| S:17766 E:17767 ||| CD
,  ||| S:17767 E:17769 ||| ,
4  ||| S:17769 E:17771 ||| CD
&  ||| S:17771 E:17773 ||| CC
5 ||| S:17773 E:17774 ||| CD
) ||| S:17774 E:17775 ||| -RRB-
.  ||| S:17775 E:17787 ||| .
In  ||| S:17787 E:17790 ||| IN
addition ||| S:17790 E:17798 ||| NN
,  ||| S:17798 E:17800 ||| ,
we  ||| S:17800 E:17803 ||| PRP
determined  ||| S:17803 E:17814 ||| VBD
if  ||| S:17814 E:17817 ||| IN
tyrosine  ||| S:17817 E:17826 ||| JJ
phosphorylation  ||| S:17826 E:17842 ||| NN
of  ||| S:17842 E:17855 ||| IN
endogenous  ||| S:17855 E:17866 ||| JJ
FAK  ||| S:17866 E:17870 ||| NNP
and  ||| S:17870 E:17874 ||| CC
endogenous  ||| S:17874 E:17885 ||| JJ
Cas  ||| S:17885 E:17889 ||| NNP
was  ||| S:17889 E:17893 ||| VBD
affected  ||| S:17893 E:17902 ||| VBN
by  ||| S:17902 E:17905 ||| IN
the  ||| S:17905 E:17919 ||| DT
presence  ||| S:17919 E:17928 ||| NN
of  ||| S:17928 E:17931 ||| IN
the  ||| S:17931 E:17935 ||| DT
chimera ||| S:17935 E:17942 ||| NN
.  ||| S:17942 E:17944 ||| .
This  ||| S:17944 E:17949 ||| DT
was  ||| S:17949 E:17953 ||| VBD
not  ||| S:17953 E:17957 ||| RB
the  ||| S:17957 E:17961 ||| DT
case ||| S:17961 E:17965 ||| NN
.  ||| S:17965 E:17967 ||| .
Figure  ||| S:17967 E:17984 ||| NN
7bdemonstrates  ||| S:17984 E:17999 ||| NN
that  ||| S:17999 E:18004 ||| IN
there  ||| S:18004 E:18010 ||| EX
was  ||| S:18010 E:18014 ||| VBD
no  ||| S:18014 E:18017 ||| DT
difference  ||| S:18017 E:18028 ||| NN
in  ||| S:18028 E:18031 ||| IN
tyrosine  ||| S:18031 E:18050 ||| JJ
phosphorylation  ||| S:18050 E:18066 ||| NN
or  ||| S:18066 E:18069 ||| CC
association  ||| S:18069 E:18081 ||| NN
with  ||| S:18081 E:18086 ||| IN
tyrosine  ||| S:18086 E:18105 ||| JJ
phosphorylated  ||| S:18105 E:18120 ||| JJ
proteins  ||| S:18120 E:18129 ||| NNS
of  ||| S:18129 E:18132 ||| IN
either  ||| S:18132 E:18139 ||| DT
FAK  ||| S:18139 E:18143 ||| NNP
or  ||| S:18143 E:18146 ||| CC
endogenous  ||| S:18146 E:18157 ||| JJ
Cas  ||| S:18157 E:18171 ||| NNS
upon  ||| S:18171 E:18176 ||| IN
stable  ||| S:18176 E:18183 ||| JJ
expression  ||| S:18183 E:18194 ||| NN
of  ||| S:18194 E:18197 ||| IN
the  ||| S:18197 E:18201 ||| DT
tyrosine  ||| S:18201 E:18210 ||| FW
phosphorylated  ||| S:18210 E:18225 ||| FW
Cas  ||| S:18225 E:18239 ||| FW
SD  ||| S:18239 E:18242 ||| FW
chimera ||| S:18242 E:18249 ||| FW
.  ||| S:18249 E:18279 ||| .
Tyrosine  ||| S:18279 E:18288 ||| NNP
phosphorylated  ||| S:18288 E:18303 ||| VBD
Cas  ||| S:18303 E:18307 ||| NNP
SD  ||| S:18307 E:18310 ||| NNP
acts  ||| S:18310 E:18315 ||| VBZ
as  ||| S:18315 E:18318 ||| IN
a  ||| S:18318 E:18320 ||| DT
decoy  ||| S:18320 E:18326 ||| NN
for  ||| S:18326 E:18340 ||| IN
v-crk  ||| S:18340 E:18346 ||| JJ
and  ||| S:18346 E:18350 ||| CC
endogenous  ||| S:18350 E:18361 ||| JJ
c-crk  ||| S:18361 E:18377 ||| NN
As  ||| S:18377 E:18380 ||| IN
the  ||| S:18380 E:18384 ||| DT
tyrosine  ||| S:18384 E:18393 ||| FW
phosphorylated  ||| S:18393 E:18408 ||| FW
Cas  ||| S:18408 E:18412 ||| FW
substrate  ||| S:18412 E:18422 ||| FW
domain  ||| S:18422 E:18439 ||| FW
acts  ||| S:18439 E:18444 ||| NNS
as  ||| S:18444 E:18447 ||| IN
a  ||| S:18447 E:18449 ||| DT
dominant  ||| S:18449 E:18458 ||| JJ
negative  ||| S:18458 E:18467 ||| JJ
for  ||| S:18467 E:18471 ||| IN
v-crk  ||| S:18471 E:18477 ||| JJ
mediated  ||| S:18477 E:18496 ||| JJ
transformation  ||| S:18496 E:18511 ||| NN
and  ||| S:18511 E:18515 ||| CC
JNK  ||| S:18515 E:18519 ||| NNP
activation ||| S:18519 E:18529 ||| NN
,  ||| S:18529 E:18531 ||| ,
and  ||| S:18531 E:18535 ||| CC
can  ||| S:18535 E:18539 ||| MD
also  ||| S:18539 E:18544 ||| RB
interact  ||| S:18544 E:18563 ||| VBN
with  ||| S:18563 E:18568 ||| IN
v-crk  ||| S:18568 E:18574 ||| JJ
and  ||| S:18574 E:18578 ||| CC
c-crk  ||| S:18578 E:18584 ||| NNP
( ||| S:18584 E:18585 ||| -LRB-
data  ||| S:18585 E:18590 ||| NNS
not  ||| S:18590 E:18594 ||| RB
shown ||| S:18594 E:18599 ||| VBN
) ||| S:18599 E:18600 ||| -RRB-
,  ||| S:18600 E:18602 ||| ,
we  ||| S:18602 E:18605 ||| PRP
wanted  ||| S:18605 E:18612 ||| VBD
to  ||| S:18612 E:18625 ||| TO
determine  ||| S:18625 E:18635 ||| VB
if  ||| S:18635 E:18638 ||| IN
it  ||| S:18638 E:18641 ||| PRP
could  ||| S:18641 E:18647 ||| MD
compete  ||| S:18647 E:18655 ||| VB
for  ||| S:18655 E:18659 ||| IN
binding  ||| S:18659 E:18667 ||| VBG
of  ||| S:18667 E:18670 ||| IN
v-  ||| S:18670 E:18673 ||| JJ
and  ||| S:18673 E:18677 ||| CC
c-crk  ||| S:18677 E:18693 ||| JJ
to  ||| S:18693 E:18696 ||| TO
endogenous  ||| S:18696 E:18707 ||| VB
Cas ||| S:18707 E:18710 ||| NNP
.  ||| S:18710 E:18712 ||| .
We  ||| S:18712 E:18715 ||| PRP
transfected  ||| S:18715 E:18727 ||| VBP
v-crk  ||| S:18727 E:18733 ||| JJ
alone  ||| S:18733 E:18739 ||| NN
or  ||| S:18739 E:18742 ||| CC
along  ||| S:18742 E:18758 ||| RB
with  ||| S:18758 E:18763 ||| IN
the  ||| S:18763 E:18767 ||| DT
chimera  ||| S:18767 E:18775 ||| NN
of  ||| S:18775 E:18778 ||| IN
the  ||| S:18778 E:18782 ||| DT
attenuated  ||| S:18782 E:18793 ||| FW
Src  ||| S:18793 E:18797 ||| FW
kinase  ||| S:18797 E:18804 ||| FW
domain  ||| S:18804 E:18821 ||| FW
fused  ||| S:18821 E:18827 ||| FW
to  ||| S:18827 E:18830 ||| TO
the  ||| S:18830 E:18834 ||| DT
C-terminal  ||| S:18834 E:18845 ||| JJ
crk  ||| S:18845 E:18849 ||| JJ
interacting  ||| S:18849 E:18861 ||| JJ
region  ||| S:18861 E:18868 ||| NN
of  ||| S:18868 E:18871 ||| IN
the  ||| S:18871 E:18875 ||| DT
Cas  ||| S:18875 E:18889 ||| JJ
substrate  ||| S:18889 E:18899 ||| JJ
domain  ||| S:18899 E:18906 ||| NN
( ||| S:18906 E:18907 ||| -LRB-
Src* ||| S:18907 E:18911 ||| NNP
/ ||| S:18911 E:18912 ||| NNP
Cas ||| S:18912 E:18915 ||| NNP
( ||| S:18915 E:18916 ||| -LRB-
3 ||| S:18916 E:18917 ||| LS
' ||| S:18917 E:18918 ||| :
SD ||| S:18918 E:18920 ||| NNP
) ||| S:18920 E:18921 ||| -RRB-
,  ||| S:18921 E:18923 ||| ,
carrying  ||| S:18923 E:18932 ||| VBG
the  ||| S:18932 E:18936 ||| DT
YDXP  ||| S:18936 E:18951 ||| NNP
motifs ||| S:18951 E:18957 ||| NNS
)  ||| S:18957 E:18959 ||| -RRB-
into  ||| S:18959 E:18964 ||| IN
Cos-7  ||| S:18964 E:18970 ||| CD
cells  ||| S:18970 E:18976 ||| NNS
and  ||| S:18976 E:18980 ||| CC
immunoprecipitated  ||| S:18980 E:18999 ||| NNS
either  ||| S:18999 E:19016 ||| CC
the  ||| S:19016 E:19020 ||| DT
chimera  ||| S:19020 E:19028 ||| NN
or  ||| S:19028 E:19031 ||| CC
v-crk  ||| S:19031 E:19037 ||| JJ
and  ||| S:19037 E:19041 ||| CC
assayed  ||| S:19041 E:19049 ||| NN
for  ||| S:19049 E:19053 ||| IN
interacting  ||| S:19053 E:19065 ||| FW
tyrosine  ||| S:19065 E:19084 ||| FW
phosphorylated  ||| S:19084 E:19099 ||| FW
proteins  ||| S:19099 E:19108 ||| FW
( ||| S:19108 E:19109 ||| -LRB-
Fig.  ||| S:19109 E:19114 ||| NNP
8a ||| S:19114 E:19116 ||| NNP
) ||| S:19116 E:19117 ||| -RRB-
.  ||| S:19117 E:19119 ||| .
Our  ||| S:19119 E:19123 ||| PRP$
analysis  ||| S:19123 E:19132 ||| NN
showed  ||| S:19132 E:19149 ||| VBD
that  ||| S:19149 E:19154 ||| DT
expression  ||| S:19154 E:19165 ||| NN
of  ||| S:19165 E:19168 ||| IN
this  ||| S:19168 E:19173 ||| DT
chimera  ||| S:19173 E:19181 ||| NN
resulted  ||| S:19181 E:19190 ||| VBD
in  ||| S:19190 E:19193 ||| IN
expression  ||| S:19193 E:19204 ||| NN
of  ||| S:19204 E:19217 ||| IN
the  ||| S:19217 E:19221 ||| DT
highly  ||| S:19221 E:19228 ||| RB
tyrosine  ||| S:19228 E:19237 ||| JJ
phosphorylated  ||| S:19237 E:19252 ||| JJ
Cas  ||| S:19252 E:19256 ||| NNP
3 ||| S:19256 E:19257 ||| NNP
' ||| S:19257 E:19258 ||| POS
SD  ||| S:19258 E:19261 ||| NNP
chimera  ||| S:19261 E:19269 ||| NNS
( ||| S:19269 E:19270 ||| -LRB-
Fig.  ||| S:19270 E:19285 ||| NNP
8a ||| S:19285 E:19287 ||| NNP
,  ||| S:19287 E:19289 ||| ,
lanes  ||| S:19289 E:19295 ||| CD
2  ||| S:19295 E:19297 ||| CD
( ||| S:19297 E:19298 ||| -LRB-
whole  ||| S:19298 E:19304 ||| JJ
cell  ||| S:19304 E:19309 ||| NN
lysates ||| S:19309 E:19316 ||| NN
)  ||| S:19316 E:19318 ||| -RRB-
or  ||| S:19318 E:19321 ||| CC
lane  ||| S:19321 E:19326 ||| CD
3 ||| S:19326 E:19327 ||| CD
,  ||| S:19327 E:19329 ||| ,
anti-chimera  ||| S:19329 E:19352 ||| JJ
immunoprecipitate ||| S:19352 E:19369 ||| NN
) ||| S:19369 E:19370 ||| -RRB-
.  ||| S:19370 E:19372 ||| .
Expression  ||| S:19372 E:19383 ||| NN
of  ||| S:19383 E:19386 ||| IN
v-crk  ||| S:19386 E:19392 ||| JJ
alone  ||| S:19392 E:19398 ||| RB
resulted  ||| S:19398 E:19407 ||| VBN
in  ||| S:19407 E:19420 ||| IN
its  ||| S:19420 E:19424 ||| PRP$
co-immunoprecipitation  ||| S:19424 E:19447 ||| JJ
with  ||| S:19447 E:19452 ||| IN
endogenous  ||| S:19452 E:19463 ||| FW
tyrosine  ||| S:19463 E:19482 ||| FW
phosphorylated  ||| S:19482 E:19497 ||| FW
Cas  ||| S:19497 E:19501 ||| FW
( ||| S:19501 E:19502 ||| -LRB-
Fig.  ||| S:19502 E:19507 ||| NNP
8a ||| S:19507 E:19509 ||| NNP
,  ||| S:19509 E:19511 ||| ,
lane  ||| S:19511 E:19516 ||| CD
4 ||| S:19516 E:19517 ||| CD
) ||| S:19517 E:19518 ||| -RRB-
.  ||| S:19518 E:19520 ||| .
By  ||| S:19520 E:19523 ||| IN
contrast ||| S:19523 E:19531 ||| NN
,  ||| S:19531 E:19543 ||| ,
co-expression  ||| S:19543 E:19557 ||| JJ
of  ||| S:19557 E:19560 ||| IN
v-crk  ||| S:19560 E:19566 ||| JJ
with  ||| S:19566 E:19571 ||| IN
the  ||| S:19571 E:19575 ||| DT
chimera  ||| S:19575 E:19583 ||| NN
resulted  ||| S:19583 E:19592 ||| VBD
in  ||| S:19592 E:19605 ||| IN
reduction  ||| S:19605 E:19615 ||| NN
in  ||| S:19615 E:19618 ||| IN
the  ||| S:19618 E:19622 ||| DT
association  ||| S:19622 E:19634 ||| NN
of  ||| S:19634 E:19637 ||| IN
v-crk  ||| S:19637 E:19643 ||| JJ
with  ||| S:19643 E:19648 ||| IN
endogenous  ||| S:19648 E:19659 ||| JJ
Cas  ||| S:19659 E:19673 ||| NNP
and  ||| S:19673 E:19677 ||| CC
in  ||| S:19677 E:19680 ||| IN
induced  ||| S:19680 E:19688 ||| JJ
association  ||| S:19688 E:19700 ||| NN
of  ||| S:19700 E:19703 ||| IN
v-crk  ||| S:19703 E:19709 ||| JJ
with  ||| S:19709 E:19714 ||| IN
the  ||| S:19714 E:19718 ||| DT
tyrosine  ||| S:19718 E:19737 ||| JJ
phosphorylated  ||| S:19737 E:19752 ||| JJ
Cas  ||| S:19752 E:19756 ||| NNP
3 ||| S:19756 E:19757 ||| NNP
' ||| S:19757 E:19758 ||| POS
SD  ||| S:19758 E:19761 ||| NNP
( ||| S:19761 E:19762 ||| -LRB-
Fig.  ||| S:19762 E:19767 ||| NNP
8a ||| S:19767 E:19769 ||| NNP
,  ||| S:19769 E:19771 ||| ,
lane  ||| S:19771 E:19776 ||| CD
5 ||| S:19776 E:19777 ||| CD
) ||| S:19777 E:19778 ||| -RRB-
.  ||| S:19778 E:19780 ||| .
To  ||| S:19780 E:19783 ||| TO
determine  ||| S:19783 E:19803 ||| VB
if  ||| S:19803 E:19806 ||| IN
the  ||| S:19806 E:19810 ||| DT
tyrosine  ||| S:19810 E:19819 ||| JJ
phosphorylated  ||| S:19819 E:19834 ||| JJ
chimera  ||| S:19834 E:19842 ||| NN
could  ||| S:19842 E:19848 ||| MD
compete  ||| S:19848 E:19856 ||| VB
with  ||| S:19856 E:19871 ||| IN
endogenous  ||| S:19871 E:19882 ||| JJ
Cas  ||| S:19882 E:19886 ||| NNS
for  ||| S:19886 E:19890 ||| IN
binding  ||| S:19890 E:19898 ||| VBG
to  ||| S:19898 E:19901 ||| TO
endogenous  ||| S:19901 E:19912 ||| VB
c-crk ||| S:19912 E:19917 ||| JJ
,  ||| S:19917 E:19919 ||| ,
we  ||| S:19919 E:19932 ||| PRP
transfected  ||| S:19932 E:19944 ||| VBP
either  ||| S:19944 E:19951 ||| RB
the  ||| S:19951 E:19955 ||| DT
isolated  ||| S:19955 E:19964 ||| FW
attenuated  ||| S:19964 E:19975 ||| FW
Src  ||| S:19975 E:19979 ||| FW
kinase  ||| S:19979 E:19996 ||| FW
domain  ||| S:19996 E:20003 ||| NN
as  ||| S:20003 E:20006 ||| IN
control ||| S:20006 E:20013 ||| NN
,  ||| S:20013 E:20015 ||| ,
or  ||| S:20015 E:20018 ||| CC
the  ||| S:20018 E:20022 ||| DT
tyrosine  ||| S:20022 E:20031 ||| FW
phosphorylated  ||| S:20031 E:20046 ||| FW
Cas  ||| S:20046 E:20060 ||| FW
substrate  ||| S:20060 E:20070 ||| FW
domain  ||| S:20070 E:20077 ||| FW
( ||| S:20077 E:20078 ||| -LRB-
Src* ||| S:20078 E:20082 ||| NNP
/ ||| S:20082 E:20083 ||| NNP
Cas ||| S:20083 E:20086 ||| NNP
( ||| S:20086 E:20087 ||| -LRB-
SD ||| S:20087 E:20089 ||| NNP
) ||| S:20089 E:20090 ||| -RRB-
)  ||| S:20090 E:20092 ||| -RRB-
into  ||| S:20092 E:20097 ||| IN
Cos-7  ||| S:20097 E:20103 ||| CD
cells ||| S:20103 E:20108 ||| NNS
,  ||| S:20108 E:20110 ||| ,
and  ||| S:20110 E:20124 ||| CC
immunoprecipitated  ||| S:20124 E:20143 ||| FW
endogenous  ||| S:20143 E:20154 ||| FW
c-crk  ||| S:20154 E:20160 ||| FW
( ||| S:20160 E:20161 ||| -LRB-
Fig.  ||| S:20161 E:20166 ||| NNP
8b ||| S:20166 E:20168 ||| NNP
) ||| S:20168 E:20169 ||| -RRB-
.  ||| S:20169 E:20181 ||| .
Immunoprecipitation  ||| S:20181 E:20201 ||| NNP
of  ||| S:20201 E:20204 ||| IN
endogenous  ||| S:20204 E:20215 ||| JJ
c-crk  ||| S:20215 E:20221 ||| NN
showed  ||| S:20221 E:20238 ||| VBD
association  ||| S:20238 E:20250 ||| NN
with  ||| S:20250 E:20255 ||| IN
endogenous  ||| S:20255 E:20266 ||| JJ
Cas  ||| S:20266 E:20270 ||| NNP
( ||| S:20270 E:20271 ||| -LRB-
Fig.  ||| S:20271 E:20276 ||| NNP
8b ||| S:20276 E:20278 ||| NNP
,  ||| S:20278 E:20280 ||| ,
lane  ||| S:20280 E:20285 ||| CD
1 ||| S:20285 E:20286 ||| CD
) ||| S:20286 E:20287 ||| -RRB-
,  ||| S:20287 E:20289 ||| ,
while  ||| S:20289 E:20305 ||| IN
co-expression  ||| S:20305 E:20319 ||| JJ
of  ||| S:20319 E:20322 ||| IN
the  ||| S:20322 E:20326 ||| DT
tyrosine  ||| S:20326 E:20335 ||| FW
phosphorylated  ||| S:20335 E:20350 ||| FW
Cas  ||| S:20350 E:20364 ||| FW
substrate  ||| S:20364 E:20374 ||| FW
domain  ||| S:20374 E:20381 ||| FW
resulted  ||| S:20381 E:20390 ||| VBN
in  ||| S:20390 E:20393 ||| IN
reduced  ||| S:20393 E:20401 ||| JJ
association  ||| S:20401 E:20413 ||| NN
of  ||| S:20413 E:20426 ||| IN
endogenous  ||| S:20426 E:20437 ||| JJ
c-crk  ||| S:20437 E:20443 ||| NN
with  ||| S:20443 E:20448 ||| IN
endogenous  ||| S:20448 E:20459 ||| JJ
Cas  ||| S:20459 E:20463 ||| NNP
and  ||| S:20463 E:20467 ||| CC
association  ||| S:20467 E:20479 ||| NN
with  ||| S:20479 E:20494 ||| IN
the  ||| S:20494 E:20498 ||| DT
tyrosine  ||| S:20498 E:20507 ||| FW
phosphorylated  ||| S:20507 E:20522 ||| FW
chimera  ||| S:20522 E:20530 ||| FW
( ||| S:20530 E:20531 ||| -LRB-
Fig.  ||| S:20531 E:20536 ||| NNP
8b ||| S:20536 E:20538 ||| NNP
,  ||| S:20538 E:20540 ||| ,
lane  ||| S:20540 E:20545 ||| CD
2 ||| S:20545 E:20546 ||| CD
) ||| S:20546 E:20547 ||| -RRB-
.  ||| S:20547 E:20559 ||| .
These  ||| S:20559 E:20565 ||| DT
data  ||| S:20565 E:20570 ||| NNS
suggest  ||| S:20570 E:20578 ||| VBP
that  ||| S:20578 E:20583 ||| IN
the  ||| S:20583 E:20587 ||| DT
tyrosine  ||| S:20587 E:20596 ||| JJ
phosphorylated  ||| S:20596 E:20621 ||| JJ
substrate  ||| S:20621 E:20631 ||| JJ
domain  ||| S:20631 E:20638 ||| NN
of  ||| S:20638 E:20641 ||| IN
Cas  ||| S:20641 E:20645 ||| NNP
acts  ||| S:20645 E:20650 ||| VBZ
as  ||| S:20650 E:20653 ||| IN
a  ||| S:20653 E:20655 ||| DT
decoy  ||| S:20655 E:20661 ||| NN
for  ||| S:20661 E:20665 ||| IN
binding  ||| S:20665 E:20673 ||| VBG
to  ||| S:20673 E:20676 ||| TO
v-  ||| S:20676 E:20689 ||| JJ
and  ||| S:20689 E:20693 ||| CC
c-crk  ||| S:20693 E:20699 ||| JJ
thereby  ||| S:20699 E:20707 ||| RB
interfering  ||| S:20707 E:20719 ||| VBG
with  ||| S:20719 E:20724 ||| IN
signaling  ||| S:20724 E:20734 ||| VBG
to  ||| S:20734 E:20737 ||| TO
JNK  ||| S:20737 E:20751 ||| NNP
activation  ||| S:20751 E:20762 ||| NN
and  ||| S:20762 E:20766 ||| CC
transformation ||| S:20766 E:20780 ||| NN
.  ||| S:20780 E:20813 ||| .
Discussion  ||| S:20813 E:20832 ||| NNP
Adaptor  ||| S:20832 E:20840 ||| NNP
proteins  ||| S:20840 E:20849 ||| NNS
that  ||| S:20849 E:20854 ||| IN
regulate  ||| S:20854 E:20863 ||| FW
tyrosine  ||| S:20863 E:20872 ||| FW
kinase  ||| S:20872 E:20879 ||| FW
signaling  ||| S:20879 E:20897 ||| FW
pathways  ||| S:20897 E:20906 ||| FW
fall  ||| S:20906 E:20911 ||| NN
into  ||| S:20911 E:20916 ||| IN
two  ||| S:20916 E:20920 ||| CD
major  ||| S:20920 E:20926 ||| JJ
categories ||| S:20926 E:20936 ||| NNS
,  ||| S:20936 E:20938 ||| ,
those  ||| S:20938 E:20944 ||| DT
primarily  ||| S:20944 E:20962 ||| RB
with  ||| S:20962 E:20967 ||| IN
protein ||| S:20967 E:20974 ||| FW
/ ||| S:20974 E:20975 ||| FW
protein  ||| S:20975 E:20983 ||| FW
interaction  ||| S:20983 E:20995 ||| FW
domains  ||| S:20995 E:21003 ||| FW
such  ||| S:21003 E:21008 ||| JJ
as  ||| S:21008 E:21011 ||| IN
SH2 ||| S:21011 E:21014 ||| NNP
,  ||| S:21014 E:21016 ||| ,
SH3 ||| S:21016 E:21019 ||| NNP
,  ||| S:21019 E:21029 ||| ,
PTB ||| S:21029 E:21032 ||| NNP
,  ||| S:21032 E:21034 ||| ,
and  ||| S:21034 E:21038 ||| CC
PH  ||| S:21038 E:21041 ||| NNP
domains ||| S:21041 E:21048 ||| NN
,  ||| S:21048 E:21050 ||| ,
exemplified  ||| S:21050 E:21062 ||| VBG
by  ||| S:21062 E:21065 ||| IN
the  ||| S:21065 E:21069 ||| DT
adaptor  ||| S:21069 E:21077 ||| JJ
proteins  ||| S:21077 E:21094 ||| NNS
c-crk ||| S:21094 E:21099 ||| JJ
,  ||| S:21099 E:21101 ||| ,
nck  ||| S:21101 E:21105 ||| NN
and  ||| S:21105 E:21109 ||| CC
grb-2 ||| S:21109 E:21114 ||| NNP
,  ||| S:21114 E:21116 ||| ,
and  ||| S:21116 E:21120 ||| CC
those  ||| S:21120 E:21126 ||| DT
that  ||| S:21126 E:21131 ||| WDT
are  ||| S:21131 E:21135 ||| VBP
primarily  ||| S:21135 E:21145 ||| RB
tyrosine  ||| S:21145 E:21162 ||| JJ
phosphorylated ||| S:21162 E:21176 ||| NN
,  ||| S:21176 E:21178 ||| ,
exemplified  ||| S:21178 E:21190 ||| VBG
by  ||| S:21190 E:21193 ||| IN
proteins  ||| S:21193 E:21202 ||| NNS
such  ||| S:21202 E:21207 ||| JJ
as  ||| S:21207 E:21210 ||| IN
Cas ||| S:21210 E:21213 ||| NNP
,  ||| S:21213 E:21215 ||| ,
Dok ||| S:21215 E:21218 ||| NNP
,  ||| S:21218 E:21228 ||| ,
IRS-1  ||| S:21228 E:21234 ||| NNP
and  ||| S:21234 E:21238 ||| CC
2 ||| S:21238 E:21239 ||| CD
,  ||| S:21239 E:21241 ||| ,
Slp-76 ||| S:21241 E:21247 ||| NNP
,  ||| S:21247 E:21249 ||| ,
LAT ||| S:21249 E:21252 ||| NNP
,  ||| S:21252 E:21254 ||| ,
TRIM  ||| S:21254 E:21259 ||| NNP
or  ||| S:21259 E:21262 ||| CC
SIT ||| S:21262 E:21265 ||| NNP
.  ||| S:21265 E:21267 ||| .
The  ||| S:21267 E:21271 ||| DT
latter  ||| S:21271 E:21278 ||| JJ
class  ||| S:21278 E:21284 ||| NN
may  ||| S:21284 E:21296 ||| MD
also  ||| S:21296 E:21301 ||| RB
have  ||| S:21301 E:21306 ||| VB
protein ||| S:21306 E:21313 ||| FW
/ ||| S:21313 E:21314 ||| FW
protein  ||| S:21314 E:21322 ||| FW
interaction  ||| S:21322 E:21334 ||| FW
domains ||| S:21334 E:21341 ||| FW
.  ||| S:21341 E:21343 ||| .
The  ||| S:21343 E:21347 ||| DT
former  ||| S:21347 E:21362 ||| JJ
class  ||| S:21362 E:21368 ||| NN
of  ||| S:21368 E:21371 ||| IN
adaptor  ||| S:21371 E:21379 ||| JJ
proteins  ||| S:21379 E:21388 ||| NNS
form  ||| S:21388 E:21393 ||| NN
complexes  ||| S:21393 E:21403 ||| NNS
with  ||| S:21403 E:21408 ||| IN
downstream  ||| S:21408 E:21427 ||| JJ
effectors  ||| S:21427 E:21437 ||| NN
in  ||| S:21437 E:21440 ||| IN
a  ||| S:21440 E:21442 ||| DT
constitutive  ||| S:21442 E:21455 ||| JJ
fashion  ||| S:21455 E:21463 ||| NN
via  ||| S:21463 E:21467 ||| IN
their  ||| S:21467 E:21473 ||| PRP$
SH3  ||| S:21473 E:21477 ||| JJ
domains ||| S:21477 E:21484 ||| NN
.  ||| S:21484 E:21494 ||| .
Signals  ||| S:21494 E:21502 ||| NNS
are  ||| S:21502 E:21506 ||| VBP
initiated  ||| S:21506 E:21516 ||| VBN
by  ||| S:21516 E:21519 ||| IN
tyrosine  ||| S:21519 E:21528 ||| JJ
phosphorylation  ||| S:21528 E:21544 ||| NN
of  ||| S:21544 E:21555 ||| IN
upstream  ||| S:21555 E:21564 ||| JJ
effectors  ||| S:21564 E:21574 ||| NN
that  ||| S:21574 E:21579 ||| IN
recruit  ||| S:21579 E:21587 ||| VBG
these  ||| S:21587 E:21593 ||| DT
adaptors  ||| S:21593 E:21602 ||| NN
to  ||| S:21602 E:21605 ||| TO
assemble  ||| S:21605 E:21622 ||| VB
larger  ||| S:21622 E:21629 ||| JJR
protein  ||| S:21629 E:21637 ||| NN
complexes  ||| S:21637 E:21647 ||| NNS
by  ||| S:21647 E:21650 ||| IN
bringing  ||| S:21650 E:21659 ||| VBG
downstream  ||| S:21659 E:21670 ||| JJ
effectors  ||| S:21670 E:21688 ||| NN
to  ||| S:21688 E:21691 ||| TO
the  ||| S:21691 E:21695 ||| DT
distinct  ||| S:21695 E:21704 ||| JJ
cellular  ||| S:21704 E:21713 ||| JJ
compartments  ||| S:21713 E:21726 ||| NN
for  ||| S:21726 E:21730 ||| IN
activation ||| S:21730 E:21740 ||| NN
.  ||| S:21740 E:21742 ||| .
Thus  ||| S:21742 E:21755 ||| RB
c-crk  ||| S:21755 E:21761 ||| JJ
interacts  ||| S:21761 E:21771 ||| JJ
constitutively  ||| S:21771 E:21786 ||| NN
with  ||| S:21786 E:21791 ||| IN
downstream  ||| S:21791 E:21802 ||| JJ
effectors  ||| S:21802 E:21820 ||| JJ
such  ||| S:21820 E:21825 ||| JJ
as  ||| S:21825 E:21828 ||| IN
C3G  ||| S:21828 E:21832 ||| CD
via  ||| S:21832 E:21836 ||| IN
its  ||| S:21836 E:21840 ||| PRP$
SH3  ||| S:21840 E:21844 ||| JJ
domains ||| S:21844 E:21851 ||| NN
,  ||| S:21851 E:21853 ||| ,
and  ||| S:21853 E:21857 ||| CC
interacts  ||| S:21857 E:21867 ||| NN
in  ||| S:21867 E:21870 ||| IN
a  ||| S:21870 E:21880 ||| DT
phosphotyrosine  ||| S:21880 E:21896 ||| JJ
dependent  ||| S:21896 E:21906 ||| JJ
fashion  ||| S:21906 E:21914 ||| NN
with  ||| S:21914 E:21919 ||| IN
tyrosine  ||| S:21919 E:21936 ||| JJ
phosphorylated  ||| S:21936 E:21951 ||| NNS
receptors  ||| S:21951 E:21961 ||| VBP
using  ||| S:21961 E:21967 ||| VBG
its  ||| S:21967 E:21971 ||| PRP$
SH2  ||| S:21971 E:21975 ||| JJ
domain  ||| S:21975 E:21982 ||| NN
[  ||| S:21982 E:21984 ||| -LRB-
39  ||| S:21984 E:21987 ||| CD
]  ||| S:21987 E:21989 ||| -RRB-
.  ||| S:21989 E:21991 ||| .
To  ||| S:21991 E:22002 ||| TO
analyze  ||| S:22002 E:22010 ||| VB
downstream  ||| S:22010 E:22021 ||| JJ
signals  ||| S:22021 E:22029 ||| NNS
regulated  ||| S:22029 E:22039 ||| VBN
by  ||| S:22039 E:22042 ||| IN
these  ||| S:22042 E:22048 ||| DT
adaptor  ||| S:22048 E:22064 ||| JJ
proteins ||| S:22064 E:22072 ||| NNS
,  ||| S:22072 E:22074 ||| ,
investigators  ||| S:22074 E:22088 ||| NNS
have  ||| S:22088 E:22093 ||| VBP
developed  ||| S:22093 E:22103 ||| VBN
methods  ||| S:22103 E:22111 ||| NNS
that  ||| S:22111 E:22116 ||| WDT
target  ||| S:22116 E:22131 ||| VBP
them  ||| S:22131 E:22136 ||| PRP
to  ||| S:22136 E:22139 ||| TO
distinct  ||| S:22139 E:22148 ||| VB
cellular  ||| S:22148 E:22157 ||| JJ
membrane  ||| S:22157 E:22166 ||| JJ
compartments  ||| S:22166 E:22179 ||| NN
by  ||| S:22179 E:22182 ||| IN
using  ||| S:22182 E:22196 ||| VBG
heterologous  ||| S:22196 E:22209 ||| NNS
targeting  ||| S:22209 E:22219 ||| VBG
sequences ||| S:22219 E:22228 ||| NNS
.  ||| S:22228 E:22230 ||| .
This  ||| S:22230 E:22235 ||| DT
leads  ||| S:22235 E:22241 ||| VBZ
to  ||| S:22241 E:22244 ||| TO
the  ||| S:22244 E:22256 ||| DT
generation  ||| S:22256 E:22267 ||| NN
of  ||| S:22267 E:22270 ||| IN
constitutive  ||| S:22270 E:22283 ||| JJ
signals  ||| S:22283 E:22291 ||| NNS
by  ||| S:22291 E:22294 ||| IN
the  ||| S:22294 E:22298 ||| DT
adaptor  ||| S:22298 E:22306 ||| JJ
proteins  ||| S:22306 E:22323 ||| NNS
in  ||| S:22323 E:22326 ||| IN
the  ||| S:22326 E:22330 ||| DT
absence  ||| S:22330 E:22338 ||| NN
of  ||| S:22338 E:22341 ||| IN
other  ||| S:22341 E:22347 ||| JJ
upstream  ||| S:22347 E:22356 ||| JJ
signals  ||| S:22356 E:22364 ||| NNS
[  ||| S:22364 E:22366 ||| -LRB-
40  ||| S:22366 E:22369 ||| CD
]  ||| S:22369 E:22371 ||| -RRB-
.  ||| S:22371 E:22381 ||| .
The  ||| S:22381 E:22385 ||| DT
second  ||| S:22385 E:22392 ||| JJ
class  ||| S:22392 E:22398 ||| NN
of  ||| S:22398 E:22401 ||| IN
phosphotyrosine  ||| S:22401 E:22417 ||| JJ
dependent  ||| S:22417 E:22427 ||| JJ
adaptors  ||| S:22427 E:22444 ||| JJ
exemplified  ||| S:22444 E:22456 ||| NN
by  ||| S:22456 E:22459 ||| IN
proteins  ||| S:22459 E:22468 ||| NNS
such  ||| S:22468 E:22473 ||| JJ
as  ||| S:22473 E:22476 ||| IN
Cas ||| S:22476 E:22479 ||| NNP
,  ||| S:22479 E:22481 ||| ,
Dok ||| S:22481 E:22484 ||| NNP
,  ||| S:22484 E:22486 ||| ,
IRS-1  ||| S:22486 E:22492 ||| NNP
and  ||| S:22492 E:22496 ||| CC
2  ||| S:22496 E:22498 ||| CD
or  ||| S:22498 E:22509 ||| CC
Slp-76 ||| S:22509 E:22515 ||| NNP
,  ||| S:22515 E:22517 ||| ,
as  ||| S:22517 E:22520 ||| IN
cytosolic  ||| S:22520 E:22530 ||| JJ
adaptors ||| S:22530 E:22538 ||| NN
,  ||| S:22538 E:22540 ||| ,
or  ||| S:22540 E:22543 ||| CC
LAT ||| S:22543 E:22546 ||| NNP
,  ||| S:22546 E:22548 ||| ,
TRIM  ||| S:22548 E:22553 ||| NNP
or  ||| S:22553 E:22556 ||| CC
SIT  ||| S:22556 E:22560 ||| NNP
as  ||| S:22560 E:22571 ||| IN
membrane  ||| S:22571 E:22580 ||| JJ
anchored  ||| S:22580 E:22589 ||| JJ
adaptors ||| S:22589 E:22597 ||| NN
,  ||| S:22597 E:22599 ||| ,
also  ||| S:22599 E:22604 ||| RB
require  ||| S:22604 E:22612 ||| VB
the  ||| S:22612 E:22616 ||| DT
activation  ||| S:22616 E:22627 ||| NN
of  ||| S:22627 E:22638 ||| IN
upstream  ||| S:22638 E:22647 ||| JJ
signals  ||| S:22647 E:22655 ||| NNS
by  ||| S:22655 E:22658 ||| IN
tyrosine  ||| S:22658 E:22667 ||| JJ
kinases  ||| S:22667 E:22675 ||| NN
for  ||| S:22675 E:22679 ||| IN
their  ||| S:22679 E:22685 ||| PRP$
function ||| S:22685 E:22693 ||| NN
.  ||| S:22693 E:22703 ||| .
This  ||| S:22703 E:22708 ||| DT
second  ||| S:22708 E:22715 ||| JJ
class  ||| S:22715 E:22721 ||| NN
of  ||| S:22721 E:22724 ||| IN
adaptor  ||| S:22724 E:22732 ||| JJ
proteins  ||| S:22732 E:22741 ||| NNS
is  ||| S:22741 E:22744 ||| VBZ
characterized  ||| S:22744 E:22758 ||| VBN
by  ||| S:22758 E:22761 ||| IN
a  ||| S:22761 E:22771 ||| DT
substrate  ||| S:22771 E:22781 ||| JJ
domain  ||| S:22781 E:22788 ||| NN
with  ||| S:22788 E:22793 ||| IN
multiple  ||| S:22793 E:22802 ||| JJ
tyrosines  ||| S:22802 E:22812 ||| NN
for  ||| S:22812 E:22824 ||| IN
phosphorylation  ||| S:22824 E:22840 ||| NN
by  ||| S:22840 E:22843 ||| IN
upstream  ||| S:22843 E:22852 ||| JJ
kinases ||| S:22852 E:22859 ||| NN
.  ||| S:22859 E:22861 ||| .
Phosphorylation  ||| S:22861 E:22877 ||| NNP
of  ||| S:22877 E:22888 ||| IN
these  ||| S:22888 E:22894 ||| DT
sites  ||| S:22894 E:22900 ||| NNS
leads  ||| S:22900 E:22906 ||| VBZ
to  ||| S:22906 E:22909 ||| TO
recruitment  ||| S:22909 E:22921 ||| VB
of  ||| S:22921 E:22924 ||| IN
other  ||| S:22924 E:22930 ||| JJ
proteins ||| S:22930 E:22938 ||| NNS
,  ||| S:22938 E:22948 ||| ,
including  ||| S:22948 E:22958 ||| VBG
the  ||| S:22958 E:22962 ||| DT
first  ||| S:22962 E:22968 ||| JJ
class  ||| S:22968 E:22974 ||| NN
of  ||| S:22974 E:22977 ||| IN
adaptor  ||| S:22977 E:22985 ||| JJ
proteins  ||| S:22985 E:22994 ||| NNS
with  ||| S:22994 E:22999 ||| IN
SH2  ||| S:22999 E:23003 ||| NNP
or  ||| S:23003 E:23014 ||| CC
PTB  ||| S:23014 E:23018 ||| NNP
domains ||| S:23018 E:23025 ||| NN
,  ||| S:23025 E:23027 ||| ,
and  ||| S:23027 E:23031 ||| CC
subsequent  ||| S:23031 E:23042 ||| JJ
signal  ||| S:23042 E:23049 ||| NN
transmission  ||| S:23049 E:23062 ||| NN
( ||| S:23062 E:23063 ||| -LRB-
see  ||| S:23063 E:23067 ||| VB
[  ||| S:23067 E:23069 ||| -LRB-
41  ||| S:23069 E:23072 ||| CD
]  ||| S:23072 E:23082 ||| -RRB-
for  ||| S:23082 E:23086 ||| IN
review ||| S:23086 E:23092 ||| NN
) ||| S:23092 E:23093 ||| -RRB-
.  ||| S:23093 E:23095 ||| .
Analysis  ||| S:23095 E:23104 ||| NN
of  ||| S:23104 E:23107 ||| IN
the  ||| S:23107 E:23111 ||| DT
specific  ||| S:23111 E:23120 ||| JJ
signals  ||| S:23120 E:23128 ||| NNS
emanating  ||| S:23128 E:23146 ||| VBN
from  ||| S:23146 E:23151 ||| IN
the  ||| S:23151 E:23155 ||| DT
second  ||| S:23155 E:23162 ||| JJ
class  ||| S:23162 E:23168 ||| NN
of  ||| S:23168 E:23171 ||| IN
adaptor  ||| S:23171 E:23179 ||| JJ
proteins  ||| S:23179 E:23188 ||| NNS
has  ||| S:23188 E:23192 ||| VBZ
been  ||| S:23192 E:23205 ||| VBN
difficult  ||| S:23205 E:23215 ||| JJ
due  ||| S:23215 E:23219 ||| JJ
to  ||| S:23219 E:23222 ||| TO
their  ||| S:23222 E:23228 ||| PRP$
dependence  ||| S:23228 E:23239 ||| NN
on  ||| S:23239 E:23242 ||| IN
upstream  ||| S:23242 E:23251 ||| JJ
kinases  ||| S:23251 E:23259 ||| NN
for  ||| S:23259 E:23271 ||| IN
tyrosine  ||| S:23271 E:23280 ||| JJ
phosphorylation  ||| S:23280 E:23296 ||| NN
of  ||| S:23296 E:23299 ||| IN
the  ||| S:23299 E:23303 ||| DT
substrate  ||| S:23303 E:23313 ||| JJ
domains  ||| S:23313 E:23321 ||| NN
for  ||| S:23321 E:23333 ||| IN
subsequent  ||| S:23333 E:23344 ||| JJ
assembly  ||| S:23344 E:23353 ||| NN
of  ||| S:23353 E:23356 ||| IN
downstream  ||| S:23356 E:23367 ||| JJ
effectors ||| S:23367 E:23376 ||| NN
.  ||| S:23376 E:23378 ||| .
While  ||| S:23378 E:23384 ||| IN
these  ||| S:23384 E:23398 ||| DT
upstream  ||| S:23398 E:23407 ||| JJ
kinases  ||| S:23407 E:23415 ||| NNS
lead  ||| S:23415 E:23420 ||| VBP
to  ||| S:23420 E:23423 ||| TO
tyrosine  ||| S:23423 E:23432 ||| VB
phosphorylation  ||| S:23432 E:23448 ||| VBN
of  ||| S:23448 E:23451 ||| IN
the  ||| S:23451 E:23463 ||| DT
adaptor  ||| S:23463 E:23471 ||| NN
and  ||| S:23471 E:23475 ||| CC
activation  ||| S:23475 E:23486 ||| NN
of  ||| S:23486 E:23489 ||| IN
downstream  ||| S:23489 E:23500 ||| JJ
effectors ||| S:23500 E:23509 ||| NN
,  ||| S:23509 E:23511 ||| ,
they  ||| S:23511 E:23524 ||| PRP
usually  ||| S:23524 E:23532 ||| RB
also  ||| S:23532 E:23537 ||| RB
activate  ||| S:23537 E:23546 ||| VBP
other  ||| S:23546 E:23552 ||| JJ
signaling  ||| S:23552 E:23562 ||| JJ
pathways  ||| S:23562 E:23571 ||| NN
that  ||| S:23571 E:23576 ||| WDT
can  ||| S:23576 E:23588 ||| MD
confound  ||| S:23588 E:23597 ||| VB
analysis  ||| S:23597 E:23606 ||| NN
of  ||| S:23606 E:23609 ||| IN
the  ||| S:23609 E:23613 ||| DT
specific  ||| S:23613 E:23622 ||| JJ
role  ||| S:23622 E:23627 ||| NN
of  ||| S:23627 E:23630 ||| IN
the  ||| S:23630 E:23634 ||| DT
tyrosine  ||| S:23634 E:23651 ||| JJ
phosphorylated  ||| S:23651 E:23666 ||| JJ
adaptor  ||| S:23666 E:23674 ||| JJ
protein ||| S:23674 E:23681 ||| NN
.  ||| S:23681 E:23691 ||| .
We  ||| S:23691 E:23694 ||| PRP
describe  ||| S:23694 E:23703 ||| VBP
a  ||| S:23703 E:23705 ||| DT
novel  ||| S:23705 E:23711 ||| NN
chimeric  ||| S:23711 E:23720 ||| NN
molecule  ||| S:23720 E:23729 ||| NN
approach  ||| S:23729 E:23738 ||| NN
that  ||| S:23738 E:23751 ||| WDT
allows  ||| S:23751 E:23758 ||| VBZ
the  ||| S:23758 E:23762 ||| DT
analysis  ||| S:23762 E:23771 ||| NN
of  ||| S:23771 E:23774 ||| IN
signaling  ||| S:23774 E:23784 ||| VBG
events  ||| S:23784 E:23791 ||| NNS
regulated  ||| S:23791 E:23801 ||| VBN
by  ||| S:23801 E:23812 ||| IN
adaptor  ||| S:23812 E:23820 ||| JJ
proteins  ||| S:23820 E:23829 ||| NNS
that  ||| S:23829 E:23834 ||| WDT
require  ||| S:23834 E:23842 ||| VBP
tyrosine  ||| S:23842 E:23851 ||| JJ
phosphorylation  ||| S:23851 E:23867 ||| NN
by  ||| S:23867 E:23878 ||| IN
upstream  ||| S:23878 E:23887 ||| JJ
signals  ||| S:23887 E:23895 ||| NNS
for  ||| S:23895 E:23899 ||| IN
which  ||| S:23899 E:23905 ||| WDT
we  ||| S:23905 E:23908 ||| PRP
used  ||| S:23908 E:23913 ||| VBD
the  ||| S:23913 E:23917 ||| DT
Cas  ||| S:23917 E:23921 ||| JJ
protein  ||| S:23921 E:23929 ||| NN
as  ||| S:23929 E:23932 ||| IN
a  ||| S:23932 E:23942 ||| DT
model ||| S:23942 E:23947 ||| NN
.  ||| S:23947 E:23949 ||| .
The  ||| S:23949 E:23953 ||| DT
adaptor  ||| S:23953 E:23961 ||| JJ
protein  ||| S:23961 E:23969 ||| NN
Cas  ||| S:23969 E:23973 ||| NNP
has  ||| S:23973 E:23977 ||| VBZ
several  ||| S:23977 E:23985 ||| JJ
domains  ||| S:23985 E:23993 ||| NN
that  ||| S:23993 E:23998 ||| WDT
are  ||| S:23998 E:24010 ||| VBP
important  ||| S:24010 E:24020 ||| JJ
for  ||| S:24020 E:24024 ||| IN
its  ||| S:24024 E:24028 ||| PRP$
function ||| S:24028 E:24036 ||| NN
,  ||| S:24036 E:24038 ||| ,
an  ||| S:24038 E:24041 ||| DT
SH3  ||| S:24041 E:24045 ||| JJ
domain ||| S:24045 E:24051 ||| NN
,  ||| S:24051 E:24053 ||| ,
a  ||| S:24053 E:24055 ||| DT
central  ||| S:24055 E:24071 ||| JJ
substrate  ||| S:24071 E:24081 ||| JJ
domain  ||| S:24081 E:24088 ||| NN
with  ||| S:24088 E:24093 ||| IN
up  ||| S:24093 E:24096 ||| RB
to  ||| S:24096 E:24099 ||| TO
15  ||| S:24099 E:24102 ||| CD
tyrosines  ||| S:24102 E:24112 ||| NNS
that  ||| S:24112 E:24117 ||| WDT
can  ||| S:24117 E:24121 ||| MD
serve  ||| S:24121 E:24127 ||| VB
as  ||| S:24127 E:24138 ||| IN
tyrosine  ||| S:24138 E:24147 ||| JJ
kinase  ||| S:24147 E:24154 ||| JJ
substrates  ||| S:24154 E:24165 ||| NN
for  ||| S:24165 E:24169 ||| IN
upstream  ||| S:24169 E:24178 ||| JJ
kinases  ||| S:24178 E:24186 ||| JJ
such  ||| S:24186 E:24191 ||| JJ
as  ||| S:24191 E:24194 ||| IN
Src  ||| S:24194 E:24206 ||| NNP
and  ||| S:24206 E:24210 ||| CC
Abl  ||| S:24210 E:24214 ||| NNP
[  ||| S:24214 E:24216 ||| -LRB-
19  ||| S:24216 E:24219 ||| CD
42  ||| S:24219 E:24222 ||| CD
43  ||| S:24222 E:24225 ||| CD
]  ||| S:24225 E:24227 ||| -RRB-
,  ||| S:24227 E:24229 ||| ,
and  ||| S:24229 E:24233 ||| CC
a  ||| S:24233 E:24235 ||| DT
C-terminal  ||| S:24235 E:24246 ||| JJ
Src  ||| S:24246 E:24250 ||| JJ
binding  ||| S:24250 E:24258 ||| JJ
domain  ||| S:24258 E:24273 ||| NN
with  ||| S:24273 E:24278 ||| IN
PXXP  ||| S:24278 E:24283 ||| NNP
motifs  ||| S:24283 E:24290 ||| NNS
for  ||| S:24290 E:24294 ||| IN
binding  ||| S:24294 E:24302 ||| VBG
to  ||| S:24302 E:24305 ||| TO
the  ||| S:24305 E:24309 ||| DT
SH3  ||| S:24309 E:24313 ||| JJ
domain  ||| S:24313 E:24320 ||| NN
of  ||| S:24320 E:24323 ||| IN
Src ||| S:24323 E:24326 ||| NNP
,  ||| S:24326 E:24328 ||| ,
and  ||| S:24328 E:24340 ||| CC
two  ||| S:24340 E:24344 ||| CD
tyrosines  ||| S:24344 E:24354 ||| NNS
providing  ||| S:24354 E:24364 ||| VBG
docking  ||| S:24364 E:24372 ||| JJ
sites  ||| S:24372 E:24378 ||| NNS
for  ||| S:24378 E:24382 ||| IN
the  ||| S:24382 E:24386 ||| DT
Src  ||| S:24386 E:24390 ||| NNP
SH2  ||| S:24390 E:24402 ||| NNP
domain  ||| S:24402 E:24409 ||| NN
upon  ||| S:24409 E:24414 ||| IN
phosphorylation  ||| S:24414 E:24430 ||| NNS
[  ||| S:24430 E:24432 ||| -LRB-
6  ||| S:24432 E:24434 ||| CD
]  ||| S:24434 E:24436 ||| -RRB-
.  ||| S:24436 E:24438 ||| .
The  ||| S:24438 E:24442 ||| DT
substrate  ||| S:24442 E:24452 ||| JJ
domain  ||| S:24452 E:24459 ||| NN
of  ||| S:24459 E:24470 ||| IN
Cas  ||| S:24470 E:24474 ||| NNP
has  ||| S:24474 E:24478 ||| VBZ
two  ||| S:24478 E:24482 ||| CD
major  ||| S:24482 E:24488 ||| JJ
types  ||| S:24488 E:24494 ||| NNS
of  ||| S:24494 E:24497 ||| IN
tyrosine  ||| S:24497 E:24506 ||| JJ
motifs  ||| S:24506 E:24513 ||| NNS
that  ||| S:24513 E:24518 ||| WDT
can  ||| S:24518 E:24522 ||| MD
be  ||| S:24522 E:24533 ||| VB
phosphorylated  ||| S:24533 E:24548 ||| NNS
and  ||| S:24548 E:24552 ||| CC
bind  ||| S:24552 E:24557 ||| JJ
downstream  ||| S:24557 E:24568 ||| JJ
effectors ||| S:24568 E:24577 ||| NN
,  ||| S:24577 E:24579 ||| ,
YQXP  ||| S:24579 E:24584 ||| NNP
( ||| S:24584 E:24585 ||| -LRB-
4  ||| S:24585 E:24595 ||| CD
copies ||| S:24595 E:24601 ||| NNS
)  ||| S:24601 E:24603 ||| -RRB-
and  ||| S:24603 E:24607 ||| CC
YDXP  ||| S:24607 E:24612 ||| NNP
motifs  ||| S:24612 E:24619 ||| NNS
( ||| S:24619 E:24620 ||| -LRB-
9  ||| S:24620 E:24622 ||| CD
copies ||| S:24622 E:24628 ||| NNS
) ||| S:24628 E:24629 ||| -RRB-
,  ||| S:24629 E:24631 ||| ,
suggesting  ||| S:24631 E:24642 ||| VBG
that  ||| S:24642 E:24647 ||| IN
at  ||| S:24647 E:24658 ||| IN
least  ||| S:24658 E:24664 ||| JJS
two  ||| S:24664 E:24668 ||| CD
classes  ||| S:24668 E:24676 ||| NNS
of  ||| S:24676 E:24679 ||| IN
downstream  ||| S:24679 E:24690 ||| JJ
effectors ||| S:24690 E:24699 ||| NN
,  ||| S:24699 E:24701 ||| ,
one  ||| S:24701 E:24705 ||| CD
capable  ||| S:24705 E:24713 ||| JJ
of  ||| S:24713 E:24724 ||| IN
binding  ||| S:24724 E:24732 ||| VBG
to  ||| S:24732 E:24735 ||| TO
YDXP  ||| S:24735 E:24740 ||| NNP
motifs  ||| S:24740 E:24747 ||| NNS
and  ||| S:24747 E:24751 ||| CC
the  ||| S:24751 E:24755 ||| DT
other  ||| S:24755 E:24761 ||| JJ
capable  ||| S:24761 E:24769 ||| JJ
of  ||| S:24769 E:24772 ||| IN
binding  ||| S:24772 E:24780 ||| VBG
to  ||| S:24780 E:24791 ||| TO
YQXP  ||| S:24791 E:24796 ||| NNP
motifs ||| S:24796 E:24802 ||| NNS
,  ||| S:24802 E:24804 ||| ,
are  ||| S:24804 E:24808 ||| VBP
assembled  ||| S:24808 E:24818 ||| VBN
by  ||| S:24818 E:24821 ||| IN
this  ||| S:24821 E:24826 ||| DT
adaptor  ||| S:24826 E:24834 ||| JJ
protein ||| S:24834 E:24841 ||| NN
.  ||| S:24841 E:24851 ||| .
Tyrosine  ||| S:24851 E:24860 ||| JJ
phosphorylation  ||| S:24860 E:24876 ||| NN
of  ||| S:24876 E:24879 ||| IN
the  ||| S:24879 E:24883 ||| DT
substrate  ||| S:24883 E:24893 ||| JJ
domain  ||| S:24893 E:24900 ||| NN
leads  ||| S:24900 E:24906 ||| VBZ
to  ||| S:24906 E:24917 ||| TO
the  ||| S:24917 E:24921 ||| DT
recruitment  ||| S:24921 E:24933 ||| NN
of  ||| S:24933 E:24936 ||| IN
other  ||| S:24936 E:24942 ||| JJ
downstream  ||| S:24942 E:24953 ||| NNS
adaptors  ||| S:24953 E:24962 ||| VBP
such  ||| S:24962 E:24967 ||| JJ
as  ||| S:24967 E:24970 ||| IN
crk  ||| S:24970 E:24982 ||| NN
and  ||| S:24982 E:24986 ||| CC
nck ||| S:24986 E:24989 ||| NN
,  ||| S:24989 E:24991 ||| ,
as  ||| S:24991 E:24994 ||| RB
well  ||| S:24994 E:24999 ||| RB
as  ||| S:24999 E:25002 ||| IN
other  ||| S:25002 E:25008 ||| JJ
downstream  ||| S:25008 E:25019 ||| FW
effectors  ||| S:25019 E:25029 ||| FW
possessing  ||| S:25029 E:25048 ||| FW
SH2  ||| S:25048 E:25052 ||| FW
domains ||| S:25052 E:25059 ||| FW
,  ||| S:25059 E:25061 ||| ,
and  ||| S:25061 E:25065 ||| CC
signaling  ||| S:25065 E:25075 ||| VBG
events  ||| S:25075 E:25082 ||| NNS
attributed  ||| S:25082 E:25093 ||| VBD
to  ||| S:25093 E:25096 ||| TO
this  ||| S:25096 E:25101 ||| DT
domain  ||| S:25101 E:25116 ||| NN
include  ||| S:25116 E:25124 ||| VBP
activation  ||| S:25124 E:25135 ||| VBN
of  ||| S:25135 E:25138 ||| IN
the  ||| S:25138 E:25142 ||| DT
JNK  ||| S:25142 E:25146 ||| NNP
MAPK  ||| S:25146 E:25151 ||| NNP
pathway  ||| S:25151 E:25159 ||| NN
and  ||| S:25159 E:25163 ||| CC
control  ||| S:25163 E:25171 ||| NN
of  ||| S:25171 E:25182 ||| IN
adhesion  ||| S:25182 E:25191 ||| NN
and  ||| S:25191 E:25195 ||| CC
migration  ||| S:25195 E:25205 ||| NN
of  ||| S:25205 E:25208 ||| IN
cells  ||| S:25208 E:25214 ||| NNS
[  ||| S:25214 E:25216 ||| -LRB-
6  ||| S:25216 E:25218 ||| CD
10  ||| S:25218 E:25221 ||| CD
16  ||| S:25221 E:25224 ||| CD
38  ||| S:25224 E:25227 ||| CD
44  ||| S:25227 E:25230 ||| CD
]  ||| S:25230 E:25232 ||| -RRB-
.  ||| S:25232 E:25234 ||| .
We  ||| S:25234 E:25245 ||| PRP
constructed  ||| S:25245 E:25257 ||| VBD
a  ||| S:25257 E:25259 ||| DT
chimera  ||| S:25259 E:25267 ||| NN
between  ||| S:25267 E:25275 ||| IN
a  ||| S:25275 E:25277 ||| DT
kinase  ||| S:25277 E:25284 ||| NN
that  ||| S:25284 E:25289 ||| IN
phosphorylates  ||| S:25289 E:25312 ||| JJ
Cas  ||| S:25312 E:25325 ||| NNS
in  ||| S:25325 E:25328 ||| IN
vivo  ||| S:25328 E:25333 ||| NN
and  ||| S:25333 E:25337 ||| CC
the  ||| S:25337 E:25341 ||| DT
substrate  ||| S:25341 E:25351 ||| JJ
domain  ||| S:25351 E:25358 ||| NN
of  ||| S:25358 E:25369 ||| IN
Cas ||| S:25369 E:25372 ||| NNP
,  ||| S:25372 E:25374 ||| ,
in  ||| S:25374 E:25377 ||| IN
order  ||| S:25377 E:25383 ||| NN
to  ||| S:25383 E:25386 ||| TO
determine  ||| S:25386 E:25396 ||| VB
events  ||| S:25396 E:25403 ||| NNS
regulated  ||| S:25403 E:25413 ||| VBN
by  ||| S:25413 E:25416 ||| IN
this  ||| S:25416 E:25421 ||| DT
domain ||| S:25421 E:25427 ||| NN
.  ||| S:25427 E:25437 ||| .
We  ||| S:25437 E:25440 ||| PRP
constructed  ||| S:25440 E:25452 ||| VBP
chimeras  ||| S:25452 E:25461 ||| VBN
by  ||| S:25461 E:25464 ||| IN
placing  ||| S:25464 E:25472 ||| VBG
the  ||| S:25472 E:25476 ||| DT
Cas  ||| S:25476 E:25480 ||| NNP
SD  ||| S:25480 E:25483 ||| NNP
at  ||| S:25483 E:25486 ||| IN
either  ||| S:25486 E:25493 ||| RB
the  ||| S:25493 E:25505 ||| DT
N-terminus  ||| S:25505 E:25516 ||| JJ
or  ||| S:25516 E:25519 ||| CC
C-terminus  ||| S:25519 E:25530 ||| JJ
of  ||| S:25530 E:25533 ||| IN
the  ||| S:25533 E:25537 ||| DT
Src  ||| S:25537 E:25541 ||| JJ
kinase  ||| S:25541 E:25548 ||| JJ
domain ||| S:25548 E:25554 ||| NN
.  ||| S:25554 E:25556 ||| .
However ||| S:25556 E:25563 ||| RB
,  ||| S:25563 E:25573 ||| ,
we  ||| S:25573 E:25576 ||| PRP
found  ||| S:25576 E:25582 ||| VBD
that  ||| S:25582 E:25587 ||| IN
placing  ||| S:25587 E:25595 ||| VBG
the  ||| S:25595 E:25599 ||| DT
Cas  ||| S:25599 E:25603 ||| NNP
SD  ||| S:25603 E:25606 ||| NNP
at  ||| S:25606 E:25609 ||| IN
the  ||| S:25609 E:25613 ||| DT
N-terminus  ||| S:25613 E:25624 ||| JJ
of  ||| S:25624 E:25627 ||| IN
the  ||| S:25627 E:25639 ||| DT
Src  ||| S:25639 E:25643 ||| JJ
kinase  ||| S:25643 E:25650 ||| JJ
domain  ||| S:25650 E:25657 ||| NN
was  ||| S:25657 E:25661 ||| VBD
inferior  ||| S:25661 E:25670 ||| VBN
to  ||| S:25670 E:25673 ||| TO
placing  ||| S:25673 E:25681 ||| VB
it  ||| S:25681 E:25684 ||| PRP
at  ||| S:25684 E:25687 ||| IN
the  ||| S:25687 E:25699 ||| DT
C-terminus  ||| S:25699 E:25710 ||| JJ
with  ||| S:25710 E:25715 ||| IN
regards  ||| S:25715 E:25723 ||| VBG
to  ||| S:25723 E:25726 ||| TO
tyrosine  ||| S:25726 E:25735 ||| VB
phosphorylation  ||| S:25735 E:25751 ||| VBN
of  ||| S:25751 E:25754 ||| IN
the  ||| S:25754 E:25766 ||| DT
Cas  ||| S:25766 E:25770 ||| NNP
SD ||| S:25770 E:25772 ||| NNP
.  ||| S:25772 E:25774 ||| .
Subsequently ||| S:25774 E:25786 ||| RB
,  ||| S:25786 E:25788 ||| ,
in  ||| S:25788 E:25791 ||| IN
all  ||| S:25791 E:25795 ||| PDT
our  ||| S:25795 E:25799 ||| PRP$
experiments  ||| S:25799 E:25811 ||| NNS
reported ||| S:25811 E:25819 ||| VBD
,  ||| S:25819 E:25821 ||| ,
we  ||| S:25821 E:25832 ||| PRP
used  ||| S:25832 E:25837 ||| VBD
chimeras  ||| S:25837 E:25846 ||| VBN
of  ||| S:25846 E:25849 ||| IN
the  ||| S:25849 E:25853 ||| DT
Cas  ||| S:25853 E:25857 ||| NNP
SD  ||| S:25857 E:25860 ||| NNP
fused  ||| S:25860 E:25866 ||| VBD
to  ||| S:25866 E:25869 ||| TO
the  ||| S:25869 E:25873 ||| DT
C-terminus  ||| S:25873 E:25884 ||| JJ
of  ||| S:25884 E:25887 ||| IN
the  ||| S:25887 E:25899 ||| DT
Src  ||| S:25899 E:25903 ||| JJ
kinase  ||| S:25903 E:25910 ||| JJ
domains ||| S:25910 E:25917 ||| NN
.  ||| S:25917 E:25919 ||| .
Rather  ||| S:25919 E:25926 ||| RB
than  ||| S:25926 E:25931 ||| IN
the  ||| S:25931 E:25935 ||| DT
WT  ||| S:25935 E:25938 ||| NNP
kinase  ||| S:25938 E:25945 ||| JJ
domain  ||| S:25945 E:25952 ||| NN
of  ||| S:25952 E:25963 ||| IN
Src ||| S:25963 E:25966 ||| NNP
,  ||| S:25966 E:25968 ||| ,
we  ||| S:25968 E:25971 ||| PRP
used  ||| S:25971 E:25976 ||| VBD
an  ||| S:25976 E:25979 ||| DT
attenuated  ||| S:25979 E:25990 ||| FW
Src  ||| S:25990 E:25994 ||| FW
kinase  ||| S:25994 E:26001 ||| FW
domain  ||| S:26001 E:26008 ||| FW
( ||| S:26008 E:26009 ||| -LRB-
Y416F ||| S:26009 E:26014 ||| NNP
)  ||| S:26014 E:26016 ||| -RRB-
as  ||| S:26016 E:26019 ||| IN
the  ||| S:26019 E:26031 ||| DT
fusion  ||| S:26031 E:26038 ||| NN
partner  ||| S:26038 E:26046 ||| NN
for  ||| S:26046 E:26050 ||| IN
our  ||| S:26050 E:26054 ||| PRP$
chimera  ||| S:26054 E:26062 ||| NN
to  ||| S:26062 E:26065 ||| TO
avoid  ||| S:26065 E:26071 ||| VB
phosphorylation  ||| S:26071 E:26087 ||| NNS
and  ||| S:26087 E:26099 ||| CC
activation  ||| S:26099 E:26110 ||| NN
of  ||| S:26110 E:26113 ||| IN
other  ||| S:26113 E:26119 ||| JJ
Src  ||| S:26119 E:26123 ||| JJ
substrates  ||| S:26123 E:26134 ||| NN
that  ||| S:26134 E:26139 ||| WDT
would  ||| S:26139 E:26145 ||| MD
occur  ||| S:26145 E:26151 ||| VB
with  ||| S:26151 E:26156 ||| IN
a  ||| S:26156 E:26166 ||| DT
WT  ||| S:26166 E:26169 ||| FW
kinase  ||| S:26169 E:26176 ||| FW
domain  ||| S:26176 E:26183 ||| FW
( ||| S:26183 E:26184 ||| -LRB-
data  ||| S:26184 E:26189 ||| NNS
not  ||| S:26189 E:26193 ||| RB
shown ||| S:26193 E:26198 ||| VBN
,  ||| S:26198 E:26200 ||| ,
[  ||| S:26200 E:26202 ||| -LRB-
35  ||| S:26202 E:26205 ||| CD
]  ||| S:26205 E:26207 ||| CD
) ||| S:26207 E:26208 ||| -RRB-
.  ||| S:26208 E:26210 ||| .
The  ||| S:26210 E:26214 ||| DT
attenuated  ||| S:26214 E:26233 ||| FW
Src  ||| S:26233 E:26237 ||| FW
kinase  ||| S:26237 E:26244 ||| FW
domain  ||| S:26244 E:26251 ||| FW
has  ||| S:26251 E:26255 ||| VBZ
reduced  ||| S:26255 E:26263 ||| VBN
kinase  ||| S:26263 E:26270 ||| JJ
activity  ||| S:26270 E:26279 ||| NN
and  ||| S:26279 E:26283 ||| CC
does  ||| S:26283 E:26288 ||| VBZ
not  ||| S:26288 E:26300 ||| RB
phosphorylate  ||| S:26300 E:26314 ||| FW
exogenous  ||| S:26314 E:26324 ||| FW
substrates  ||| S:26324 E:26335 ||| FW
[  ||| S:26335 E:26337 ||| -LRB-
35  ||| S:26337 E:26340 ||| CD
]  ||| S:26340 E:26342 ||| -RRB-
.  ||| S:26342 E:26344 ||| .
We  ||| S:26344 E:26347 ||| PRP
also  ||| S:26347 E:26352 ||| RB
used  ||| S:26352 E:26357 ||| VBN
a  ||| S:26357 E:26367 ||| DT
kinase  ||| S:26367 E:26374 ||| FW
inactive  ||| S:26374 E:26383 ||| FW
Src  ||| S:26383 E:26387 ||| FW
kinase  ||| S:26387 E:26394 ||| FW
domain  ||| S:26394 E:26401 ||| NN
as  ||| S:26401 E:26404 ||| IN
a  ||| S:26404 E:26406 ||| DT
control  ||| S:26406 E:26414 ||| NN
fusion  ||| S:26414 E:26429 ||| NN
protein ||| S:26429 E:26436 ||| NN
.  ||| S:26436 E:26438 ||| .
The  ||| S:26438 E:26442 ||| DT
chimera  ||| S:26442 E:26450 ||| NN
of  ||| S:26450 E:26453 ||| IN
the  ||| S:26453 E:26457 ||| DT
Cas  ||| S:26457 E:26461 ||| NNP
SD  ||| S:26461 E:26464 ||| NNP
domain  ||| S:26464 E:26471 ||| NN
fused  ||| S:26471 E:26477 ||| NN
to  ||| S:26477 E:26480 ||| TO
the  ||| S:26480 E:26492 ||| DT
attenuated  ||| S:26492 E:26503 ||| JJ
Src  ||| S:26503 E:26507 ||| JJ
kinase  ||| S:26507 E:26514 ||| JJ
domain  ||| S:26514 E:26521 ||| NN
was  ||| S:26521 E:26525 ||| VBD
highly  ||| S:26525 E:26532 ||| RB
tyrosine  ||| S:26532 E:26549 ||| JJ
phosphorylated  ||| S:26549 E:26564 ||| NN
in  ||| S:26564 E:26567 ||| IN
cells ||| S:26567 E:26572 ||| NNS
,  ||| S:26572 E:26574 ||| ,
and  ||| S:26574 E:26578 ||| CC
could  ||| S:26578 E:26584 ||| MD
bind  ||| S:26584 E:26589 ||| VB
known  ||| S:26589 E:26595 ||| VBN
Cas  ||| S:26595 E:26599 ||| JJ
binding  ||| S:26599 E:26615 ||| JJ
proteins  ||| S:26615 E:26624 ||| NNS
in  ||| S:26624 E:26627 ||| IN
cells ||| S:26627 E:26632 ||| NNS
.  ||| S:26632 E:26634 ||| .
In  ||| S:26634 E:26637 ||| IN
contrast ||| S:26637 E:26645 ||| NN
,  ||| S:26645 E:26647 ||| ,
the  ||| S:26647 E:26651 ||| DT
chimera  ||| S:26651 E:26659 ||| NN
containing  ||| S:26659 E:26670 ||| VBG
the  ||| S:26670 E:26682 ||| DT
kinase  ||| S:26682 E:26689 ||| JJ
inactive  ||| S:26689 E:26698 ||| JJ
domain  ||| S:26698 E:26705 ||| NN
was  ||| S:26705 E:26709 ||| VBD
not  ||| S:26709 E:26713 ||| RB
stably  ||| S:26713 E:26720 ||| JJ
phosphorylated  ||| S:26720 E:26735 ||| NN
in  ||| S:26735 E:26746 ||| IN
cells ||| S:26746 E:26751 ||| NNS
.  ||| S:26751 E:26753 ||| .
These  ||| S:26753 E:26759 ||| DT
findings  ||| S:26759 E:26768 ||| NNS
indicated  ||| S:26768 E:26778 ||| VBD
that  ||| S:26778 E:26783 ||| IN
this  ||| S:26783 E:26788 ||| DT
approach  ||| S:26788 E:26797 ||| NN
would  ||| S:26797 E:26803 ||| MD
be  ||| S:26803 E:26814 ||| VB
useful  ||| S:26814 E:26821 ||| JJ
in  ||| S:26821 E:26824 ||| IN
analyzing  ||| S:26824 E:26834 ||| VBG
the  ||| S:26834 E:26838 ||| DT
events  ||| S:26838 E:26845 ||| NNS
that  ||| S:26845 E:26850 ||| WDT
occur  ||| S:26850 E:26856 ||| VBP
following  ||| S:26856 E:26874 ||| VBG
tyrosine  ||| S:26874 E:26883 ||| JJ
phosphorylation  ||| S:26883 E:26899 ||| NN
of  ||| S:26899 E:26902 ||| IN
the  ||| S:26902 E:26906 ||| DT
Cas  ||| S:26906 E:26910 ||| NNP
SD  ||| S:26910 E:26913 ||| NNP
in  ||| S:26913 E:26916 ||| IN
the  ||| S:26916 E:26920 ||| DT
absence  ||| S:26920 E:26928 ||| NN
of  ||| S:26928 E:26939 ||| IN
upstream  ||| S:26939 E:26948 ||| JJ
signals  ||| S:26948 E:26956 ||| NNS
that  ||| S:26956 E:26961 ||| WDT
may  ||| S:26961 E:26965 ||| MD
activate  ||| S:26965 E:26974 ||| VB
other  ||| S:26974 E:26980 ||| JJ
signaling  ||| S:26980 E:26998 ||| JJ
pathways ||| S:26998 E:27006 ||| NN
.  ||| S:27006 E:27008 ||| .
Our  ||| S:27008 E:27012 ||| PRP$
initial  ||| S:27012 E:27020 ||| JJ
experiments  ||| S:27020 E:27032 ||| NNS
were  ||| S:27032 E:27037 ||| VBD
designed  ||| S:27037 E:27046 ||| VBN
to  ||| S:27046 E:27057 ||| TO
determine  ||| S:27057 E:27067 ||| VB
whether  ||| S:27067 E:27075 ||| IN
tyrosine  ||| S:27075 E:27084 ||| JJ
phosphorylation  ||| S:27084 E:27100 ||| NN
of  ||| S:27100 E:27103 ||| IN
the  ||| S:27103 E:27107 ||| DT
SD  ||| S:27107 E:27110 ||| NNP
of  ||| S:27110 E:27113 ||| IN
Cas  ||| S:27113 E:27125 ||| NNP
would  ||| S:27125 E:27131 ||| MD
lead  ||| S:27131 E:27136 ||| VB
to  ||| S:27136 E:27139 ||| TO
the  ||| S:27139 E:27143 ||| DT
assembly  ||| S:27143 E:27152 ||| NN
of  ||| S:27152 E:27155 ||| IN
protein  ||| S:27155 E:27163 ||| NN
complexes  ||| S:27163 E:27173 ||| NNS
and  ||| S:27173 E:27185 ||| CC
activation  ||| S:27185 E:27196 ||| NN
of  ||| S:27196 E:27199 ||| IN
downstream  ||| S:27199 E:27210 ||| JJ
effectors ||| S:27210 E:27219 ||| NN
.  ||| S:27219 E:27229 ||| .
Using  ||| S:27229 E:27235 ||| VBG
different  ||| S:27235 E:27245 ||| JJ
regions  ||| S:27245 E:27253 ||| NNS
of  ||| S:27253 E:27256 ||| IN
the  ||| S:27256 E:27260 ||| DT
Cas  ||| S:27260 E:27264 ||| NNP
SD  ||| S:27264 E:27267 ||| NNP
containing  ||| S:27267 E:27278 ||| VBG
either  ||| S:27278 E:27293 ||| RB
the  ||| S:27293 E:27297 ||| DT
YDXP  ||| S:27297 E:27302 ||| NNP
or  ||| S:27302 E:27305 ||| CC
the  ||| S:27305 E:27309 ||| DT
YQXP  ||| S:27309 E:27314 ||| NNP
motifs ||| S:27314 E:27320 ||| NNS
,  ||| S:27320 E:27322 ||| ,
we  ||| S:27322 E:27325 ||| PRP
could  ||| S:27325 E:27331 ||| MD
demonstrate  ||| S:27331 E:27343 ||| VB
that  ||| S:27343 E:27356 ||| DT
v-crk  ||| S:27356 E:27362 ||| JJ
specifically  ||| S:27362 E:27375 ||| JJ
interacts  ||| S:27375 E:27385 ||| NN
with  ||| S:27385 E:27390 ||| IN
the  ||| S:27390 E:27394 ||| DT
C-terminal  ||| S:27394 E:27405 ||| JJ
YDXP  ||| S:27405 E:27418 ||| NN
motifs  ||| S:27418 E:27425 ||| NNS
when  ||| S:27425 E:27430 ||| WRB
tyrosine  ||| S:27430 E:27439 ||| JJ
phosphorylated ||| S:27439 E:27453 ||| NN
.  ||| S:27453 E:27455 ||| .
Moreover ||| S:27455 E:27463 ||| RB
,  ||| S:27463 E:27465 ||| ,
in  ||| S:27465 E:27468 ||| IN
the  ||| S:27468 E:27480 ||| DT
absence  ||| S:27480 E:27488 ||| NN
of  ||| S:27488 E:27491 ||| IN
stable  ||| S:27491 E:27498 ||| JJ
tyrosine  ||| S:27498 E:27507 ||| NNS
phosphorylation  ||| S:27507 E:27523 ||| VBP
as  ||| S:27523 E:27526 ||| RB
seen  ||| S:27526 E:27531 ||| VBN
in  ||| S:27531 E:27534 ||| IN
the  ||| S:27534 E:27546 ||| DT
Src  ||| S:27546 E:27550 ||| NNP
kinase  ||| S:27550 E:27557 ||| FW
inactive  ||| S:27557 E:27566 ||| FW
fusions ||| S:27566 E:27573 ||| FW
,  ||| S:27573 E:27575 ||| ,
v-crk  ||| S:27575 E:27581 ||| NNP
could  ||| S:27581 E:27587 ||| MD
either  ||| S:27587 E:27594 ||| RB
induce  ||| S:27594 E:27609 ||| VB
their  ||| S:27609 E:27615 ||| PRP$
phosphorylation ||| S:27615 E:27630 ||| NN
,  ||| S:27630 E:27632 ||| ,
or  ||| S:27632 E:27635 ||| CC
protect  ||| S:27635 E:27643 ||| VB
transiently  ||| S:27643 E:27663 ||| JJ
phosphorylated  ||| S:27663 E:27678 ||| JJ
YDXP  ||| S:27678 E:27683 ||| NN
motifs  ||| S:27683 E:27690 ||| NNS
from  ||| S:27690 E:27695 ||| IN
dephosphorylation  ||| S:27695 E:27713 ||| NN
through  ||| S:27713 E:27729 ||| IN
yet  ||| S:27729 E:27733 ||| RB
unknown  ||| S:27733 E:27741 ||| JJ
mechanisms ||| S:27741 E:27751 ||| NNS
.  ||| S:27751 E:27753 ||| .
Thus  ||| S:27753 E:27758 ||| RB
while  ||| S:27758 E:27764 ||| IN
both  ||| S:27764 E:27769 ||| DT
sets  ||| S:27769 E:27774 ||| NNS
of  ||| S:27774 E:27777 ||| IN
motifs  ||| S:27777 E:27784 ||| NNS
in  ||| S:27784 E:27795 ||| IN
the  ||| S:27795 E:27799 ||| DT
Cas  ||| S:27799 E:27803 ||| NNP
SD  ||| S:27803 E:27806 ||| NNP
have  ||| S:27806 E:27811 ||| VBP
been  ||| S:27811 E:27816 ||| VBN
thought  ||| S:27816 E:27824 ||| VBN
to  ||| S:27824 E:27827 ||| TO
interact  ||| S:27827 E:27836 ||| VB
with  ||| S:27836 E:27841 ||| IN
the  ||| S:27841 E:27845 ||| DT
v-crk  ||| S:27845 E:27851 ||| JJ
SH2  ||| S:27851 E:27863 ||| CD
domain ||| S:27863 E:27869 ||| NN
,  ||| S:27869 E:27871 ||| ,
we  ||| S:27871 E:27874 ||| PRP
demonstrated  ||| S:27874 E:27887 ||| VBD
that  ||| S:27887 E:27892 ||| IN
this  ||| S:27892 E:27897 ||| DT
domain  ||| S:27897 E:27904 ||| NN
only  ||| S:27904 E:27909 ||| RB
interacts  ||| S:27909 E:27927 ||| VBN
with  ||| S:27927 E:27932 ||| IN
the  ||| S:27932 E:27936 ||| DT
YDXP  ||| S:27936 E:27941 ||| NNP
motifs ||| S:27941 E:27947 ||| NNS
.  ||| S:27947 E:27949 ||| .
Since  ||| S:27949 E:27955 ||| IN
crk  ||| S:27955 E:27959 ||| NN
is  ||| S:27959 E:27962 ||| VBZ
the  ||| S:27962 E:27966 ||| DT
major  ||| S:27966 E:27972 ||| JJ
protein  ||| S:27972 E:27988 ||| NN
reported  ||| S:27988 E:27997 ||| VBD
to  ||| S:27997 E:28000 ||| TO
bind  ||| S:28000 E:28005 ||| VB
to  ||| S:28005 E:28008 ||| TO
the  ||| S:28008 E:28012 ||| DT
Cas  ||| S:28012 E:28016 ||| NNP
SD ||| S:28016 E:28018 ||| NNP
,  ||| S:28018 E:28020 ||| ,
our  ||| S:28020 E:28024 ||| PRP$
data  ||| S:28024 E:28029 ||| NNS
suggest  ||| S:28029 E:28037 ||| VBP
that  ||| S:28037 E:28042 ||| IN
the  ||| S:28042 E:28054 ||| DT
YQXP  ||| S:28054 E:28059 ||| NNP
motifs  ||| S:28059 E:28066 ||| NNS
may  ||| S:28066 E:28070 ||| MD
interact  ||| S:28070 E:28079 ||| VB
with  ||| S:28079 E:28084 ||| IN
other  ||| S:28084 E:28090 ||| JJ
yet  ||| S:28090 E:28094 ||| RB
to  ||| S:28094 E:28097 ||| TO
be  ||| S:28097 E:28100 ||| VB
identified  ||| S:28100 E:28119 ||| VBN
downstream  ||| S:28119 E:28130 ||| JJ
effectors ||| S:28130 E:28139 ||| NN
.  ||| S:28139 E:28149 ||| .
We  ||| S:28149 E:28152 ||| PRP
also  ||| S:28152 E:28157 ||| RB
found  ||| S:28157 E:28163 ||| VBN
that  ||| S:28163 E:28168 ||| IN
while  ||| S:28168 E:28174 ||| IN
downstream  ||| S:28174 E:28185 ||| JJ
effectors  ||| S:28185 E:28195 ||| NNS
assemble  ||| S:28195 E:28212 ||| VBP
onto  ||| S:28212 E:28217 ||| IN
the  ||| S:28217 E:28221 ||| DT
tyrosine  ||| S:28221 E:28230 ||| FW
phosphorylated  ||| S:28230 E:28245 ||| FW
Cas  ||| S:28245 E:28249 ||| FW
SD  ||| S:28249 E:28252 ||| FW
domain ||| S:28252 E:28258 ||| FW
,  ||| S:28258 E:28260 ||| ,
the  ||| S:28260 E:28272 ||| DT
downstream  ||| S:28272 E:28283 ||| JJ
signals  ||| S:28283 E:28291 ||| NNS
were  ||| S:28291 E:28296 ||| VBD
not  ||| S:28296 E:28300 ||| RB
activated ||| S:28300 E:28309 ||| VBN
.  ||| S:28309 E:28311 ||| .
In  ||| S:28311 E:28314 ||| IN
particular ||| S:28314 E:28324 ||| JJ
,  ||| S:28324 E:28326 ||| ,
we  ||| S:28326 E:28337 ||| PRP
found  ||| S:28337 E:28343 ||| VBD
that  ||| S:28343 E:28348 ||| IN
the  ||| S:28348 E:28352 ||| DT
tyrosine  ||| S:28352 E:28361 ||| FW
phosphorylated  ||| S:28361 E:28376 ||| FW
Cas  ||| S:28376 E:28380 ||| FW
SD  ||| S:28380 E:28383 ||| FW
domain  ||| S:28383 E:28398 ||| FW
blocked  ||| S:28398 E:28406 ||| FW
v-crk  ||| S:28406 E:28412 ||| FW
mediated  ||| S:28412 E:28421 ||| FW
activation  ||| S:28421 E:28432 ||| FW
of  ||| S:28432 E:28435 ||| IN
the  ||| S:28435 E:28439 ||| DT
JNK  ||| S:28439 E:28443 ||| NNP
pathway ||| S:28443 E:28450 ||| NN
.  ||| S:28450 E:28452 ||| .
In  ||| S:28452 E:28463 ||| IN
addition ||| S:28463 E:28471 ||| NN
,  ||| S:28471 E:28473 ||| ,
we  ||| S:28473 E:28476 ||| PRP
found  ||| S:28476 E:28482 ||| VBD
that  ||| S:28482 E:28487 ||| DT
expression  ||| S:28487 E:28498 ||| NN
of  ||| S:28498 E:28501 ||| IN
the  ||| S:28501 E:28505 ||| DT
tyrosine  ||| S:28505 E:28522 ||| JJ
phosphorylated  ||| S:28522 E:28537 ||| JJ
Cas  ||| S:28537 E:28541 ||| NNP
SD  ||| S:28541 E:28544 ||| NNP
domain  ||| S:28544 E:28551 ||| NN
in  ||| S:28551 E:28554 ||| IN
v-crk  ||| S:28554 E:28560 ||| JJ
transformed  ||| S:28560 E:28572 ||| JJ
cells  ||| S:28572 E:28586 ||| NNS
reduced  ||| S:28586 E:28594 ||| VBD
their  ||| S:28594 E:28600 ||| PRP$
ability  ||| S:28600 E:28608 ||| NN
to  ||| S:28608 E:28611 ||| TO
grow  ||| S:28611 E:28616 ||| VB
in  ||| S:28616 E:28619 ||| IN
soft  ||| S:28619 E:28624 ||| JJ
agar ||| S:28624 E:28628 ||| NN
,  ||| S:28628 E:28630 ||| ,
a  ||| S:28630 E:28632 ||| DT
measure  ||| S:28632 E:28640 ||| NN
of  ||| S:28640 E:28651 ||| IN
their  ||| S:28651 E:28657 ||| PRP$
transformation ||| S:28657 E:28671 ||| NN
.  ||| S:28671 E:28673 ||| .
Furthermore ||| S:28673 E:28684 ||| RB
,  ||| S:28684 E:28686 ||| ,
we  ||| S:28686 E:28689 ||| PRP
found  ||| S:28689 E:28695 ||| VBD
that  ||| S:28695 E:28700 ||| IN
the  ||| S:28700 E:28712 ||| DT
tyrosine  ||| S:28712 E:28721 ||| JJ
phosphorylated  ||| S:28721 E:28736 ||| JJ
Cas  ||| S:28736 E:28740 ||| NNP
SD  ||| S:28740 E:28743 ||| NNP
competed  ||| S:28743 E:28752 ||| VBD
effectively  ||| S:28752 E:28764 ||| RB
with  ||| S:28764 E:28777 ||| IN
the  ||| S:28777 E:28781 ||| DT
endogenous  ||| S:28781 E:28792 ||| JJ
Cas  ||| S:28792 E:28796 ||| NNS
for  ||| S:28796 E:28800 ||| IN
binding  ||| S:28800 E:28808 ||| VBG
to  ||| S:28808 E:28811 ||| TO
v-crk  ||| S:28811 E:28817 ||| JJ
and  ||| S:28817 E:28821 ||| CC
endogenous  ||| S:28821 E:28840 ||| JJ
c-crk ||| S:28840 E:28845 ||| NN
,  ||| S:28845 E:28847 ||| ,
while  ||| S:28847 E:28853 ||| IN
not  ||| S:28853 E:28857 ||| RB
affecting  ||| S:28857 E:28867 ||| VBG
tyrosine  ||| S:28867 E:28876 ||| JJ
phosphorylation  ||| S:28876 E:28892 ||| NN
of  ||| S:28892 E:28903 ||| IN
proposed  ||| S:28903 E:28912 ||| JJ
upstream  ||| S:28912 E:28921 ||| JJ
proteins  ||| S:28921 E:28930 ||| NNS
such  ||| S:28930 E:28935 ||| JJ
as  ||| S:28935 E:28938 ||| IN
Fak  ||| S:28938 E:28942 ||| NNP
and  ||| S:28942 E:28946 ||| CC
endogenous  ||| S:28946 E:28957 ||| JJ
Cas ||| S:28957 E:28960 ||| NNP
.  ||| S:28960 E:28970 ||| .
Thus ||| S:28970 E:28974 ||| RB
,  ||| S:28974 E:28976 ||| ,
our  ||| S:28976 E:28980 ||| PRP$
data  ||| S:28980 E:28985 ||| NNS
suggest  ||| S:28985 E:28993 ||| VBP
that  ||| S:28993 E:28998 ||| IN
the  ||| S:28998 E:29002 ||| DT
tyrosine  ||| S:29002 E:29011 ||| JJ
phosphorylated  ||| S:29011 E:29026 ||| JJ
Cas  ||| S:29026 E:29038 ||| NNP
SD  ||| S:29038 E:29041 ||| NNP
acts  ||| S:29041 E:29046 ||| VBZ
as  ||| S:29046 E:29049 ||| IN
a  ||| S:29049 E:29051 ||| DT
decoy  ||| S:29051 E:29057 ||| NN
for  ||| S:29057 E:29061 ||| IN
endogenous  ||| S:29061 E:29072 ||| JJ
Cas  ||| S:29072 E:29076 ||| JJ
binding  ||| S:29076 E:29084 ||| JJ
proteins  ||| S:29084 E:29093 ||| NNS
and  ||| S:29093 E:29105 ||| CC
blocks  ||| S:29105 E:29112 ||| NNS
signaling  ||| S:29112 E:29122 ||| VBG
via  ||| S:29122 E:29126 ||| IN
crk  ||| S:29126 E:29130 ||| VBG
to  ||| S:29130 E:29133 ||| TO
the  ||| S:29133 E:29137 ||| DT
activation  ||| S:29137 E:29148 ||| NN
of  ||| S:29148 E:29151 ||| IN
JNK ||| S:29151 E:29154 ||| NNP
,  ||| S:29154 E:29156 ||| ,
as  ||| S:29156 E:29159 ||| RB
well  ||| S:29159 E:29172 ||| RB
as  ||| S:29172 E:29175 ||| IN
transformation  ||| S:29175 E:29190 ||| NN
of  ||| S:29190 E:29193 ||| IN
cells  ||| S:29193 E:29199 ||| NNS
by  ||| S:29199 E:29202 ||| IN
the  ||| S:29202 E:29206 ||| DT
oncogene  ||| S:29206 E:29215 ||| JJ
v-crk ||| S:29215 E:29220 ||| NN
.  ||| S:29220 E:29222 ||| .
The  ||| S:29222 E:29234 ||| DT
ability  ||| S:29234 E:29242 ||| NN
of  ||| S:29242 E:29245 ||| IN
the  ||| S:29245 E:29249 ||| DT
tyrosine  ||| S:29249 E:29258 ||| JJ
phosphorylated  ||| S:29258 E:29273 ||| JJ
Cas  ||| S:29273 E:29277 ||| NNP
SD  ||| S:29277 E:29280 ||| NNP
to  ||| S:29280 E:29283 ||| TO
act  ||| S:29283 E:29287 ||| VB
as  ||| S:29287 E:29290 ||| IN
a  ||| S:29290 E:29300 ||| DT
decoy  ||| S:29300 E:29306 ||| NN
suggests  ||| S:29306 E:29315 ||| VBZ
that  ||| S:29315 E:29320 ||| IN
while  ||| S:29320 E:29326 ||| IN
tyrosine  ||| S:29326 E:29335 ||| JJ
phosphorylation  ||| S:29335 E:29351 ||| NN
of  ||| S:29351 E:29354 ||| IN
the  ||| S:29354 E:29366 ||| DT
substrate  ||| S:29366 E:29376 ||| JJ
domain  ||| S:29376 E:29383 ||| NN
of  ||| S:29383 E:29386 ||| IN
Cas  ||| S:29386 E:29390 ||| NNP
may  ||| S:29390 E:29394 ||| MD
be  ||| S:29394 E:29397 ||| VB
important  ||| S:29397 E:29407 ||| JJ
for  ||| S:29407 E:29411 ||| IN
its  ||| S:29411 E:29415 ||| PRP$
function  ||| S:29415 E:29432 ||| NN
in  ||| S:29432 E:29435 ||| IN
assembling  ||| S:29435 E:29446 ||| VBG
downstream  ||| S:29446 E:29457 ||| JJ
signals ||| S:29457 E:29464 ||| NNS
,  ||| S:29464 E:29466 ||| ,
specific  ||| S:29466 E:29475 ||| JJ
localization  ||| S:29475 E:29488 ||| NN
of  ||| S:29488 E:29499 ||| IN
Cas  ||| S:29499 E:29503 ||| NNP
may  ||| S:29503 E:29507 ||| MD
also  ||| S:29507 E:29512 ||| RB
be  ||| S:29512 E:29515 ||| VB
critical  ||| S:29515 E:29524 ||| JJ
for  ||| S:29524 E:29528 ||| IN
its  ||| S:29528 E:29532 ||| PRP$
downstream  ||| S:29532 E:29543 ||| JJ
functions ||| S:29543 E:29552 ||| NNS
.  ||| S:29552 E:29562 ||| .
Indeed ||| S:29562 E:29568 ||| RB
,  ||| S:29568 E:29570 ||| ,
phosphorylated  ||| S:29570 E:29585 ||| FW
endogenous  ||| S:29585 E:29596 ||| FW
Cas  ||| S:29596 E:29600 ||| NNP
is  ||| S:29600 E:29603 ||| VBZ
localized  ||| S:29603 E:29613 ||| VBN
to  ||| S:29613 E:29616 ||| TO
FAK  ||| S:29616 E:29628 ||| NNP
and  ||| S:29628 E:29632 ||| CC
the  ||| S:29632 E:29636 ||| DT
focal  ||| S:29636 E:29642 ||| JJ
adhesions  ||| S:29642 E:29652 ||| NN
via  ||| S:29652 E:29656 ||| IN
its  ||| S:29656 E:29660 ||| PRP$
SH3  ||| S:29660 E:29664 ||| JJ
domain  ||| S:29664 E:29671 ||| NN
and ||| S:29671 E:29674 ||| CC
/ ||| S:29674 E:29675 ||| NNP
or  ||| S:29675 E:29678 ||| CC
its  ||| S:29678 E:29682 ||| PRP$
Src  ||| S:29682 E:29694 ||| JJ
binding  ||| S:29694 E:29702 ||| JJ
domain  ||| S:29702 E:29709 ||| NN
in  ||| S:29709 E:29712 ||| IN
its  ||| S:29712 E:29716 ||| PRP$
distal  ||| S:29716 E:29723 ||| JJ
C-terminus ||| S:29723 E:29733 ||| NN
,  ||| S:29733 E:29735 ||| ,
both  ||| S:29735 E:29740 ||| CC
were  ||| S:29740 E:29745 ||| VBD
excluded  ||| S:29745 E:29762 ||| VBN
from  ||| S:29762 E:29767 ||| IN
our  ||| S:29767 E:29771 ||| PRP$
chimera ||| S:29771 E:29778 ||| NN
,  ||| S:29778 E:29780 ||| ,
suggesting  ||| S:29780 E:29791 ||| VBG
that  ||| S:29791 E:29796 ||| IN
proper  ||| S:29796 E:29803 ||| JJ
localization  ||| S:29803 E:29816 ||| NN
of  ||| S:29816 E:29827 ||| IN
the  ||| S:29827 E:29831 ||| DT
tyrosine  ||| S:29831 E:29840 ||| JJ
phosphorylated  ||| S:29840 E:29855 ||| JJ
substrate  ||| S:29855 E:29865 ||| JJ
domain  ||| S:29865 E:29872 ||| NN
may  ||| S:29872 E:29876 ||| MD
be  ||| S:29876 E:29887 ||| VB
required  ||| S:29887 E:29896 ||| VBN
for  ||| S:29896 E:29900 ||| IN
Cas  ||| S:29900 E:29904 ||| NNP
activity  ||| S:29904 E:29913 ||| NN
[  ||| S:29913 E:29915 ||| -LRB-
30  ||| S:29915 E:29918 ||| CD
45  ||| S:29918 E:29921 ||| CD
]  ||| S:29921 E:29923 ||| -RRB-
.  ||| S:29923 E:29947 ||| .
Conclusions  ||| S:29947 E:29967 ||| NNS
A  ||| S:29967 E:29969 ||| DT
number  ||| S:29969 E:29976 ||| NN
of  ||| S:29976 E:29979 ||| IN
proteins  ||| S:29979 E:29988 ||| NNS
have  ||| S:29988 E:29993 ||| VBP
been  ||| S:29993 E:29998 ||| VBN
identified  ||| S:29998 E:30009 ||| VBN
that  ||| S:30009 E:30014 ||| IN
bind  ||| S:30014 E:30019 ||| NN
to  ||| S:30019 E:30030 ||| TO
the  ||| S:30030 E:30034 ||| DT
substrate  ||| S:30034 E:30044 ||| JJ
domain  ||| S:30044 E:30051 ||| NN
of  ||| S:30051 E:30054 ||| IN
Cas ||| S:30054 E:30057 ||| NNP
,  ||| S:30057 E:30059 ||| ,
however  ||| S:30059 E:30067 ||| RB
the  ||| S:30067 E:30071 ||| DT
large  ||| S:30071 E:30077 ||| JJ
number  ||| S:30077 E:30084 ||| NN
of  ||| S:30084 E:30095 ||| IN
tyrosines  ||| S:30095 E:30105 ||| NN
and  ||| S:30105 E:30109 ||| CC
potential  ||| S:30109 E:30119 ||| JJ
binding  ||| S:30119 E:30127 ||| JJ
sites  ||| S:30127 E:30133 ||| NNS
for  ||| S:30133 E:30137 ||| IN
downstream  ||| S:30137 E:30156 ||| JJ
effectors  ||| S:30156 E:30166 ||| NNS
suggest  ||| S:30166 E:30174 ||| VBP
that  ||| S:30174 E:30179 ||| IN
there  ||| S:30179 E:30185 ||| EX
may  ||| S:30185 E:30189 ||| MD
be  ||| S:30189 E:30192 ||| VB
more ||| S:30192 E:30196 ||| RBR
.  ||| S:30196 E:30198 ||| .
We  ||| S:30198 E:30201 ||| PRP
propose  ||| S:30201 E:30209 ||| VBP
that  ||| S:30209 E:30222 ||| IN
our  ||| S:30222 E:30226 ||| PRP$
chimeric  ||| S:30226 E:30235 ||| JJ
approach  ||| S:30235 E:30244 ||| NN
can  ||| S:30244 E:30248 ||| MD
be  ||| S:30248 E:30251 ||| VB
used  ||| S:30251 E:30256 ||| VBN
to  ||| S:30256 E:30259 ||| TO
identify  ||| S:30259 E:30268 ||| VB
Cas  ||| S:30268 E:30272 ||| JJ
binding  ||| S:30272 E:30288 ||| JJ
proteins  ||| S:30288 E:30297 ||| NNS
in  ||| S:30297 E:30300 ||| IN
mammalian  ||| S:30300 E:30310 ||| JJ
cells  ||| S:30310 E:30316 ||| NNS
in  ||| S:30316 E:30319 ||| IN
the  ||| S:30319 E:30323 ||| DT
absence  ||| S:30323 E:30331 ||| NN
of  ||| S:30331 E:30334 ||| IN
specific  ||| S:30334 E:30351 ||| JJ
upstream  ||| S:30351 E:30360 ||| NN
signals  ||| S:30360 E:30368 ||| VBZ
normally  ||| S:30368 E:30377 ||| RB
required  ||| S:30377 E:30386 ||| VBN
for  ||| S:30386 E:30390 ||| IN
tyrosine  ||| S:30390 E:30407 ||| JJ
phosphorylation  ||| S:30407 E:30423 ||| NN
of  ||| S:30423 E:30426 ||| IN
the  ||| S:30426 E:30430 ||| DT
Cas  ||| S:30430 E:30434 ||| JJ
substrate  ||| S:30434 E:30444 ||| JJ
domain ||| S:30444 E:30450 ||| NN
.  ||| S:30450 E:30452 ||| .
We  ||| S:30452 E:30455 ||| PRP
can  ||| S:30455 E:30459 ||| MD
also  ||| S:30459 E:30472 ||| RB
use  ||| S:30472 E:30476 ||| VB
this  ||| S:30476 E:30481 ||| DT
approach  ||| S:30481 E:30490 ||| NN
to  ||| S:30490 E:30493 ||| TO
ask  ||| S:30493 E:30497 ||| VB
which  ||| S:30497 E:30503 ||| WDT
tyrosines  ||| S:30503 E:30513 ||| VBZ
within  ||| S:30513 E:30520 ||| IN
the  ||| S:30520 E:30524 ||| DT
SD  ||| S:30524 E:30527 ||| NNP
of  ||| S:30527 E:30538 ||| IN
Cas  ||| S:30538 E:30542 ||| NNP
can  ||| S:30542 E:30546 ||| MD
act  ||| S:30546 E:30550 ||| VB
as  ||| S:30550 E:30553 ||| IN
decoys  ||| S:30553 E:30560 ||| NN
for  ||| S:30560 E:30564 ||| IN
specific  ||| S:30564 E:30573 ||| JJ
downstream  ||| S:30573 E:30584 ||| JJ
signals  ||| S:30584 E:30600 ||| NNS
attributed  ||| S:30600 E:30611 ||| VBD
to  ||| S:30611 E:30614 ||| TO
the  ||| S:30614 E:30618 ||| DT
SD  ||| S:30618 E:30621 ||| NNP
of  ||| S:30621 E:30624 ||| IN
Cas ||| S:30624 E:30627 ||| NNP
.  ||| S:30627 E:30629 ||| .
Other  ||| S:30629 E:30635 ||| JJ
uses  ||| S:30635 E:30640 ||| NNS
for  ||| S:30640 E:30644 ||| IN
such  ||| S:30644 E:30649 ||| PDT
a  ||| S:30649 E:30651 ||| DT
chimera  ||| S:30651 E:30667 ||| NNS
include  ||| S:30667 E:30675 ||| VBP
screening  ||| S:30675 E:30685 ||| VBG
approaches  ||| S:30685 E:30696 ||| NNS
such  ||| S:30696 E:30701 ||| JJ
as  ||| S:30701 E:30704 ||| IN
the  ||| S:30704 E:30708 ||| DT
yeast  ||| S:30708 E:30714 ||| NN
two-hybrid  ||| S:30714 E:30733 ||| JJ
screen  ||| S:30733 E:30740 ||| NN
to  ||| S:30740 E:30743 ||| TO
select  ||| S:30743 E:30750 ||| VB
proteins  ||| S:30750 E:30759 ||| NNS
that  ||| S:30759 E:30764 ||| IN
interact  ||| S:30764 E:30773 ||| NN
with  ||| S:30773 E:30778 ||| IN
the  ||| S:30778 E:30782 ||| DT
tyrosine  ||| S:30782 E:30799 ||| JJ
phosphorylated  ||| S:30799 E:30814 ||| JJ
Cas  ||| S:30814 E:30818 ||| NNP
SD ||| S:30818 E:30820 ||| NNP
.  ||| S:30820 E:30822 ||| .
Finally ||| S:30822 E:30829 ||| RB
,  ||| S:30829 E:30831 ||| ,
we  ||| S:30831 E:30834 ||| PRP
can  ||| S:30834 E:30838 ||| MD
theoretically  ||| S:30838 E:30852 ||| RB
target  ||| S:30852 E:30867 ||| VB
this  ||| S:30867 E:30872 ||| DT
tyrosine  ||| S:30872 E:30881 ||| JJ
phosphorylated  ||| S:30881 E:30896 ||| JJ
chimera  ||| S:30896 E:30904 ||| NN
to  ||| S:30904 E:30907 ||| TO
specific  ||| S:30907 E:30916 ||| JJ
areas  ||| S:30916 E:30922 ||| NNS
of  ||| S:30922 E:30933 ||| IN
the  ||| S:30933 E:30937 ||| DT
cell  ||| S:30937 E:30942 ||| NN
to  ||| S:30942 E:30945 ||| TO
determine  ||| S:30945 E:30955 ||| VB
which  ||| S:30955 E:30961 ||| WDT
cellular  ||| S:30961 E:30970 ||| JJ
localization  ||| S:30970 E:30983 ||| NN
will  ||| S:30983 E:30996 ||| MD
recover  ||| S:30996 E:31004 ||| VB
the  ||| S:31004 E:31008 ||| DT
activation  ||| S:31008 E:31019 ||| NN
of  ||| S:31019 E:31022 ||| IN
downstream  ||| S:31022 E:31033 ||| JJ
Cas  ||| S:31033 E:31037 ||| JJ
functions ||| S:31037 E:31046 ||| NNS
.  ||| S:31046 E:31048 ||| .
This  ||| S:31048 E:31061 ||| DT
chimeric  ||| S:31061 E:31070 ||| JJ
approach  ||| S:31070 E:31079 ||| NN
can  ||| S:31079 E:31083 ||| MD
also  ||| S:31083 E:31088 ||| RB
be  ||| S:31088 E:31091 ||| VB
extended  ||| S:31091 E:31100 ||| VBN
to  ||| S:31100 E:31103 ||| TO
other  ||| S:31103 E:31109 ||| JJ
adaptor  ||| S:31109 E:31125 ||| JJ
proteins  ||| S:31125 E:31134 ||| NNS
that  ||| S:31134 E:31139 ||| WDT
require  ||| S:31139 E:31147 ||| VBP
upstream  ||| S:31147 E:31156 ||| JJ
signals  ||| S:31156 E:31164 ||| NNS
for  ||| S:31164 E:31168 ||| IN
tyrosine  ||| S:31168 E:31185 ||| JJ
phosphorylation ||| S:31185 E:31200 ||| NN
,  ||| S:31200 E:31202 ||| ,
creating  ||| S:31202 E:31211 ||| FW
tyrosine  ||| S:31211 E:31220 ||| FW
phosphorylated  ||| S:31220 E:31235 ||| FW
decoys  ||| S:31235 E:31242 ||| FW
or  ||| S:31242 E:31253 ||| FW
targeting  ||| S:31253 E:31263 ||| FW
tyrosine  ||| S:31263 E:31272 ||| FW
phosphorylated  ||| S:31272 E:31287 ||| FW
substrate  ||| S:31287 E:31297 ||| FW
domains  ||| S:31297 E:31305 ||| FW
or  ||| S:31305 E:31308 ||| CC
full  ||| S:31308 E:31321 ||| JJ
length  ||| S:31321 E:31328 ||| NN
adaptor  ||| S:31328 E:31336 ||| NN
proteins  ||| S:31336 E:31345 ||| NNS
in  ||| S:31345 E:31348 ||| IN
transgenic  ||| S:31348 E:31359 ||| JJ
cellular  ||| S:31359 E:31368 ||| JJ
and  ||| S:31368 E:31372 ||| CC
animal  ||| S:31372 E:31387 ||| JJ
systems ||| S:31387 E:31394 ||| NNS
.  ||| S:31394 E:31396 ||| .
We  ||| S:31396 E:31399 ||| PRP
also  ||| S:31399 E:31404 ||| RB
propose  ||| S:31404 E:31412 ||| VB
that  ||| S:31412 E:31417 ||| DT
similar  ||| S:31417 E:31425 ||| JJ
approaches  ||| S:31425 E:31436 ||| NNS
could  ||| S:31436 E:31442 ||| MD
be  ||| S:31442 E:31453 ||| VB
used  ||| S:31453 E:31458 ||| VBN
for  ||| S:31458 E:31462 ||| IN
analyzing  ||| S:31462 E:31472 ||| VBG
proteins  ||| S:31472 E:31481 ||| NNS
that  ||| S:31481 E:31486 ||| WDT
are  ||| S:31486 E:31490 ||| VBP
phosphorylated  ||| S:31490 E:31505 ||| VBN
on  ||| S:31505 E:31516 ||| IN
serine  ||| S:31516 E:31523 ||| NN
or  ||| S:31523 E:31526 ||| CC
threonine  ||| S:31526 E:31536 ||| NNS
and  ||| S:31536 E:31540 ||| CC
assemble  ||| S:31540 E:31549 ||| JJ
complexes ||| S:31549 E:31558 ||| NNS
,  ||| S:31558 E:31560 ||| ,
such  ||| S:31560 E:31565 ||| JJ
as  ||| S:31565 E:31568 ||| IN
14-3-3 ||| S:31568 E:31574 ||| NNP
,  ||| S:31574 E:31584 ||| ,
for  ||| S:31584 E:31588 ||| IN
analysis  ||| S:31588 E:31597 ||| NN
of  ||| S:31597 E:31600 ||| IN
their  ||| S:31600 E:31606 ||| PRP$
downstream  ||| S:31606 E:31617 ||| JJ
signals  ||| S:31617 E:31625 ||| NNS
or  ||| S:31625 E:31628 ||| CC
identification  ||| S:31628 E:31651 ||| NN
of  ||| S:31651 E:31654 ||| IN
binding  ||| S:31654 E:31662 ||| JJ
proteins ||| S:31662 E:31670 ||| NNS
.  ||| S:31670 E:31694 ||| .
Materials  ||| S:31694 E:31704 ||| NNS
and  ||| S:31704 E:31708 ||| CC
Methods  ||| S:31708 E:31735 ||| NNP
Materials  ||| S:31735 E:31755 ||| NNPS
Antibodies  ||| S:31755 E:31766 ||| NNP
against  ||| S:31766 E:31774 ||| IN
the  ||| S:31774 E:31778 ||| DT
following  ||| S:31778 E:31788 ||| JJ
proteins  ||| S:31788 E:31797 ||| NNS
were  ||| S:31797 E:31812 ||| VBD
obtained  ||| S:31812 E:31821 ||| VBN
from  ||| S:31821 E:31826 ||| IN
the  ||| S:31826 E:31830 ||| DT
following  ||| S:31830 E:31840 ||| JJ
suppliers  ||| S:31840 E:31850 ||| NNS
or  ||| S:31850 E:31853 ||| CC
individuals ||| S:31853 E:31864 ||| NNS
:  ||| S:31864 E:31876 ||| :
ant-phosphotyrosine ||| S:31876 E:31895 ||| NNP
,  ||| S:31895 E:31897 ||| ,
RC20-HRP  ||| S:31897 E:31906 ||| NNP
( ||| S:31906 E:31907 ||| -LRB-
Transduction  ||| S:31907 E:31920 ||| NNP
Laboratories ||| S:31920 E:31932 ||| NNPS
,  ||| S:31932 E:31944 ||| ,
Lexington ||| S:31944 E:31953 ||| NNP
,  ||| S:31953 E:31955 ||| ,
KY ||| S:31955 E:31957 ||| NNP
) ||| S:31957 E:31958 ||| -RRB-
;  ||| S:31958 E:31960 ||| :
anti-HA  ||| S:31960 E:31968 ||| NNP
( ||| S:31968 E:31969 ||| -LRB-
Boehringer  ||| S:31969 E:31980 ||| NNP
Mannheim ||| S:31980 E:31988 ||| NNP
,  ||| S:31988 E:32000 ||| ,
Indianapolis ||| S:32000 E:32012 ||| NNP
,  ||| S:32012 E:32014 ||| ,
IN ||| S:32014 E:32016 ||| IN
) ||| S:32016 E:32017 ||| -RRB-
;  ||| S:32017 E:32019 ||| :
anti-gag  ||| S:32019 E:32028 ||| NNP
( ||| S:32028 E:32029 ||| -LRB-
Dr.  ||| S:32029 E:32033 ||| NNP
R.  ||| S:32033 E:32036 ||| NNP
Birge ||| S:32036 E:32041 ||| NNP
,  ||| S:32041 E:32043 ||| ,
New  ||| S:32043 E:32047 ||| NNP
Jersey  ||| S:32047 E:32064 ||| NNP
Medical  ||| S:32064 E:32072 ||| NNP
School ||| S:32072 E:32078 ||| NNP
,  ||| S:32078 E:32080 ||| ,
Newark ||| S:32080 E:32086 ||| NNP
,  ||| S:32086 E:32088 ||| ,
NJ ||| S:32088 E:32090 ||| NNP
) ||| S:32090 E:32091 ||| -RRB-
;  ||| S:32091 E:32093 ||| :
anti-JNK  ||| S:32093 E:32102 ||| NNP
( ||| S:32102 E:32103 ||| -LRB-
NEB ||| S:32103 E:32106 ||| NNP
,  ||| S:32106 E:32108 ||| ,
Beverley ||| S:32108 E:32116 ||| NNP
,  ||| S:32116 E:32128 ||| ,
MA ||| S:32128 E:32130 ||| NNP
) ||| S:32130 E:32131 ||| -RRB-
;  ||| S:32131 E:32133 ||| :
anti-c-crk  ||| S:32133 E:32144 ||| NNP
( ||| S:32144 E:32145 ||| -LRB-
Santa  ||| S:32145 E:32151 ||| NNP
Cruz  ||| S:32151 E:32156 ||| NNP
Biotechnology ||| S:32156 E:32169 ||| NNP
,  ||| S:32169 E:32171 ||| ,
Santa  ||| S:32171 E:32177 ||| NNP
Cruz ||| S:32177 E:32181 ||| NNP
,  ||| S:32181 E:32193 ||| ,
CA ||| S:32193 E:32195 ||| NNP
) ||| S:32195 E:32196 ||| -RRB-
;  ||| S:32196 E:32198 ||| :
anti-C3G  ||| S:32198 E:32207 ||| CD
( ||| S:32207 E:32208 ||| -LRB-
Dr.  ||| S:32208 E:32212 ||| NNP
Beatrice  ||| S:32212 E:32221 ||| NNP
Knudsen ||| S:32221 E:32228 ||| NNP
,  ||| S:32228 E:32230 ||| ,
Weill  ||| S:32230 E:32236 ||| NNP
Medical  ||| S:32236 E:32254 ||| NNP
College  ||| S:32254 E:32262 ||| NNP
of  ||| S:32262 E:32265 ||| IN
Cornell  ||| S:32265 E:32273 ||| NNP
University ||| S:32273 E:32283 ||| NNP
,  ||| S:32283 E:32285 ||| ,
NY ||| S:32285 E:32287 ||| NNP
,  ||| S:32287 E:32289 ||| ,
NY ||| S:32289 E:32291 ||| NNP
) ||| S:32291 E:32292 ||| -RRB-
;  ||| S:32292 E:32294 ||| :
anti-FAK  ||| S:32294 E:32303 ||| JJ
and  ||| S:32303 E:32317 ||| CC
anti-Cas  ||| S:32317 E:32326 ||| NNP
( ||| S:32326 E:32327 ||| -LRB-
Transduction  ||| S:32327 E:32340 ||| NNP
Laboratories ||| S:32340 E:32352 ||| NNPS
,  ||| S:32352 E:32354 ||| ,
Lexington ||| S:32354 E:32363 ||| NNP
,  ||| S:32363 E:32365 ||| ,
KY ||| S:32365 E:32367 ||| NNP
) ||| S:32367 E:32368 ||| -RRB-
.  ||| S:32368 E:32398 ||| .
Cloning  ||| S:32398 E:32406 ||| NNP
and  ||| S:32406 E:32410 ||| CC
chimera  ||| S:32410 E:32418 ||| JJ
construction  ||| S:32418 E:32441 ||| NN
The  ||| S:32441 E:32445 ||| DT
kinase  ||| S:32445 E:32452 ||| JJ
domains  ||| S:32452 E:32460 ||| NN
of  ||| S:32460 E:32463 ||| IN
the  ||| S:32463 E:32467 ||| DT
c-Src  ||| S:32467 E:32473 ||| JJ
Y416F  ||| S:32473 E:32479 ||| CD
mutant  ||| S:32479 E:32486 ||| NNS
( ||| S:32486 E:32487 ||| -LRB-
kind  ||| S:32487 E:32502 ||| NN
gift  ||| S:32502 E:32507 ||| NN
of  ||| S:32507 E:32510 ||| IN
Dr.  ||| S:32510 E:32514 ||| NNP
Joan  ||| S:32514 E:32519 ||| NNP
Brugge ||| S:32519 E:32525 ||| NNP
,  ||| S:32525 E:32527 ||| ,
Harvard  ||| S:32527 E:32535 ||| NNP
Medical  ||| S:32535 E:32543 ||| NNP
School ||| S:32543 E:32549 ||| NNP
,  ||| S:32549 E:32551 ||| ,
Boston ||| S:32551 E:32557 ||| NNP
,  ||| S:32557 E:32569 ||| ,
MA ||| S:32569 E:32571 ||| NNP
)  ||| S:32571 E:32573 ||| -RRB-
or  ||| S:32573 E:32576 ||| CC
the  ||| S:32576 E:32580 ||| DT
kinase  ||| S:32580 E:32587 ||| FW
inactive  ||| S:32587 E:32596 ||| FW
c-Src  ||| S:32596 E:32602 ||| FW
( ||| S:32602 E:32603 ||| -LRB-
K295M ||| S:32603 E:32608 ||| NNP
,  ||| S:32608 E:32610 ||| ,
[  ||| S:32610 E:32612 ||| -LRB-
46  ||| S:32612 E:32615 ||| CD
]  ||| S:32615 E:32617 ||| CD
) ||| S:32617 E:32618 ||| -RRB-
,  ||| S:32618 E:32620 ||| ,
were  ||| S:32620 E:32635 ||| VBD
amplified  ||| S:32635 E:32645 ||| VBN
by  ||| S:32645 E:32648 ||| IN
PCR  ||| S:32648 E:32652 ||| NNP
and  ||| S:32652 E:32656 ||| CC
cloned  ||| S:32656 E:32663 ||| VBN
in  ||| S:32663 E:32666 ||| IN
pJ3H  ||| S:32666 E:32671 ||| NNP
and  ||| S:32671 E:32675 ||| CC
pJ3M ||| S:32675 E:32679 ||| NNP
,  ||| S:32679 E:32681 ||| ,
two  ||| S:32681 E:32685 ||| CD
vectors  ||| S:32685 E:32703 ||| NN
for  ||| S:32703 E:32707 ||| IN
HA-  ||| S:32707 E:32711 ||| JJ
and  ||| S:32711 E:32715 ||| CC
Myc-tagging  ||| S:32715 E:32727 ||| JJ
at  ||| S:32727 E:32730 ||| IN
the  ||| S:32730 E:32734 ||| DT
N-terminus  ||| S:32734 E:32745 ||| JJ
of  ||| S:32745 E:32748 ||| IN
the  ||| S:32748 E:32752 ||| DT
protein  ||| S:32752 E:32770 ||| NN
( ||| S:32770 E:32771 ||| -LRB-
kind  ||| S:32771 E:32776 ||| NN
gifts  ||| S:32776 E:32782 ||| NNS
from  ||| S:32782 E:32787 ||| IN
Dr.  ||| S:32787 E:32791 ||| NNP
J.  ||| S:32791 E:32794 ||| NNP
Chernoff ||| S:32794 E:32802 ||| NNP
,  ||| S:32802 E:32804 ||| ,
Fox  ||| S:32804 E:32808 ||| NNP
Chase  ||| S:32808 E:32814 ||| NNP
Cancer  ||| S:32814 E:32831 ||| NNP
Center ||| S:32831 E:32837 ||| NNP
,  ||| S:32837 E:32839 ||| ,
Philadelphia ||| S:32839 E:32851 ||| NNP
,  ||| S:32851 E:32853 ||| ,
PA ||| S:32853 E:32855 ||| NNP
,  ||| S:32855 E:32857 ||| ,
[  ||| S:32857 E:32859 ||| -LRB-
47  ||| S:32859 E:32862 ||| CD
]  ||| S:32862 E:32864 ||| CD
) ||| S:32864 E:32865 ||| -RRB-
.  ||| S:32865 E:32867 ||| .
The  ||| S:32867 E:32871 ||| DT
pEBG-JNK  ||| S:32871 E:32880 ||| NN
was  ||| S:32880 E:32884 ||| VBD
a  ||| S:32884 E:32896 ||| DT
kind  ||| S:32896 E:32901 ||| NN
gift  ||| S:32901 E:32906 ||| NN
of  ||| S:32906 E:32909 ||| IN
Dr.  ||| S:32909 E:32913 ||| NNP
Bruce  ||| S:32913 E:32919 ||| NNP
Mayer  ||| S:32919 E:32925 ||| NNP
( ||| S:32925 E:32926 ||| -LRB-
Harvard  ||| S:32926 E:32934 ||| NNP
Medical  ||| S:32934 E:32942 ||| NNP
School ||| S:32942 E:32948 ||| NNP
,  ||| S:32948 E:32960 ||| ,
Boston ||| S:32960 E:32966 ||| NNP
,  ||| S:32966 E:32968 ||| ,
MA ||| S:32968 E:32970 ||| NNP
) ||| S:32970 E:32971 ||| -RRB-
.  ||| S:32971 E:32973 ||| .
The  ||| S:32973 E:32977 ||| DT
substrate  ||| S:32977 E:32987 ||| JJ
domain  ||| S:32987 E:32994 ||| NN
of  ||| S:32994 E:32997 ||| IN
Cas  ||| S:32997 E:33001 ||| NNP
( ||| S:33001 E:33002 ||| -LRB-
Fig.  ||| S:33002 E:33007 ||| CD
1 ||| S:33007 E:33008 ||| CD
,  ||| S:33008 E:33010 ||| ,
a.a ||| S:33010 E:33013 ||| NNP
.  ||| S:33013 E:33015 ||| .
L  ||| S:33015 E:33027 ||| NNP
157to  ||| S:33027 E:33033 ||| NNP
R  ||| S:33033 E:33035 ||| NNP
516 ||| S:33035 E:33038 ||| CD
)  ||| S:33038 E:33040 ||| -RRB-
was  ||| S:33040 E:33044 ||| VBD
amplified  ||| S:33044 E:33054 ||| VBN
by  ||| S:33054 E:33057 ||| IN
PCR  ||| S:33057 E:33061 ||| NNP
and  ||| S:33061 E:33065 ||| CC
fused  ||| S:33065 E:33071 ||| NN
in  ||| S:33071 E:33074 ||| IN
frame  ||| S:33074 E:33080 ||| NN
to  ||| S:33080 E:33093 ||| TO
the  ||| S:33093 E:33097 ||| DT
C-terminus  ||| S:33097 E:33108 ||| JJ
of  ||| S:33108 E:33111 ||| IN
the  ||| S:33111 E:33115 ||| DT
attenuated  ||| S:33115 E:33126 ||| FW
SrcY416F  ||| S:33126 E:33135 ||| FW
kinase  ||| S:33135 E:33142 ||| FW
domain  ||| S:33142 E:33159 ||| FW
( ||| S:33159 E:33160 ||| -LRB-
Src* ||| S:33160 E:33164 ||| NNP
) ||| S:33164 E:33165 ||| -RRB-
,  ||| S:33165 E:33167 ||| ,
or  ||| S:33167 E:33170 ||| CC
to  ||| S:33170 E:33173 ||| TO
the  ||| S:33173 E:33177 ||| DT
C-terminus  ||| S:33177 E:33188 ||| JJ
of  ||| S:33188 E:33191 ||| IN
the  ||| S:33191 E:33195 ||| DT
inactive  ||| S:33195 E:33204 ||| FW
SrcK295M  ||| S:33204 E:33223 ||| FW
kinase  ||| S:33223 E:33230 ||| FW
domain  ||| S:33230 E:33237 ||| FW
( ||| S:33237 E:33238 ||| -LRB-
Src  ||| S:33238 E:33242 ||| NNP
KM ||| S:33242 E:33244 ||| NNP
) ||| S:33244 E:33245 ||| -RRB-
.  ||| S:33245 E:33247 ||| .
Subfragments  ||| S:33247 E:33260 ||| NNP
of  ||| S:33260 E:33263 ||| IN
the  ||| S:33263 E:33267 ||| DT
Cas  ||| S:33267 E:33271 ||| JJ
substrate  ||| S:33271 E:33291 ||| JJ
domain  ||| S:33291 E:33298 ||| NN
were  ||| S:33298 E:33303 ||| VBD
generated  ||| S:33303 E:33313 ||| VBN
in  ||| S:33313 E:33316 ||| IN
the  ||| S:33316 E:33320 ||| DT
same  ||| S:33320 E:33325 ||| JJ
fashion ||| S:33325 E:33332 ||| NN
,  ||| S:33332 E:33334 ||| ,
with  ||| S:33334 E:33339 ||| IN
the  ||| S:33339 E:33353 ||| DT
N-terminal  ||| S:33353 E:33364 ||| JJ
subdomain  ||| S:33364 E:33374 ||| NNS
( ||| S:33374 E:33375 ||| -LRB-
a.a ||| S:33375 E:33378 ||| NNP
.  ||| S:33378 E:33380 ||| .
L  ||| S:33380 E:33382 ||| NNP
157to  ||| S:33382 E:33388 ||| NNP
A  ||| S:33388 E:33390 ||| NNP
324 ||| S:33390 E:33393 ||| CD
,  ||| S:33393 E:33395 ||| ,
1  ||| S:33395 E:33397 ||| CD
YKVP  ||| S:33397 E:33402 ||| JJ
motif  ||| S:33402 E:33418 ||| NN
and  ||| S:33418 E:33422 ||| CC
4  ||| S:33422 E:33424 ||| CD
YQXP  ||| S:33424 E:33429 ||| NN
motifs ||| S:33429 E:33435 ||| NNS
)  ||| S:33435 E:33437 ||| -RRB-
and  ||| S:33437 E:33441 ||| CC
the  ||| S:33441 E:33445 ||| DT
C-terminal  ||| S:33445 E:33456 ||| JJ
subdomain  ||| S:33456 E:33466 ||| NNS
( ||| S:33466 E:33467 ||| -LRB-
a.a ||| S:33467 E:33470 ||| NNP
.  ||| S:33470 E:33472 ||| .
S  ||| S:33472 E:33484 ||| NNP
325to  ||| S:33484 E:33490 ||| NNP
R  ||| S:33490 E:33492 ||| NNP
516 ||| S:33492 E:33495 ||| CD
,  ||| S:33495 E:33497 ||| ,
9  ||| S:33497 E:33499 ||| CD
YDXP  ||| S:33499 E:33504 ||| NN
motifs ||| S:33504 E:33510 ||| NNS
)  ||| S:33510 E:33512 ||| -RRB-
of  ||| S:33512 E:33515 ||| IN
Cas  ||| S:33515 E:33519 ||| NNP
amplified ||| S:33519 E:33528 ||| NN
.  ||| S:33528 E:33530 ||| .
Experiments  ||| S:33530 E:33552 ||| NNS
used  ||| S:33552 E:33557 ||| VBD
the  ||| S:33557 E:33561 ||| DT
chimeras  ||| S:33561 E:33570 ||| NN
expressed  ||| S:33570 E:33580 ||| VBD
either  ||| S:33580 E:33587 ||| RB
via  ||| S:33587 E:33591 ||| IN
the  ||| S:33591 E:33595 ||| DT
pJ3H  ||| S:33595 E:33600 ||| JJ
vector ||| S:33600 E:33606 ||| NN
,  ||| S:33606 E:33618 ||| ,
or  ||| S:33618 E:33621 ||| CC
the  ||| S:33621 E:33625 ||| DT
HA-tagged  ||| S:33625 E:33635 ||| JJ
chimera  ||| S:33635 E:33643 ||| JJ
subcloned  ||| S:33643 E:33653 ||| NN
into  ||| S:33653 E:33658 ||| IN
the  ||| S:33658 E:33662 ||| DT
expression  ||| S:33662 E:33683 ||| NN
vector  ||| S:33683 E:33690 ||| NN
pMEXneo  ||| S:33690 E:33698 ||| NNS
[  ||| S:33698 E:33700 ||| -LRB-
48  ||| S:33700 E:33703 ||| CD
]  ||| S:33703 E:33705 ||| -RRB-
.  ||| S:33705 E:33707 ||| .
The  ||| S:33707 E:33711 ||| DT
oncogene  ||| S:33711 E:33720 ||| JJ
v-crk  ||| S:33720 E:33726 ||| JJ
and  ||| S:33726 E:33730 ||| CC
its  ||| S:33730 E:33744 ||| PRP$
mutants  ||| S:33744 E:33752 ||| JJ
cloned  ||| S:33752 E:33759 ||| NN
into  ||| S:33759 E:33764 ||| IN
pMEXneo  ||| S:33764 E:33772 ||| NNS
have  ||| S:33772 E:33777 ||| VBP
been  ||| S:33777 E:33782 ||| VBN
described  ||| S:33782 E:33792 ||| VBN
[  ||| S:33792 E:33794 ||| -LRB-
49  ||| S:33794 E:33797 ||| CD
50  ||| S:33797 E:33800 ||| CD
]  ||| S:33800 E:33812 ||| -RRB-
.  ||| S:33812 E:33842 ||| .
Cell  ||| S:33842 E:33847 ||| NN
culture  ||| S:33847 E:33855 ||| NN
and  ||| S:33855 E:33859 ||| CC
transfection  ||| S:33859 E:33872 ||| NNS
and  ||| S:33872 E:33876 ||| CC
soft  ||| S:33876 E:33881 ||| JJ
agar  ||| S:33881 E:33896 ||| JJ
assays  ||| S:33896 E:33913 ||| JJ
Cos-7  ||| S:33913 E:33919 ||| NN
and  ||| S:33919 E:33923 ||| CC
NIH3T3  ||| S:33923 E:33930 ||| CD
cells  ||| S:33930 E:33936 ||| NNS
were  ||| S:33936 E:33941 ||| VBD
grown  ||| S:33941 E:33947 ||| VBN
in  ||| S:33947 E:33950 ||| IN
DMEM  ||| S:33950 E:33955 ||| NNP
containing  ||| S:33955 E:33976 ||| VBG
10 ||| S:33976 E:33978 ||| CD
%  ||| S:33978 E:33980 ||| NN
FCS  ||| S:33980 E:33984 ||| NNP
and  ||| S:33984 E:33988 ||| CC
antibiotics  ||| S:33988 E:34000 ||| NN
at  ||| S:34000 E:34003 ||| IN
37°C  ||| S:34003 E:34008 ||| CD
with  ||| S:34008 E:34013 ||| IN
5 ||| S:34013 E:34014 ||| CD
%  ||| S:34014 E:34016 ||| NN
CO  ||| S:34016 E:34030 ||| NNP
2  ||| S:34030 E:34032 ||| CD
.  ||| S:34032 E:34034 ||| .
Cos-7  ||| S:34034 E:34040 ||| NNP
cells  ||| S:34040 E:34046 ||| NNS
were  ||| S:34046 E:34051 ||| VBD
transfected  ||| S:34051 E:34063 ||| VBN
by  ||| S:34063 E:34076 ||| IN
calcium  ||| S:34076 E:34084 ||| JJ
phosphate  ||| S:34084 E:34094 ||| JJ
method ||| S:34094 E:34100 ||| NN
,  ||| S:34100 E:34102 ||| ,
while  ||| S:34102 E:34108 ||| IN
the  ||| S:34108 E:34112 ||| DT
NIH3T3  ||| S:34112 E:34119 ||| CD
cells  ||| S:34119 E:34125 ||| NNS
were  ||| S:34125 E:34140 ||| VBD
transfected  ||| S:34140 E:34152 ||| VBN
using  ||| S:34152 E:34158 ||| VBG
Lipofectin  ||| S:34158 E:34169 ||| NNP
( ||| S:34169 E:34170 ||| -LRB-
Gibco ||| S:34170 E:34175 ||| NNP
,  ||| S:34175 E:34177 ||| ,
BRL ||| S:34177 E:34180 ||| NNP
) ||| S:34180 E:34181 ||| -RRB-
.  ||| S:34181 E:34183 ||| .
Growth  ||| S:34183 E:34190 ||| NN
of  ||| S:34190 E:34203 ||| IN
cells  ||| S:34203 E:34209 ||| NNS
in  ||| S:34209 E:34212 ||| IN
soft  ||| S:34212 E:34217 ||| JJ
agar  ||| S:34217 E:34222 ||| NN
was  ||| S:34222 E:34226 ||| VBD
performed  ||| S:34226 E:34236 ||| VBN
as  ||| S:34236 E:34239 ||| RB
described  ||| S:34239 E:34249 ||| VBN
[  ||| S:34249 E:34251 ||| -LRB-
51  ||| S:34251 E:34254 ||| CD
]  ||| S:34254 E:34266 ||| -RRB-
.  ||| S:34266 E:34296 ||| .
Cell  ||| S:34296 E:34301 ||| NNP
Lysis ||| S:34301 E:34306 ||| NNP
,  ||| S:34306 E:34308 ||| ,
Immunoprecipitation  ||| S:34308 E:34328 ||| NNP
and  ||| S:34328 E:34332 ||| CC
Kinase  ||| S:34332 E:34349 ||| NNP
Assays  ||| S:34349 E:34366 ||| NNP
Cell  ||| S:34366 E:34371 ||| NNP
lysis ||| S:34371 E:34376 ||| NN
,  ||| S:34376 E:34378 ||| ,
Immunoprecipitation ||| S:34378 E:34397 ||| NNP
,  ||| S:34397 E:34399 ||| ,
SDS-PAGE ||| S:34399 E:34407 ||| NNP
,  ||| S:34407 E:34409 ||| ,
and  ||| S:34409 E:34413 ||| CC
Western  ||| S:34413 E:34431 ||| JJ
blotting  ||| S:34431 E:34440 ||| NN
were  ||| S:34440 E:34445 ||| VBD
performed  ||| S:34445 E:34455 ||| VBN
exactly  ||| S:34455 E:34463 ||| RB
as  ||| S:34463 E:34466 ||| RB
described  ||| S:34466 E:34476 ||| VBN
[  ||| S:34476 E:34478 ||| -LRB-
48  ||| S:34478 E:34481 ||| CD
]  ||| S:34481 E:34483 ||| -RRB-
.  ||| S:34483 E:34495 ||| .
Tyrosine  ||| S:34495 E:34504 ||| JJ
phosphorylation  ||| S:34504 E:34520 ||| NN
of  ||| S:34520 E:34523 ||| IN
chimeras  ||| S:34523 E:34532 ||| NN
and  ||| S:34532 E:34536 ||| CC
other  ||| S:34536 E:34542 ||| JJ
substrates  ||| S:34542 E:34563 ||| NN
were  ||| S:34563 E:34568 ||| VBD
determined  ||| S:34568 E:34579 ||| VBN
following  ||| S:34579 E:34589 ||| VBG
immunoprecipitation  ||| S:34589 E:34609 ||| NNS
using  ||| S:34609 E:34615 ||| VBG
the  ||| S:34615 E:34629 ||| DT
indicated  ||| S:34629 E:34639 ||| JJ
antibodies  ||| S:34639 E:34650 ||| NNS
and  ||| S:34650 E:34654 ||| CC
probing  ||| S:34654 E:34662 ||| VBG
with  ||| S:34662 E:34667 ||| IN
RC20-HRP  ||| S:34667 E:34686 ||| CD
anti-phosphotyrosine  ||| S:34686 E:34707 ||| JJ
antibodies ||| S:34707 E:34717 ||| NNS
.  ||| S:34717 E:34719 ||| .
Expression  ||| S:34719 E:34730 ||| NN
of  ||| S:34730 E:34733 ||| IN
the  ||| S:34733 E:34747 ||| DT
chimeras  ||| S:34747 E:34756 ||| NN
was  ||| S:34756 E:34760 ||| VBD
determined  ||| S:34760 E:34771 ||| VBN
with  ||| S:34771 E:34776 ||| IN
anti-HA  ||| S:34776 E:34784 ||| JJ
antibodies ||| S:34784 E:34794 ||| NNS
.  ||| S:34794 E:34796 ||| .
Western  ||| S:34796 E:34814 ||| JJ
blots  ||| S:34814 E:34820 ||| NN
were  ||| S:34820 E:34825 ||| VBD
developed  ||| S:34825 E:34835 ||| VBN
using  ||| S:34835 E:34841 ||| VBG
ECL+  ||| S:34841 E:34846 ||| NNP
( ||| S:34846 E:34847 ||| -LRB-
Amersham  ||| S:34847 E:34856 ||| NNP
Pharmacia ||| S:34856 E:34865 ||| NNP
) ||| S:34865 E:34866 ||| -RRB-
.  ||| S:34866 E:34899 ||| .
Author ||| S:34899 E:34905 ||| NN
's  ||| S:34905 E:34908 ||| POS
contributions  ||| S:34908 E:34930 ||| NNS
AA  ||| S:34930 E:34933 ||| NN
carried  ||| S:34933 E:34941 ||| VBD
out  ||| S:34941 E:34945 ||| RP
the  ||| S:34945 E:34949 ||| DT
construction  ||| S:34949 E:34962 ||| NN
of  ||| S:34962 E:34965 ||| IN
the  ||| S:34965 E:34969 ||| DT
Src ||| S:34969 E:34972 ||| NNP
/ ||| S:34972 E:34973 ||| NNP
Cas  ||| S:34973 E:34977 ||| NNP
chimeras ||| S:34977 E:34985 ||| NN
,  ||| S:34985 E:34995 ||| ,
and  ||| S:34995 E:34999 ||| CC
characterized  ||| S:34999 E:35013 ||| VBD
the  ||| S:35013 E:35017 ||| DT
chimeras  ||| S:35017 E:35026 ||| NN
with  ||| S:35026 E:35031 ||| IN
the  ||| S:35031 E:35035 ||| DT
help  ||| S:35035 E:35040 ||| NN
of  ||| S:35040 E:35043 ||| IN
MK ||| S:35043 E:35045 ||| NNP
.  ||| S:35045 E:35047 ||| .
AA  ||| S:35047 E:35050 ||| NN
also  ||| S:35050 E:35063 ||| RB
performed  ||| S:35063 E:35073 ||| VBN
JNK  ||| S:35073 E:35077 ||| NNP
assays  ||| S:35077 E:35084 ||| NN
in  ||| S:35084 E:35087 ||| IN
transient  ||| S:35087 E:35097 ||| JJ
transfections ||| S:35097 E:35110 ||| NN
,  ||| S:35110 E:35112 ||| ,
analyzed  ||| S:35112 E:35129 ||| VBD
the  ||| S:35129 E:35133 ||| DT
association  ||| S:35133 E:35145 ||| NN
of  ||| S:35145 E:35148 ||| IN
the  ||| S:35148 E:35152 ||| DT
chimeras  ||| S:35152 E:35161 ||| NN
with  ||| S:35161 E:35166 ||| IN
crk  ||| S:35166 E:35170 ||| NN
and  ||| S:35170 E:35174 ||| CC
drafted  ||| S:35174 E:35182 ||| VBD
the  ||| S:35182 E:35194 ||| DT
manuscript ||| S:35194 E:35204 ||| NN
.  ||| S:35204 E:35206 ||| .
KHK  ||| S:35206 E:35210 ||| NNP
generated  ||| S:35210 E:35220 ||| VBD
stable  ||| S:35220 E:35227 ||| JJ
cell  ||| S:35227 E:35232 ||| NN
lines  ||| S:35232 E:35238 ||| NNS
carrying  ||| S:35238 E:35247 ||| VBG
the  ||| S:35247 E:35259 ||| DT
chimeras ||| S:35259 E:35267 ||| NN
,  ||| S:35267 E:35269 ||| ,
and  ||| S:35269 E:35273 ||| CC
characterized  ||| S:35273 E:35287 ||| VBD
these  ||| S:35287 E:35293 ||| DT
lines  ||| S:35293 E:35299 ||| NNS
in  ||| S:35299 E:35302 ||| IN
soft  ||| S:35302 E:35307 ||| JJ
agar  ||| S:35307 E:35320 ||| JJ
transformation  ||| S:35320 E:35335 ||| NN
assays ||| S:35335 E:35341 ||| NN
,  ||| S:35341 E:35343 ||| ,
activation  ||| S:35343 E:35354 ||| VBG
of  ||| S:35354 E:35357 ||| IN
JNK ||| S:35357 E:35360 ||| NNP
,  ||| S:35360 E:35362 ||| ,
tyrosine  ||| S:35362 E:35379 ||| JJ
phosphorylation  ||| S:35379 E:35395 ||| NN
of  ||| S:35395 E:35398 ||| IN
FAK ||| S:35398 E:35401 ||| NNP
,  ||| S:35401 E:35403 ||| ,
endogenous  ||| S:35403 E:35414 ||| VBG
Cas  ||| S:35414 E:35418 ||| NNP
and  ||| S:35418 E:35422 ||| CC
association  ||| S:35422 E:35434 ||| NN
of  ||| S:35434 E:35445 ||| IN
C3G  ||| S:35445 E:35449 ||| CD
with  ||| S:35449 E:35454 ||| IN
endogenous  ||| S:35454 E:35465 ||| JJ
crk ||| S:35465 E:35468 ||| NN
.  ||| S:35468 E:35470 ||| .
AA  ||| S:35470 E:35473 ||| NN
conceived  ||| S:35473 E:35483 ||| NN
of  ||| S:35483 E:35486 ||| IN
the  ||| S:35486 E:35490 ||| DT
study  ||| S:35490 E:35496 ||| NN
and  ||| S:35496 E:35500 ||| CC
HH  ||| S:35500 E:35511 ||| NNP
provided  ||| S:35511 E:35520 ||| VBD
intellectual  ||| S:35520 E:35533 ||| JJ
input ||| S:35533 E:35538 ||| NN
.  ||| S:35538 E:35540 ||| .
The  ||| S:35540 E:35544 ||| DT
manuscript  ||| S:35544 E:35555 ||| NN
was  ||| S:35555 E:35559 ||| VBD
written  ||| S:35559 E:35575 ||| VBN
with  ||| S:35575 E:35580 ||| IN
the  ||| S:35580 E:35584 ||| DT
input  ||| S:35584 E:35590 ||| NN
of  ||| S:35590 E:35593 ||| IN
all  ||| S:35593 E:35597 ||| PDT
the  ||| S:35597 E:35601 ||| DT
authors  ||| S:35601 E:35609 ||| NNS
and  ||| S:35609 E:35613 ||| CC
all  ||| S:35613 E:35617 ||| DT
authors  ||| S:35617 E:35625 ||| NNS
read  ||| S:35625 E:35630 ||| VBP
and  ||| S:35630 E:35642 ||| CC
approved  ||| S:35642 E:35651 ||| VBD
the  ||| S:35651 E:35655 ||| DT
final  ||| S:35655 E:35661 ||| JJ
version  ||| S:35661 E:35669 ||| NN
of  ||| S:35669 E:35672 ||| IN
the  ||| S:35672 E:35676 ||| DT
manuscript ||| S:35676 E:35686 ||| NN
.  ||| S:35686 E:35703 ||| .
